INDEX
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K10-K/A
☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 20202021
or
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________
COMMISSION FILE NUMBER 000-30205
CMC Materials, Inc.
(Exact name of registrant as specified in its charter)

Delaware
36-4324765
Delaware36-4324765
(State of Incorporation)(I.R.S. Employer Identification No.)

870 North Commons Drive
60504
Aurora, Illinois(Zip Code)
(Address of principal executive offices)
Registrant'sRegistrant’s telephone number, including area code: (630) 375-6631
Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.001 par value
CCMP
The NASDAQ Stock Market LLC
Securities registered pursuant to Section 12(g) of the Act:  None
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.       Yes    No
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes    No
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     Yes    No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes    No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large“large accelerated filer," "accelerated” “accelerated filer," "smaller” “smaller reporting company," and "emerging“emerging growth company"company” in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
 ☒
Large accelerated filerxAccelerated filerNon-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   o


Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes     No


INDEX
The aggregate market value of the registrant'sregistrant’s Common Stock held beneficially or of record by stockholders who are not affiliates of the registrant, based upon the closing price of the Common Stock on March 31, 2020,2021, as reported by the NASDAQ Global Select Market, was approximately $3,301,374,488.$5,125,185,387.  For the purposes hereof, "affiliates"“affiliates” include all executive officers and directors of the registrant.
As of October 31, 2020,January 7, 2022, the Company had 29,081,61728,568,967 shares of Common Stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE


Portions ofEXPLANATORY NOTE

This Amendment No. 1 on Form 10-K/A (this “Form 10-K/A”) to the registrant's definitive Proxy Statement for the Annual Meeting of Stockholders to be held on March 3, 2021, are incorporated by reference in Part III of this Annual Report on Form 10-K to the extent stated herein.
This Annual Report on Form 10-K includes statements that constitute "forward-looking statements" within the meaning of federal securities regulations. For more detail regarding "forward-looking statements" see Item 7 of Part II of this Annual Report on Form 10-K.


INDEX
CMC MATERIALS, INC.
FORM 10-K
FOR THE FISCAL YEAR ENDED SEPTEMBER 30, 2020
Page



INDEX
FORWARD-LOOKING STATEMENTS
This Annual Report on Form 10-K includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. This Act provides a safe harbor for forward-looking statements to encourage companies to provide prospective information about themselves so long as they identify these statements as forward-looking and provide meaningful cautionary statements identifying important factors that could cause actual results to differ from the projected results. All statements other than statements of historical fact we make in this Annual Report on Form 10-K are forward-looking and address a variety of subjects including, for example, future sales and operating results; growth or contraction, and trends in the industries and markets in which CMC Materials, Inc. ("CMC'', "the Company'', "us'', "we'', or "our''), participates, such as the semiconductor, and oil and gas industries; the acquisition of, investment in, or collaboration with other entities, including the Company’s acquisition of KMG Chemicals, Inc. (“KMG”), and the expected benefits and synergies of such acquisitions; divestment or disposition, or cessation of investment in certain of the Company’s businesses; new product introductions; development of new products, technologies and markets; product performance; the financial conditions of the Company's customers; the competitive landscape that relates to the Company's business; the Company's supply chain; natural disasters; various economic or political factors and international or national events, including related to global public health crises such as the COVID-19 pandemic ("Pandemic"), and the enactment of trade sanctions, tariffs, or other similar matters; the generation, protection and acquisition of intellectual property, and litigation related to such intellectual property or third party intellectual property; environmental, health and safety laws and regulations, and related compliance; the operation of facilities by the Company; the Company's management; foreign exchange fluctuation; the Company's current or future tax rate, including the effects of changes to tax laws in the jurisdictions in which the company operates; cybersecurity threats; financing facilities and related debt, pay off or payment of principal and interest, and compliance with covenants and other terms; and, uses and investment of the Company's cash balance, including dividends and share repurchases, which may be suspended, terminated or modified at any time for any reason by the Company, based on a variety of factors. Statements that are not historical facts, including statements about CMC’s beliefs, plans and expectations, are forward-looking statements. Such statements are based on current expectations of CMC’s management and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. Except as required by law, CMC undertakes no obligation to update forward-looking statements made by it to reflect new information, subsequent events or circumstances. The section entitled "Risk Factors" of this Annual Report on Form 10-K describes some, but not all, of the factors that could cause these differences.




INDEX
PART I
ITEM 1. BUSINESS
OUR COMPANY
CMC Materials, Inc., which was incorporated in the state of Delaware in 1999, is a leading global supplier of consumable materials to semiconductor manufacturers and pipeline companies. We operate our business within two reportable segments: Electronic Materials and Performance Materials.
RECENT DEVELOPMENTS
Effective October 1, 2020, the Company changed its name from “Cabot Microelectronics Corporation” to “CMC Materials, Inc.” Our new name reflects our expanded product offerings and industries in which we participate following our acquisition of KMG in fiscal 2019 (the “Acquisition”).
We completed the Acquisition on November 15, 2018 (“Acquisition Date”), and since then we have included the results of KMG, which produces and distributes specialty chemicals and performance materials for the semiconductor industry, pipeline and adjacent industries, and industrial wood preservation industry, in our consolidated results. For additional information, refer to Note 4 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
In the fourth quarter of fiscal 2019, we made a decision to close KMG-Bernuth, Inc.’s (“KMG-Bernuth”) Matamoros, Mexico and Tuscaloosa, Alabama wood treatment facilities and cease participating in the wood treatment business by approximately the end of calendar year 2021, and focus our strategy and future capital investments on our core businesses. Leading up to the planned closure of the Matamoros and Tuscaloosa facilities, we intend to continue to operate the existing facilities and serve our wood treatment customers. For additional information, refer to Note 10 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
ELECTRONIC MATERIALS SEGMENT
The Electronic Materials segment consists of our chemical mechanical planarization (“CMP”) slurries business, CMP polishing pads business, and our electronic chemicals business. These businesses supply consumable products used in integrated circuit (“IC”) device manufacturing and other aspects of the semiconductor and data storage industries.
IC devices, or "chips", are components in a wide range of electronic systems for computing, communications, manufacturing and transportation. The multi-step manufacturing process for IC devices typically begins with a circular wafer of pure silicon, then undergoes a process of alternating insulating and conducting layers until the desired wiring within the IC device is achieved. At the conclusion of the process, the wafer is cut into the individual IC devices, which are then packaged to form individual chips. Consumers most frequently encounter IC devices in smart phones and tablets, desktop or laptop computers, automotive applications, gaming devices, and televisions.
CMP SLURRIES AND CMP PADS
The Company develops, produces, and sells CMP slurries for polishing a wide range of materials used in IC devices, including tungsten, dielectric materials, copper, tantalum (commonly referred to as "barrier"), and aluminum, and for polishing bare silicon wafers, as well as disk substrates and magnetic heads used in hard disk drives. We also develop, manufacture, and sell CMP polishing pads, which are used in conjunction with slurries in the CMP process. Our CMP pads can be used on a variety of polishing tools and wafers, over a range of technology nodes and applications, including tungsten, copper, and dielectrics.
CMP slurries and pads (“CMP consumables”) are used to remove excess material that is deposited during the IC manufacturing process and to level and smooth the surfaces of the layers of IC devices via a combination of chemical reactions and mechanical abrasion, leaving minimal residue and defects on the surface, with only the material necessary for circuit integrity remaining. CMP enables IC device manufacturers to produce smaller, faster, and more complex IC with a greater density of transistors. CMP also helps reduce the number of defective or substandard IC devices, which increases the device yield. An effective CMP process is achieved through technical optimization of the CMP consumables in conjunction with an appropriately designed CMP process and generally requires slurries and pads to be qualified in its processes through an extensive series of tests and evaluations. While this qualification process varies depending on numerous factors, it is generally quite costly and may take six months or longer to complete. IC device manufacturers usually assess quality, cost, time required, and impact on production when they consider implementing or switching to a new CMP slurry or pad.
3

INDEX
ELECTRONIC CHEMICALS
In our electronic chemicals business, we offer semiconductor-grade wet chemicals with purities that extend to the parts-per-trillion (ppt) level. We produce and sell high-purity process chemicals through the formulation, purification, and blending of acids, solvents, and other wet chemicals primarily used to etch, clean, and dry silicon wafers during the production of semiconductors, photovoltaics (solar cells), and flat panel displays.
Our electronic chemicals products include sulfuric, phosphoric, nitric and hydrofluoric acids, ammonium hydroxide, hydrogen peroxide, isopropyl alcohol, other specialty organic solvents and various blends of chemicals. As the IC manufacturing process moves to more advanced technology nodes and the complexity of the process continues to increase, quality and purity of the materials becomes even more critical to the device yield. Increasing levels of purity and achieving lower levels of variation in our electronic chemicals business are required to enable next-generation IC technologies. Our advanced chemical purification technologies, including distillation, ion exchange, gas adsorption, and filtration, are designed to provide consistently low contaminant levels in a variety of high-purity process chemicals. We continue to work to develop industry-leading metrology and analytical methods to measure the purity levels achieved.
STRATEGY
Technology and innovation are vital to our Electronic Materials business, and we devote significant resources to research and development. We believe our focused effort on advanced technologies with technology-leading customers enables us to provide more compelling new products as semiconductor devices continue to advance. We focus our research and development activity to deliver innovative consumable products for advanced applications for our technology-leading customers. We have strategically located our research and development and clean room facilities, manufacturing operations, and related quality, field application, technical and customer support teams to be responsive to our customers' needs, which we believe provides us with a competitive advantage.
We also focus on building close relationships with our customers. We collaborate with them to identify and deliver new and improved solutions, to integrate our products into their manufacturing processes, and to assist them with supply, warehouse and inventory management.
We believe another competitive advantage is product and supply chain quality. Our customers demand continuous improvement in our products, in terms of product performance, quality and consistency. In pursuit of this, we work to continuously improve and innovate with respect to our own products, and as part of that, we require our raw materials suppliers, who provide us with certain important elements of our CMP slurries, pads and electronic chemicals, to do the same. We believe our capabilities in supply chain management and quality systems differentiate us from our competitors, and that our worldwide CMP consumables manufacturing plants and global network of suppliers also provide supply chain flexibility as needed. In our electronic chemicals business, we are responsible for product performance, purity levels and analytical testing, and in our view, our ability to maintain high quality levels and superior supply chain process is a competitive advantage.
INDUSTRY TRENDS
SEMICONDUCTOR INDUSTRY
Demand within the semiconductor industry is driven by smart phones, tablets, personal computers (“PCs”), servers, and a wide range of other electronic applications, including high-performance computing and artificial intelligence. Over time, overall semiconductor industry demand has fluctuated as a result of numerous factors, including the changing mix of demand drivers, semiconductor fab utilization, pressure to reduce costs, and the pace of technology advancement.
Over the past several years there has been a significant shift in semiconductor industry demand from IC devices for PCs to hand-held consumer electronic devices. Future demand for advanced semiconductor devices is expected to be driven by applications such as high performance computing, virtual and augmented reality, artificial intelligence, and 5G; demand for greater connectivity with wearables, peripherals, the internet of things, and increased semiconductor content in automobiles. While demand conditions may fluctuate, we continue to believe that semiconductor industry demand will grow over the long term based on increased usage of IC devices in existing applications, as seen in fiscal 2020 due to increased technology needs and renewed demand for PC’s due to “work from home” and remote learning as a result of the Pandemic, as well as future applications.
4

INDEX
Over the past several years, we have seen consolidation in the customer base within the semiconductor industry. Costs to achieve the required scale in manufacturing within the semiconductor industry continue to rise, along with the related costs of research and development, and larger manufacturers generally have greater access to the resources necessary to manage their businesses.
As demand for more advanced and lower cost electronic devices grows, there is ongoing pressure on IC device manufacturers to reduce their costs. Manufacturers have historically reduced cost and simultaneously improved device performance by migrating to smaller technology nodes. To achieve performance and cost improvements, semiconductor manufacturers are placing greater emphasis on new device architectures, including 3D memory and FinFET. Many manufacturers reduce costs by pursuing ever-increasing scale in their operations, while seeking to reduce their production costs by increasing their production yields regardless of their scale. However, as the industry continues to shrink dimensions, leading edge technology node transitions are becoming more challenging due to technical and physical obstacles, and the pace of technology change has slowed. Thus, they look for semiconductor materials products, such as CMP consumables and electronic chemicals, to help enable the achievement of technology progression with quality and performance attributes that can help them achieve their overall performance targets, cost structure, and to drive yield improvement.
DEMAND
Demand for our CMP consumables and electronic chemicals products reflects semiconductor industry demand patterns in terms of growth, cyclicality and seasonality, and varying demand for specific device types. Consistent with other participants in the semiconductor industry, we experienced relatively stable demand conditions in our fiscal 2020 despite global macroeconomic uncertainty caused by the Pandemic. Over the long term, we anticipate worldwide demand for CMP consumables and electronic chemicals used by IC device manufacturers to grow as a result of expected long-term growth in wafer starts, and the trend to more advanced technologies. With respect to CMP consumables, we believe there will continue to be an associated increase in the number of CMP polishing steps required to produce these advanced devices, and the introduction of new materials that are expected to require CMP. With respect to electronic chemicals, we believe there will be increasing demand as customers are transitioning to advanced technology nodes, which require an increasing number of processing steps used on each wafer and materials with higher purity levels.
COMPETITION
We compete in the semiconductor industry, which is characterized by technology advances, demanding requirements for product quality and consistency, and lower cost of ownership. We face competition from other suppliers of electronic materials.We believe we are the leading global supplier of CMP slurries, with a broad range of innovative solutions. Our CMP slurry competitors range from small companies that compete with a single product or in a single geographic region, to divisions of global companies with multiple lines of CMP products. With respect to CMP polishing pads, DuPont has held the leading position in this area for many years. Several other companies also participate in CMP consumables.
For our electronic chemicals business, there are various competitors with whom we compete in different regions. In North America, these include Honeywell, Kanto Corporation and Avantor. Outside the United States (U.S.), other providers in Europe are BASF, Technic and Honeywell, and in Asia, BASF and Kanto Corporation, among others. We believe our business in Europe is comparable to other providers, and other than in Singapore, at present we do not participate materially in the business in Asia.
CUSTOMERS, SALES, AND MARKETING
Within the semiconductor industry, our customers are generally producers of logic or memory IC devices, or providers of IC foundry services. Some logic customers, and so-called "fabless" companies, outsource some or all the production of their devices to foundries, which provide contract manufacturing services, in order to avoid the high cost of process development, construction and operation of a fab, or to provide additional capacity when needed.
We market our products primarily through direct sales to our customers, although we use distributors in certain areas. We believe this strategy of primarily direct sales provides us an additional means to collaborate closely with our customers and provides our customers with the most efficient means by which to procure our products. As part of our sales process, our logistics and sales personnel provide supply, warehouse and inventory management services for our customers.
For additional information on our customers, refer to Note 2 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
5

INDEX
RESEARCH, DEVELOPMENT AND TECHNICAL
As technology advances and semiconductor materials and designs increase in complexity, these challenges require significant investments in research, development and technical support (“R&D”), and we plan to continue to devote significant resources to R&D, and balance our efforts between shorter and longer-term industry needs.
Our global R&D team includes experts from the semiconductor industry and scientists and engineers from key disciplines required for the development of high-performance CMP consumable products. We operate CMP consumable product R&D facilities primarily in the U.S., with certain development capabilities in Taiwan and South Korea, in Singapore for data storage, and in Japan for silicon wafer products. We also operate electronic chemicals product development facilities in the U.S., Europe, and Singapore.
RAW MATERIALS SUPPLY
Engineered abrasive particles are significant raw materials we use in many of our CMP slurries. Our strategy is to secure various sources of different raw materials, as appropriate, to enable the desired performance of our products, and monitor those sources as necessary to provide supply assurance. We have multi-year supply agreements with several suppliers for the purchase of raw materials in the interest of supply and quality assurance, and to control costs.
In our electronic chemicals business, we rely on a variety of suppliers for our raw materials, some of which we purchase pursuant to purchase orders, and others which we purchase under supply contracts. The number of suppliers is often limited, particularly as to the specific grade of raw material required by us to supply high purity products to our customers.
PERFORMANCE MATERIALS SEGMENT
Our Performance Materials segment includes our pipeline and industrial materials (“PIM”) business, wood treatment business, and precision optics business. We are a leading global provider of products, services, and solutions for optimizing pipeline throughput and maximizing performance and safety. Our PIM products include drag-reducing agents (“DRAs”), valve greases, cleaners and sealants, and related equipment supporting pipeline and adjacent industries. We also provide routine and emergency maintenance services as well as training for customers in the pipeline and adjacent industries worldwide. Through QED Technologies International, Inc. (“QED”), our precision optics business, we serve the precision optics industry with capital equipment, consumables, and services. KMG-Bernuth operates the wood treatment business, which manufactures and sells wood treatment preservatives made from pentachlorophenol (“penta”).
PIM PRODUCTS AND SERVICES
We are a leading global provider of performance products and services to pipeline companies. We supply DRAs, valve greases, cleaners and sealants, and related services and equipment, including routine and emergency valve maintenance services and training, to customers in the pipeline and adjacent industries. Our PIM products and services provide value-added specialty products that optimize pipeline efficiency, lower operating costs, and enhance safety. We operate facilities for the manufacture, formulation and distribution of our products in the U.S. and Canada. Our PIM products are sold under the brands Flowchem, Sealweld, and Val-Tex.
We provide polymer-based DRAs for crude oil transmission. We have several product offerings to meet specific customer needs depending on the physical properties of the oil being pumped and various geographic climate conditions. Our products provide benefit to our customers by reducing the pressure loss in a pipeline due to turbulent flow within it. This allows pipeline operators to maximize product flow while maintaining safe operating pressure and reducing energy consumption.
We develop, manufacture, and sell products used for maintaining and extending the operational lifespan of lubricated isolation valves. We also service valves inline and under pressure through our field services division and provide accredited training to customers in the pipeline and adjacent industries globally.
6

INDEX
QED
QED is a leading provider of deterministic finishing and advanced measurement technology to the precision optics industry. We design and produce precision polishing and metrology systems for advanced optics applications that allow customers to attain near-perfect shape and surface finish on a range of optical components such as mirrors, lenses and prisms. QED's products also include magneto-rheological polishing fluids, consumables, spare and replacement parts, as well as optical polishing services and other customer support services. We are applying our technical expertise in polishing techniques to applications in other industries where shaping, enabling, and enhancing the performance of surfaces is critical to success. We believe precision optics are pervasive, serving several large existing industries such as semiconductor equipment, aerospace, defense, biomedical, research and digital imaging.
WOOD TREATMENT
The wood treatment preservatives business supplies penta-based products to industrial customers in the U.S. and Canada who use this preservative to pressure treat utility poles and crossarms to extend their useful life by protecting against insect damage and decay. Penta products include solid blocks, which are manufactured by KMG-Bernuth at its facility in Matamoros, Mexico, and penta concentrate liquid that is processed from penta blocks at KMG-Bernuth’s plant in Tuscaloosa, Alabama. We are the only manufacturer of penta-based preservatives in North America.
In the fourth quarter of fiscal 2019, we made a decision to close KMG-Bernuth’s Matamoros, Mexico and Tuscaloosa, Alabama wood treatment facilities and cease participating in the wood treatment business by approximately the end of calendar year 2021, and focus our strategy and future capital investments on our core businesses.Leading up to the planned closure of the Matamoros and Tuscaloosa facilities, we intend to continue to operate the existing facilities and serve our wood treatment customers. For additional information, refer to Note 9 and Note 10 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
STRATEGY
Our strategy for our Performance Materials segment focuses on expanding the PIM business, delivering high quality products to our customers, and driving demand for our products.
PIM PRODUCTS AND SERVICES
We focus on providing superior customer service to our customers while delivering consistent, high quality DRA products that meet their needs at a competitive price. We intend to continue to serve current customers as they bring new capacity online and to grow our business through attracting and serving new customers. In addition, we continue to develop other products focused on the pipeline transmission area for which we believe DRAs can serve currently unmet needs.
Additionally, we continue to work to drive demand for our products by promoting valve best practices to energy industry operators that align with current and trending global regulations and sustainable practices. Our primary focus is the promotion of our critical sealing products as an alternative to more costly mechanical solutions for achieving isolation in aged infrastructure.
QED
Our focus for QED is to provide innovative and industry-leading products and services to the precision optics industry. We continue to drive demand for our products to new and existing customers by developing new equipment and capabilities, pursuing emerging applications, and communicating the unique value offered by our products.
DEMAND
PIM PRODUCTS AND SERVICES
Demand for our PIM products and services is driven by new pipeline construction, increasing rate of adoption, oil and gas production capacity, and focus on safety for the aging infrastructure. Demand for our PIM products decreased significantly in the second half of fiscal 2020 as a result of the Pandemic and the related extreme global reduction in and restrictions related to plane, automotive, and industrial activity.
7

INDEX
QED
Demand for products produced by QED is typically driven by the trends in the underlying industries that utilize precision optics, such as semiconductor equipment, aerospace, defense, research, biomedical, and digital imaging. Since our primary QED business is the sale of capital equipment, our results are typically affected by levels of capital spending in these industries. Historically, capital spending is cyclical, and is impacted by general macroeconomic conditions, government spending and policies, as well as industry-specific trends and dynamics.
COMPETITION
In our PIM business, LiquidPower Specialty Products Inc. holds a leading position in DRAs, with Baker Hughes as another primary provider. For our additional PIM products and services, however, participants include numerous other businesses with none appearing to hold a leadership position.
In QED, there are few direct competitors but we believe our technology is unique and provides a competitive advantage to customers in the precision optics industry, which still relies heavily on traditional artisanal methods of fabrication.
In our wood treatment business, we are the only manufacturer of penta-based wood treatment preservatives in North America.
CUSTOMERS, SALES, AND MARKETING
PIM PRODUCTS AND SERVICES
We provide DRAs to several major mid-stream pipeline transmission companies both domestically and internationally. We have a U.S.-based sales network, a U.S.-based transportation and logistics operations, and a global network of distributors and agents to manage the sales and delivery of our products. For our additional PIM products and services, we market and sell to pipeline and adjacent industry customers, such as service companies, and major utility distribution companies via direct sales and channel partners.
QED
QED supports customers in the semiconductor equipment, aerospace, defense, research, biomedical, and digital imaging industries. QED counts among its worldwide customers leading precision optics manufacturers, major semiconductor original equipment manufacturers, research institutions, and contractors to the U.S. and other governments.
WOOD TREATMENT
We are the only manufacturer of penta-based wood treatment preservatives in North America and only supply penta to customers in the U.S. and Canada. We do not have other products or business in this area.
RESEARCH, DEVELOPMENT AND TECHNICAL
For our PIM products, we focus our U.S.-based research and development activities on both improving existing product performance as well as developing new products and technologies to serve our customers’ needs.
For QED, R&D activities are primarily focused on the development of new polishing and metrology capabilities, as well as additional capabilities for our polishing services group.
RAW MATERIALS SUPPLY
For both our PIM products and our wood treatment products, we depend on outside suppliers for the raw materials needed to produce them and are subject to fluctuations in the price of those materials, which we purchase from a limited number of suppliers. Most of QED’s is capital equipment-based, thus, there are minimal raw material supply issues that we face within this business unit.
8

INDEX
INTELLECTUAL PROPERTY
We believe our intellectual property is important to our success and ability to compete, and in addition to it, we also differentiate our products and technology by their high quality and reliability, and our quality systems, global supply chain and logistics. As of October 31, 2020, we had 1,301 active worldwide patents, of which 268 U.S. patents, and 344 pending worldwide patent applications, of which 45 are in the U.S.
Many of these patents are important to our continued development of new and innovative products for CMP and related processes, as well as for new businesses. Our patents have a range of duration. We attempt to protect our intellectual property rights through a combination of patent, trademark, copyright and trade secret laws, use of certain manufacturing technologies, exclusive contractual arrangements with suppliers, and with employee and third party-nondisclosure and assignment agreements. We refresh our intellectual property on an ongoing basis through continued innovation. We vigorously protect and defend our intellectual property and have been successful in this regard.
Most of our intellectual property has been developed internally, but we also may acquire intellectual property from others to enhance our intellectual property portfolio. These enhancements may be via licenses or assignments, or we may acquire certain proprietary technology and intellectual property when we make acquisitions. We believe these technology rights can enhance our competitive advantage by providing us with future product development opportunities and expanding our intellectual property portfolio.
ENVIRONMENTAL, SAFETY AND HEALTH AND OTHER REGULATORY MATTERS
ENVIRONMENTAL, SAFETY AND HEALTH MATTERS
Our facilities and operations are subject to various environmental, safety, and human health laws and regulations, both at a federal and state or local level, including those relating to air emissions, wastewater discharges, chemical manufacture and distribution, the handling and disposal of solid and hazardous wastes, storage and disposal, and various other occupational safety and health matters. Governmental authorities can enforce compliance with their regulations, and violators may be subject to civil, criminal, and administrative penalties, injunctions, or both. We believe that our facilities are in substantial compliance with applicable environmental laws and regulations. Our major operations in the U.S., Japan, Singapore, South Korea, Taiwan, France, Italy, and the United Kingdom are certified under current ISO 14001 Environmental and OHSAS 18001 Safety and Health standards, which require that we implement and operate according to various procedures that demonstrate waste reduction, energy conservation, injury reduction and other environmental, health and safety and sustainability objectives. We have achieved certification under the revised ISO 14001 standards and are now actively pursuing certification under revised OHSAS 18001 standards that will transition to ISO 45001 standards over the next three years. We have incurred, and will continue to incur, capital and operating expenditures and other costs in complying with environmental, safety and health laws and regulations in the U.S. and other countries in which we do business, but we do not expect these costs will be material. For additional information, refer to “Item, 1A. Risk Factors”, Item 3 “Legal Proceedings”, and Note 20 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
EMPLOYMENT AND LABOR RELATIONS MATTERS
We are subject to numerous foreign, federal, state and local government laws and regulations governing our relationships with our employees, including those relating to minimum wage, overtime, working conditions, hiring and firing, non-discrimination, work permits and employee benefits. We believe that our operations are conducted in compliance in all material respects with such laws and regulations. We have not experienced any significant work stoppages or disruptions to our business relating to employee matters. We believe that our relationship with our employees is good. For additional information, refer to “Item, 1A. Risk Factors.” and Item 1, Business, Environmental, Safety and Health and Other Regulatory Matters -- “Employees and Talent (Human Capital) Management.”
IMPORT AND EXPORT CONTROL AND RELATED MATTERS
We manufacture, market and sell our products both inside and outside the U.S. Certain products are subject to the Export Administration Regulations, administered by the U.S. Department of Commerce, Bureau of Industry and Security, which require that we obtain an export license before we can export certain controlled products or technology to specified countries. Additionally, some of our products are subject to the International Traffic in Arms Regulations, which restrict the export of information and material that may be used for military or intelligence applications by a foreign person. We also are subject to the import regulations administered by U.S. Customs and Border Protection, and to the regulations administered by the U.S. Department of the Treasury, Office of Foreign Assets Control, implementing economic sanctions against designated countries, governments, and persons based on U.S. foreign policy and national security considerations.
9

INDEX
Similar controls exist in other countries and regions. Failure to comply with these laws could result in sanctions by the U.S. or other respective government, including substantial monetary penalties, denial of import or export or other privileges and debarment from government contracts. We maintain an import and export compliance program under which we screen import and export and other transactions against current lists of restricted imports or exports or other transactions, destinations and end users with the objective of managing related decisions, transactions and shipping and banking logistics to comply with these requirements.
EMPLOYEES AND TALENT (HUMAN CAPITAL) MANAGEMENT
We believe our employees are the foundation of our success. Our overall talent acquisition and retention strategy is designed to attract and retain diverse and qualified candidates to meet our performance goals on an ongoing basis and enable the success of the Company.
We are focused on employee safety and health and a shared culture of results, caring, candor, and learning, which are foundations of our Company’s values, and are expressed in our Code of Business Conduct, to which all employees certify, and related policies and procedures in the countries in which we do business. With respect to employee health and safety measures, we focus on ongoing education with respect to environmental, health and safety (“EHS”) matters, and injury prevention and reduction across all our operations. We track injury rates on an ongoing basis and compare them to the average injury rates for chemical manufacturers as well as to semiconductor industry manufacturers; we believe we have been significantly below each of these industry averages for the past five years. In fiscal 2020 we urgently focused our EHS efforts around the world, including education and enhanced health and safety protocols, on employee well-being and prevention of the spread of the Pandemic at our facilities and in our communities. For additional information, refer to “Item 1A. Risk Factors.”
As of September 30, 2020, we employed 2,082 individuals, including 1,413 in operations, 252 in research and development and technical, 417 in sales, general and administration. Approximately 1,091 of these individuals located in the U.S. and approximately 991 of these individuals located outside of the U.S., with 716 in Asia Pacific, 199 in Europe and 76 in Canada and Mexico. With respect to gender diversity, we believe the percentage of women in our worldwide workforce is at least generally comparable to averages in the chemical and semiconductor industries. Of our Executive Officers 50% identify as female, and 50% identify as male.
In general, our employees are not covered by collective bargaining agreements, but we do have some workers who are subject to such agreements, part of workers’ councils, or similar arrangements, primarily in Europe, Mexico, and Singapore. We provide various employee benefits to our employees around the world. Some examples of this are: an employee stock purchase plan, a parental leave program, and a paid time off program to global employees; statutory health care and pension benefits to our employees outside the U.S.; and, a health and welfare benefits plan and a defined contribution savings plan to U.S. employees. See Note 18 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
FINANCIAL INFORMATION ABOUT GEOGRAPHIC AREAS
For financial information about geographic areas, see Note 23 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
AVAILABLE INFORMATION
Our annual reports on Form 10-K, quarterly reports on Form 10-Q, definitive proxy statements on Schedule 14A, current reports on Form 8-K, and any amendments to those reports, as well as any other filings with the Securities and Exchange Commission (“SEC”), are made available free of charge on our Company website, www.cmcmaterials.com, as soon as reasonably practicable after such reports are filed or furnished with the SEC. Our Code of Business Conduct and certain other governance documents are also available on our website, www.cmcmaterials.com. Statements regarding beneficial ownership of our securities by our executive officers and directors are made available on our Company website following the filing of such with the SEC. In addition, the SEC's website (http://www.sec.gov) contains reports, proxy statements, and other information that we file electronically with the SEC.
10

INDEX
ITEM 1A. RISK FACTORS
RISKS RELATING TO OUR BUSINESS, STRATEGY AND OPERATIONS
OUR BUSINESS AND RESULTS OF OPERATIONS MAY BE ADVERSELY AFFECTED BY THE CORONAVIRUS (COVID-19) PANDEMIC AND RELATED ADVERSE IMPACT TO WORLDWIDE ECONOMIC AND INDUSTRY CONDITIONS
The global spread of the Pandemic has created significant volatility, uncertainty and economic disruption across the world and in the countries and locations in which we and our customers and suppliers operate. In our third and fourth fiscal quarters of 2020, businesses in our Electronic Materials segment remained generally stable despite the Pandemic. With respect to our Performance Materials segment, the Pandemic had a significant adverse impact on our Performance Materials’ PIM business in our third and fourth fiscal quarters of 2020, as the demand for DRAs declined significantly due to the ongoing dislocation in the energy sector occasioned by the Pandemic as well as certain geopolitical factors, as described below. The extent to which the Pandemic may further impact our business, operations, results of operations and financial condition is uncertain and difficult to estimate, and depends on numerous evolving factors that we may not be able to accurately predict, which may include: A decrease in short-term and long-term demand and pricing for our products and services, and an ongoing global economic recession that could further reduce demand and/or pricing for our products and services resulting from actions taken by governments, businesses, or the general public in an effort to limit exposure to and spread of such infectious diseases, such as ongoing or renewed travel restrictions, quarantines, and business shutdowns or slowdowns; Negative impacts to our operations, including reductions in production levels, R&D activities, and qualification activities with our customers, and increased costs resulting from our efforts to mitigate the impact of the Pandemic through additional or continued social-distancing measures we have enacted at our locations around the world in an effort to protect our employees’ health and well-being (including working from home, reducing the number of employees or others in our sites at any one time and how such individuals perform work while at our sites, redesigning or adjusting our manufacturing, R&D and office facilities, and suspending or limiting employee travel); Deterioration of worldwide credit and financial markets that could limit our ability to obtain external financing to fund our operations and capital expenditures, result in losses on our holdings of cash and investments due to failures of financial institutions and other parties, and result in losses on our accounts receivables due to credit defaults or our customers’ inability to pay; and, Disruptions to our supply chain in connection with the sourcing of materials, equipment and logistics or other services and support necessary to our business as a result of the Pandemic and efforts to contain the spread of the Pandemic. To the extent possible if and when the Pandemic is contained or abates, the resumption of what was previously considered normal business operations after such interruption may be delayed or constrained by lingering effects of the Pandemic on our Company and our customers, suppliers, and third-party service providers. These effects, alone or taken together, could have a material adverse effect on our business, results of operations, legal exposure, or financial condition. A further sustained or prolonged outbreak or return of the Pandemic in the places in which we do business, such as is currently being experienced in the U.S. and Europe, could exacerbate the adverse impact of such measures on our Company.
11

INDEX
DEMAND FOR OUR PRODUCTS FLUCTUATES AND OUR BUSINESS MAY BE ADVERSELY AFFECTED BY WORLDWIDE ECONOMIC, INDUSTRY AND OTHER CONDITIONS
Our business is affected by economic and industry conditions, such as those currently being adversely affected by the Pandemic, and the majority of our revenue derives from our Electronic Materials segment, which is primarily dependent upon semiconductor industry demand. With respect to our Electronic Materials segment, historically, semiconductor industry demand has fluctuated due to economic and industry cycles and seasonal shifts in demand, which can affect our business, causing demand for our electronic materials products to fluctuate. For example, prior to the Pandemic, the relatively soft demand conditions in the semiconductor industry that had commenced in our second fiscal quarter of 2019 and continued into our first fiscal quarter of 2020 had begun to ameliorate in the beginning of the second fiscal quarter of 2020. However, although our Electronic Materials segment experienced relatively stable conditions during the third and fourth fiscal quarters of 2020, the ongoing nature of the Pandemic has created uncertainty as to demand conditions for the semiconductor industry going forward into our fiscal 2021 and beyond. Furthermore, competitive dynamics within the semiconductor industry may impact our business. Our limited visibility to future customer orders makes it difficult for us to predict industry trends, especially during unusual adverse circumstances, such as the Pandemic. If the global economy or the semiconductor industry weakens further, whether in general or as a result of the Pandemic or other specific factors, such as macroeconomic factors, or unpredictable events such as natural disasters, geopolitical conditions and international trade tensions, civil unrest, or additional global health crises, we could experience material adverse impacts on our results of operations and financial condition. Some additional factors that may affect demand for our electronic materials products include: demand trends for different types of electronic devices, such as logic versus memory IC devices, or digital versus analog IC devices; the various technology nodes at which those products are manufactured; customers' efficiencies in the use of CMP consumables and/or high-purity process chemicals (“electronic chemicals”); customers' device architectures and specific manufacturing processes; the short order to delivery time for our products; quarter-to-quarter changes in customer order patterns; market share and competitive gains and losses; and pricing changes by us and our competitors.
As to our Performance Materials segment, which continues to be an area of potential continued growth for us over the longer term, our PIM business may be impacted by changes in the utilities and/or oil and gas industries, such as we saw in our third and fourth fiscal quarters of 2020 resulting from ongoing significant dislocation in these industries occasioned by geopolitical disputes such as those that commenced in March 2020 between the Organization of Petroleum Exporting Countries ("OPEC") and Russia, and a confluence of an excess in oil capacity due to these factors and the ongoing Pandemic and efforts to contain the Pandemic. Relatedly, as described, volatility in oil and natural gas prices may impact our customers’ activity levels, including production, and as we saw during the third and fourth fiscal quarters of 2020, we experienced a significant drop in demand for our related PIM products and services. Expectations about future prices and price volatility are important in determining future spending levels for customers of our PIM products and services. The ongoing volatility in worldwide oil and natural gas prices and markets are an extreme example of historical volatility in this sector, and such volatility is likely to continue in the future. As is currently the case, prices for oil and natural gas are subject to wide fluctuations in response to relatively minor or major changes in the supply of and demand for oil and natural gas, market uncertainty and a variety of additional factors that are beyond our control. These factors include, but are not limited to, decreases or increases in supplies from U.S. shale production or other oil production, geopolitical conditions, including uprisings, civil unrest, and international trade tensions, sovereign debt crises, the domestic and foreign supply of oil and natural gas, the level of consumer demand due to economic growth or contraction such as currently seen related to the Pandemic, and other factors in countries such as China, weather conditions, domestic and foreign governmental regulations and taxes, the price and availability of alternative fuels, the health of international economic and credit markets, the ability of the members of the OPEC and other state-controlled oil companies to agree upon and maintain oil price and production controls, and general economic conditions, such as those currently seen related to the Pandemic.
Further, adverse global economic, industry and other conditions such as those related to the ongoing Pandemic could have other negative effects on our Company. For instance, we could experience negative impacts on cash flows due to the inability of our customers to pay their obligations to us, or our production processes could be harmed if our suppliers cannot fulfill their obligations to us. As a result of these or other conditions, we also might have to reduce the carrying value of goodwill and other intangible assets, which could harm our financial position and results of operations.
12

INDEX
WE MAY PURSUE ACQUISITIONS OF, INVESTMENTS IN, AND MERGERS OR STRATEGIC ALLIANCES WITH OTHER ENTITIES, WHICH COULD DISRUPT OUR OPERATIONS AND HARM OUR OPERATING RESULTS IF THEY ARE UNSUCCESSFUL, OR WE MAY ENCOUNTER UNANTICIPATED ISSUES IN IMPLEMENTING THEM
We expect to continue to make investments in technologies, assets and companies, either through acquisitions, mergers, investments or alliances, in order to supplement our organic growth and development efforts. Acquisitions, mergers, and investments, including our acquisitions of KMG, which we completed in November 2018, involve numerous risks, including the following: difficulties and risks in integrating the operations, technologies, products and personnel of acquired companies; difficulties and risks from unanticipated issues arising subsequent to a transaction related to the other entity; potential disruption of relationships with third parties such as customers or suppliers; diversion of management's attention from normal daily operations of the business; increased risk associated with foreign operations; potential difficulties and risks in entering markets or industries in which we have limited or no direct prior experience and/or where competitors have stronger positions; potential difficulties and unexpected situations arising in operating new businesses with different business models; facilities and operations; potential difficulties with regulatory or contract compliance in areas in which we have limited or no experience; initial dependence on unfamiliar supply chains or relatively small supply partners; insufficient revenue to offset increased expenses associated with acquisitions; potential loss of key employees of the acquired companies; or inability to effectively cooperate and collaborate with our alliance partners.
Further, we may never realize the perceived or anticipated benefits of a business combination or merger with, or asset or other acquisition of, or investments in, other entities. Transactions such as the Acquisition could and in some cases have had negative effects on our results of operations, in areas such as contingent liabilities, gross margins, amortization charges related to intangible assets and other effects of accounting for the purchases of other business entities. Investments in and acquisitions of technology-related or early-stage companies or assets are inherently risky because these businesses or assets may never develop, and we may incur losses related to these investments.
In addition, we may be required to impair the carrying value of these acquisitions or investments to reflect other than temporary declines in their value. The carrying value of goodwill represents the fair value of acquired businesses in excess of identifiable assets and liabilities as of the acquisition date. The carrying value of other intangible assets represents the fair value of customer relationships, tradenames and other acquired intangible assets as of the acquisition date. Goodwill and other acquired intangible assets expected to contribute indefinitely to our cash flows are not amortized, but must be evaluated for impairment by management at least annually. If the carrying value exceeds the implied fair value of goodwill, the goodwill is considered impaired and is reduced to fair value via a non-cash charge to earnings. If the carrying value of an indefinite-lived intangible asset is greater than its fair value, the intangible asset is considered impaired and is reduced to fair value via a non-cash charge to earnings. If the value of goodwill or other acquired intangible assets is impaired, our results of operations and financial condition could be adversely affected. Examples of asset impairment charges we recently incurred include the charge we took in the fourth quarter of fiscal 2019 and the fourth quarter of fiscal 2020 related to the KMG wood treatment business. Absent a sale of the wood treatment business, as we approach the previously announced closure date of the wood treatment facilities and there are fewer estimated future cash flows, we expect that the carrying value of the wood treatment asset group will not be recoverable, resulting in future impairments of intangible assets and goodwill. The amount of such impairments could be material and could adversely affect our results of operations and financial condition. See Notes 9 and 10 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for additional discussion.
Furthermore, the integration of the acquired businesses into our operations is a complex and time-consuming process that may not be successful. Our Company has a limited history of integrating significant acquisitions, and the process of integration may produce unforeseen operating difficulties and expenditures. As demonstrated in the Acquisition, the primary areas of focus for successfully combining those businesses with our operations may include and have included, among others: retaining and integrating key employees; realizing synergies; aligning customer and supplier interfaces, and operations across the combined business; integrating enterprise resource planning and other information technology systems; and, managing the growth of the combined company. Even if we successfully integrate an acquired business, such as KMG, into our operations, there can be no assurance that we will realize the anticipated benefits of the Acquisition.
13

INDEX
WE HAVE A CONCENTRATED PRODUCT RANGE WITHIN EACH OF OUR SEGMENTS AND OUR PRODUCTS MAY BECOME OBSOLETE, OR TECHNOLOGICAL CHANGES MAY REDUCE OR LIMIT INCREASES IN THE CONSUMPTION OF OUR PRODUCTS
Although our product offerings expanded with the Acquisition, our business remains substantially dependent on products in our Electronic Materials segment, such as CMP slurries, pads and electronic chemicals, which account for the majority of our revenue. We have identified our Performance Materials segment as another area of potential continued growth and the product offerings in our Performance Materials segment are similarly concentrated. As such, our business would suffer if these products became obsolete or if consumption of these products decreased. Our success depends on our ability to keep pace with technological changes and advances in the industries in which we operate, particularly the semiconductor industry, and to adapt, improve and customize our products in response to evolving customer needs and industry trends. Since its inception, the semiconductor industry, which is the largest industry in which we operate, has experienced technological changes and advances in the design, manufacture, performance and application of IC devices. Our customers continually pursue lower cost of ownership and higher quality and performance of materials consumed in their manufacturing processes, including CMP slurries and pads and electronic chemicals, as a means to reduce costs, increase the yield in their manufacturing facilities, and achieve desired performance of the IC devices they produce. We expect these technological changes, and this drive toward lower costs, higher quality and performance and higher yields, will continue in the future. Potential technology developments in the semiconductor industry, as well as our customers' efforts to reduce consumption of CMP consumables, including through use of smaller quantities, could render our products less important to the IC device manufacturing process.
A SIGNIFICANT AMOUNT OF OUR BUSINESS COMES FROM A LIMITED NUMBER OF LARGE CUSTOMERS AND OUR REVENUE AND PROFITS COULD DECREASE SIGNIFICANTLY IF WE LOST ONE OR MORE OF THESE CUSTOMERS OR BUSINESS FROM THEM
Our customer base is concentrated among a limited number of large customers in each of our segments. Currently, our principal business is to supply electronic materials primarily to the semiconductor industry. The semiconductor industry has been consolidating as the larger semiconductor manufacturers have generally grown faster than the smaller ones, through business gains, mergers and acquisitions, and strategic alliances. Industry analysts predict that this trend will continue, which means the semiconductor industry will continue to be comprised of fewer and larger participants in the future if their prediction is correct. In addition, our customer base in our pipeline-related businesses is also somewhat concentrated, with large entities predominant, and outside of the U.S., these entities frequently are state-owned or sponsored, and limited in number per country. One or more of these principal customers could stop buying products from us or could substantially reduce the quantity of products purchased from us. Our principal customers in both of our segments also hold considerable purchasing power, which can impact the pricing and terms of sale of our products. Any deferral or significant reduction in the quantity or price of products sold to these principal customers could seriously harm our business, financial condition and results of operations.
ANY PROBLEM OR DISRUPTION IN OUR SUPPLY CHAIN, INCLUDING SUPPLY OF OUR MOST IMPORTANT RAW MATERIALS, OR IN OUR ABILITY TO MANUFACTURE OR DELIVER OUR PRODUCTS TO OUR CUSTOMERS, COULD ADVERSELY AFFECT OUR RESULTS OF OPERATIONS
We depend on our supply chain to enable us to meet the demands of our customers. Our supply chain includes the raw materials we use to manufacture our products, our production operations and the means by which we deliver our products to our customers. Our business could be adversely affected by any problem or interruption in the supply of the key raw materials we use in our products, including raw materials that do not meet the stringent quality and consistency requirements of our customers, any problem or interruption that may occur during production or delivery of our products, such as weather-related problems, natural disasters, global public health crises such as the ongoing Pandemic, geopolitical, trade or labor-related issues, civil unrest, or any difficulty in producing sufficient quantities of our products to meet growing demand from our customers. In particular, severe weather conditions have the potential to adversely affect our operations, damage facilities and increase our costs, and those conditions may also have an indirect effect on our operations by disrupting services provided by service companies or suppliers with whom we have a business relationship. Additionally, some of our full-time employees are represented by labor unions, works councils or comparable organizations, particularly in Mexico and Europe. An extended work stoppage, slowdown or other action by our employees could significantly disrupt our business. As our current agreements with labor unions and works councils expire, we cannot provide assurance that new agreements will be reached at the end of each period without union action, or that a new agreement will be reached on terms satisfactory to us. Future labor contracts may be on terms that result in higher labor costs to us, which also could adversely affect our results of operations. Our supply chain may also be negatively impacted by unanticipated price increases due to supply restrictions beyond the control of our Company or our raw materials suppliers, such as those related to the Pandemic.
14

INDEX
We believe it would be difficult to promptly secure alternative sources of key raw materials in the event one of our suppliers becomes unable to supply us with sufficient quantities of raw materials that meet the quality and technical specifications required by us and our customers. In addition, new contract terms, forced production or manufacturing changes, contractual amendments to existing agreements with, or non-performance by, our suppliers, including any significant financial distress our suppliers may suffer, could adversely affect us. Also, if we change the supplier or type of key raw materials we use to make our products, in particular our electronic materials products, or are required to purchase them from a different manufacturer or manufacturing facility or otherwise modify our products, in certain circumstances our customers might have to requalify our products for their manufacturing processes and products. The requalification process could take a significant amount of time and expense to complete and could occupy technical resources of our customers that might otherwise be used to evaluate our new products, thus delaying potential revenue growth, or motivate our customers to consider purchasing products from our competitors, possibly interrupting or reducing our sales of products to these customers, especially sales of our electronic materials products to our semiconductor industry customers, but also with respect to our PIM products to our pipeline and adjacent industry customers.
OUR BUSINESS COULD BE SERIOUSLY HARMED IF OUR COMPETITORS DEVELOP COMPETITIVE PRODUCTS, OFFER BETTER PRICING, SERVICE OR OTHER TERMS, OR OBTAIN OR ASSERT CERTAIN INTELLECTUAL PROPERTY RIGHTS
Competition from other electronic materials or performance materials manufacturers or any new entrants could seriously harm our business and results of operations, and this competition could continue to increase. Competition has and will likely continue to impact the prices we are able to charge for our products, as well as our overall business. In addition, our competitors could have, obtain or assert intellectual property rights that could affect or restrict our ability to market our existing products and/or to innovate and develop new products, thus increasing our costs of doing business, could attempt to introduce products similar to ours following the expiration of our patents, or could attempt to introduce products that do not fall within the scope of our intellectual property rights.
WE ARE SUBJECT TO RISKS ASSOCIATED WITH OUR INTERNATIONAL OPERATIONS
We currently have operations and a large customer base outside the U.S. Approximately 65% of our revenue was generated by sales to customers outside the U.S. for the fiscal year ended September 30, 2020. We may encounter risks in doing business in certain countries other than the U.S., including, but not limited to, adverse changes in economic and political conditions, both in foreign locations and in the U.S. with respect to non-U.S. operations of U.S. businesses like ours, geopolitical and/or trade tensions, global health crises such as the ongoing Pandemic, civil unrest, fluctuation in exchange rates, changes in international trade requirements and sanctions and/or tariffs that affect our business and that of our customers and suppliers, compliance with a variety of foreign laws and regulations and related audits and investigations, as well as difficulty in enforcing business and customer contracts and agreements, including protection of intellectual property rights. We also may encounter risks that we may not be able to repatriate additional earnings from our operations outside of the U.S., derive anticipated tax benefits of these operations or recover the investments made in them, whether due to regulatory or policy changes in the U.S. or in the countries outside of the U.S. in which we do business, or other factors.
In particular, China continues to be an important market for the semiconductor industry, and an area of continued potential growth for us. As business between China and the rest of the world has continued to grow, there is risk that geopolitical, regulatory, trade, political and global public health crises such as the Pandemic could adversely affect business for companies like ours based on the complex relationships among China, the U.S., and other countries in the Asia Pacific region or elsewhere, which could have a material adverse impact on our business. In addition, there are risks that the Chinese government may, among other things, require the use of local suppliers, compel companies that do business in China to partner with local companies to conduct business, or, provide incentives to government-backed local customers to buy from local suppliers rather than companies like ours, all of which could adversely impact our business, including our results of operations. Also, as has been seen over our last fiscal year, there are risks that the U.S. government may impose additional export restrictions on technology and products that companies that operate in the semiconductor industry supply or use in China, which could adversely impact our business and our results of operations.
In addition, we have operations and customers located in the United Kingdom, which recently has exited the European Union (“EU”). Although the United Kingdom and the EU have agreed to operate under transitional provisions under which most EU law would remain in force in the United Kingdom until the end of December 2020, it is at present unclear as to what trade agreement the parties will operate under following such time, and what impacts such might have on our business.
15

INDEX
LEGAL, COMPLIANCE AND REGULATORY RISKS
WE ARE SUBJECT TO EXTENSIVE ENVIRONMENTAL LAWS AND REGULATIONS AND MAY INCUR COSTS THAT HAVE AN ADVERSE EFFECT ON OUR FINANCIAL CONDITION AS A RESULT OF VIOLATIONS OF OR LIABILITIES UNDER THEM
Like other companies involved in environmentally sensitive businesses, our operations and properties are subject to extensive and stringent federal, state, local and foreign EHS laws and regulations, including those concerning, among other things:
•    the marketing, sale, use and registration of our chemical products, such as penta, which is part of the wood treatment business in our Performance Materials segment;
•    the treatment, storage and disposal of wastes;
•    the investigation and remediation of contaminated media including but not limited to soil and groundwater;
•    the discharge of effluents into waterways;
•    the emission of substances into the air; and
•    other matters relating to environmental protection and various health and safety matters.
The United States Environmental Protection Agency (“EPA”) and other federal and state agencies in the U.S., as well as comparable agencies in other countries where we have facilities or sell our products, such as Canada or Mexico, have the authority to promulgate regulations that could have a material adverse impact on our operations. These EHS laws and regulations may require permits for certain types of operations, require the installation of expensive pollution control equipment, place restrictions upon operations or impose substantial liability for pollution and otherEHS concerns resulting from our operations. Compliance with EHS laws and regulations has resulted in ongoing costs for us and could restrict our ability to modify or expand our facilities, continue production, require us to install costly pollution control equipment, or incur significant other expenses, including environmental compliance costs. We continue to manage environmental compliance activities at certain sites, such as at KMG-Bernuth's Tuscaloosa, Alabama facility as described in Note 20 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K. We have incurred, and expect to continue to incur, significant costs to comply with EHS laws or to address liabilities for contamination resulting from past or present operations. Federal, state and foreign governmental authorities may seek fines and penalties, as well as injunctive relief, for violation of EHS laws and regulations, and could, among other things, impose liability on us to cleanup or mitigate environmental, natural resources or other damages resulting from a release of pesticides, hazardous materials or other chemicals into the environment. We maintain insurance coverage for sudden and accidental environmental damages. We do not believe that insurance coverage for environmental damage that occurs over time is available at a reasonable cost. Also, we do not believe that insurance coverage for the full potential liability that could be caused by sudden and accidental incidences is available at a reasonable cost. Accordingly, we may be subject to an uninsured or under-insured loss in such cases; although unknown at present, the KMG-Bernuth warehouse fire described in Note 20 of this Annual Report on Form 10-K may be such an instance.
The distribution, sale and use of our products is subject to prior governmental approvals and thereafter ongoing governmental regulation: Our products are subject to laws administered by federal, state and foreign governments, including regulations requiring registration, approval and labeling. The labeling requirements restrict the use and type of application for our products. More stringent restrictions could make our products less desirable which would adversely affect our sales and profitability. All venues where our penta products are used also require registration prior to marketing or use.
Governmental regulatory authorities have required, and may require in the future, that certain scientific testing and data production be provided on our products. Under the Federal Insecticide, Fungicide and Rodenticide Act (“FIFRA”), the EPA requires registrants to submit a wide range of scientific data to support U.S. registrations. This requirement significantly increases our Operating expenses, and we expect those expenses will continue in the future while we operate the wood treatment business. Because scientific analyses are constantly improving, we cannot determine with certainty whether or not new or additional tests may be required by regulatory authorities. While good laboratory practice standards specify the minimum practices and procedures that must be followed in order to ensure the quality and integrity of data related to these tests submitted to the EPA, there can be no assurance that the EPA will not request certain tests or studies be repeated. In addition, more stringent legislation or requirements may be imposed in the future. Amendments to the Toxic Substances Control Act could result in increased regulation and required testing of chemicals we manufacture and could increase the costs of compliance for our operations. We can provide no assurance that the cost of such compliance will not adversely affect our profitability. Our products could also be subject to other future regulatory action that may result in restricting or completely banning their use which could have an adverse effect on our performance and results of operations.

16

INDEX
1. The Registration, Evaluation and Authorization of Chemicals (“REACH”) legislation may affect our ability to manufacture and sell certain products in the EU: REACH requires chemical manufacturers and importers in the EU to prove the safety of their products. We were required to pre-register certain products and file comprehensive reports, including testing data, on each chemical substance, and perform chemical safety assessments. Additionally, substances of high concern are subject to an authorization process. Authorization may result in restrictions on certain uses of products or even prohibitions on the manufacture or importation of products. The full registration requirements of REACH have been phased in over several years, and we have incurred additional expense to cause the registration of our products under these regulations. REACH may also affect our ability to import, manufacture and sell certain products in the EU. In addition, other countries and regions of the world already have or may adopt legislation similar to REACH that affect our business, affect our ability to import, manufacture or sell certain products in these jurisdictions, and have required or will require us to incur increased costs.
2. The classification of penta as a Persistent Organic Pollutant (“POP”) under the Stockholm Convention may adversely affect our ability to manufacture or sell our penta products: The Conference of the Parties (“COP”) accepted the recommendation of the United Nations Persistent Organic Pollutant Review Committee that the use of penta should be banned except that its use for the treatment of utility poles and crossarms could continue for an extended period of five to ten years. KMG-Bernuth supplies penta to industrial customers who use it primarily to treat utility poles and crossarms. The U.S. is not bound by the determination of the COP because it did not ratify the Stockholm Convention treaty. Canada and Mexico are governed by the treaty. KMG-Bernuth's sole penta manufacturing facility is located in Matamoros, Mexico, and its processing facility is located in Tuscaloosa, Alabama. As a result of the classification of penta as a POP, the Mexican government requires KMG-Bernuth to cease producing penta in Mexico by the end of calendar year 2021. In July 2020, the Canadian government released a proposed order that sales and use of penta in Canada be ceased, but such proposed order is subject to a comment period and is not final, and no timing for any such order, if implemented, has been proposed. In October 2020, the EPA indicated it was inclined to issue a proposed order that provided alternatives, one similar to Canada’s proposed order and one that would provide reregistration according to certain additional occupational use parameters to those currently existing, but any such proposed order would be subject to a comment period, including with respect to the second alternative, would be expected to provide a transition period intended not to disrupt customers of penta. In July 2019, KMG-Bernuth had communicated plans to close both the Matamoros and Tuscaloosa facilities by the end of calendar year 2021 and to consolidate into and build a new facility. However, in November 2019, we communicated that we will not build a new facility, and that while we intend to explore various options for the wood treatment business we did not intend to continue the business past approximately the end of calendar year 2021. We took a restructuring charge and asset impairment charges in our fourth fiscal quarter of 2019 related to the decision to close the Matamoros and Tuscaloosa facilities and to not build a new plant, and as described further in Note 10 of this Annual Report on Form 10-K, we have taken an additional impairment charge in our fourth fiscal quarter of 2020 and expect to take additional impairment charges related to the wood treatment business through the end of calendar year 2021. No assurance can be given that we will not incur significant expenditures in connection with closing the facilities, or that the ultimate action of the COP and our related decisions will not adversely impact on our financial condition and results of operation.
3. If our products are not re-registered by the EPA or are re-registered subject to new restrictions, our ability to sell our products may be curtailed or significantly limited: as described above, KMG-Bernuth's penta product registrations are under continuous review by the EPA under FIFRA. The failure of KMG-Bernuth's products to be re-registered, to satisfy the registration review by the EPA, or the imposition of new use, labeling or other restrictions in connection with re-registration could have an adverse effect on our financial condition and results of operations.
4. Our use of hazardous materials exposes us to potential liabilities: Our manufacturing and distribution of chemical products, such as our electronic chemicals, involves the controlled use of hazardous materials. Our operations, therefore, are subject to various associated risks, including chemical spills, discharges or releases of toxic or hazardous substances or gases, fires, mechanical failure, storage facility leaks and similar events. Our suppliers are subject to similar risks that may adversely impact the availability of raw materials. While we adapt our manufacturing and distribution processes to the environmental control standards of regulatory authorities, we cannot completely eliminate the risk of accidental contamination or injury from hazardous or regulated materials, including injury of our employees, individuals who handle our products or goods treated with our products, or others who claim to have been exposed to our products, nor can we completely eliminate the unanticipated interruption or suspension of operations at our facilities due to such events. We may be held liable for significant damages or fines in the event of contamination or injury, and such assessed damages or fines could have an adverse effect on our financial performance and results of operations.
17

INDEX
CURRENT OR FUTURE CLIMATE CHANGE REGULATIONS COULD RESULT IN INCREASED OPERATING COSTS AND REDUCED DEMAND FOR OUR PRODUCTS
The U.S. has notified the United Nations of its intention to withdraw from the Paris Climate Agreement and to date, has not ratified the Kyoto Protocol. The Clean Air Act has been interpreted to regulate greenhouse gas (“GHG”) emissions and the EPA is using its existing regulatory authority to develop regulations requiring reduction in GHG emissions from various categories of sources, such as when a permit is required due to emissions of other pollutants. Because of the lack of any comprehensive legislation program addressing GHGs, a number of U.S. federal laws related to GHG emissions have been considered by the U.S. Congress from time to time and various state, local and regional regulations and initiatives have been enacted or are being considered related to GHGs.
Member States of the EU each have an overall cap on emissions, which are approved by the European Commission, and implement the EU Emissions Trading Directive as a commitment to the Kyoto Protocol. GHG emissions are regulated by Member States through the EU Emission Trading System and the EU Effort Sharing Decision/Regulation depending upon the industry sector. Organizations apply to the Member State for an allowance of GHG emissions. These allowances are tradable so as to enable companies that manage to reduce their GHG emissions to sell their excess allowances to companies that are not reaching their emissions objectives. Failure to purchase sufficient allowances will require the purchase of allowances at a current market price.
Any laws or regulations that may be adopted to restrict or reduce emissions of GHGs could cause an increase to our raw material costs, require us to incur increased operating costs, and have an adverse effect on demand for our products and our financial performance and results for our business.
In addition to GHG and climate change regulatory developments and legislation, we are continuing to evaluate and assess the potential impact on our business of the ongoing transition worldwide to a low carbon, resilient economy as well as physical effects resulting from climate change.
OUR PRODUCTS MAY BE RENDERED OBSOLETE OR LESS ATTRACTIVE BY CHANGES IN INDUSTRY REQUIREMENTS OR BY SUPPLY-CHAIN DRIVEN PRESSURES TO SHIFT TO ENVIRONMENTALLY PREFERABLE ALTERNATIVES
Changes in regulatory, legislative and industry requirements, or changes driven by supply-chain pressures, may shift current customers away from products using penta, products containing hazardous materials, or certain of our other products and toward alternative products that are believed to have fewer environmental effects. The EPA, foreign and state regulators, local governments, private environmental advocacy organizations, investors and investor advisory firms, and a number of large industrial companies have proposed or adopted policies designed to decrease the use of a variety of chemicals, including penta and others included in certain of our products, such as those containing hazardous materials. Our ability to anticipate changes in regulatory, legislative, investor and industryrequirements, or changes driven by supply-chain pressures, affects our ability to remain competitive. Further, we may not be able to comply with changed or new regulatory or industrial standards that may be necessary for us to remain competitive.
We cannot assure you that the EPA, foreign and state regulators or local governments will not restrict the uses of penta or certain of our other products or ban the use of one or more of these products or the raw materials in them. Similarly, companies who use our products may decide to reduce significantly or cease the use of our products voluntarily. As a result, our products may become obsolete or less attractive to our customers.
18

INDEX
GENERAL COMMERCIAL, OPERATIONAL, FINANCIAL AND REGULATORY RISKS
BECAUSE WE RELY ON OUR INTELLECTUAL PROPERTY, OUR FAILURE TO ADEQUATELY OBTAIN OR PROTECT IT COULD SIGNIFICANTLY HARM OUR BUSINESS
Protection of intellectual property is particularly important in the semiconductor industry, which is the primary industry in which we participate, because we develop complex technical formulas and processes for products that are proprietary in nature and differentiate our products from those of our competitors. Our intellectual property is important to our success and ability to compete. We attempt to protect our intellectual property rights through a combination of patent, trademark, copyright and trade secret laws, as well as employee and third-party nondisclosure and assignment agreements. In addition, we protect our product differentiation through various other means, such as proprietary supply arrangements for certain raw materials, and use of certain manufacturing technologies. Due to our international operations, we pursue protection in different jurisdictions, which may provide varying degrees of protection, and we cannot provide assurance that we can obtain adequate protection in each such jurisdiction. Our failure to obtain or maintain adequate protection of our intellectual property rights for any reason, including through the patent prosecution process or in the event of litigation related to such intellectual property, which we pursue when necessary to protect our rights against others who are found to be misusing our intellectual property, could seriously harm our business. In addition, certain types of intellectual property, such as patents, expire after a certain period of time, and products protected by our patents then lose such protection, so we refresh our intellectual property portfolio on an ongoing basis through continued innovation, and failure to do so could adversely affect our business. Also, the costs of obtaining or protecting our intellectual property could negatively affect our operating results.
OUR INABILITY TO ATTRACT AND RETAIN KEY PERSONNEL COULD CAUSE OUR BUSINESS TO SUFFER
We utilize and rely upon a global workforce. If we fail to attract and retain the necessary managerial, technical and customer support personnel, our business and our ability to maintain existing and obtain new customers, develop new products and provide acceptable levels of customer service could suffer. We compete worldwide with other participants in the industries in which we do business for qualified personnel, particularly those with significant experience in the semiconductor and pipeline industries. The loss of services of key employees, or our inability to obtain or maintain visas or other travel or residency documents on their behalf with respect to our business needs, could harm our business and results of operations. Periodically, we engage in succession planning for our key employees, and our Board of Directors reviews succession planning for our executive officers, including our chief executive officer, on an annual basis.
BECAUSE WE HAVE LIMITED EXPERIENCE IN BUSINESS AREAS OUTSIDE OF ELECTRONIC MATERIALS AND PERFORMANCE MATERIALS, EXPANSION OF OUR BUSINESS INTO OTHER PRODUCTS AND APPLICATIONS MAY NOT BE SUCCESSFUL
An element of our strategy has been to leverage our customer relationships, technological expertise and other capabilities and competencies to expand our business. For example, we have made acquisitions to expand beyond CMP consumables into other electronic materials product areas, as well as into performance materials product areas in which we have limited experience. Expanding our business into new product areas could involve technologies, production processes and business models in which we have limited experience, and we may not be able to develop and produce products or provide services that satisfy customers' needs, or we may be unable to keep pace with technological or other developments. Or, we may decide that we no longer wish to pursue these new business initiatives. Also, our competitors may have or obtain intellectual property rights that could restrict our ability to market our existing products and/or to innovate and develop new products.
TAX INCREASES OR CHANGES IN TAX RULES MAY ADVERSELY AFFECT OUR FINANCIAL RESULTS
As a company conducting business on a global basis, we are exposed, both directly and indirectly, to effects of changes in U.S., state, local and foreign tax rules. In December 2017, comprehensive tax legislation was enacted in the U.S. under the Tax Cuts and Jobs Act (the “Tax Act”). Known and certain estimated effects based upon current interpretation of the Tax Act have been incorporated into our financial results. Adjustments to income tax amounts could be material to our results of operations and cash flows. In addition, there is a risk that state or foreign jurisdictions may amend their tax laws, whether in response to the Tax Act or otherwise, which could have a material impact on our future results of operations and cash flows.
19

INDEX
CERTAIN CRITICAL INFORMATION SYSTEMS COULD BE SUSCEPTIBLE TO CYBERSECURITY AND OTHER THREATS
We maintain and rely upon certain critical information systems for the effective operation of our business. These information systems include, but are not limited to, telecommunications, the Internet, our corporate intranet, various computer hardware and software applications, network communications, and email. These information systems may be owned and maintained by us, our outsourced providers, or third parties such as vendors, contractors, and Cloud providers. All these information systems are subject to disruption, breach or failure from various sources including, but not limited to, attacks, degradation, and failures resulting from potential sources, including viruses, malware, denial of service, destructive or inadequate code, power failures, and physical damage. Confidential and/or sensitive information stored on these information systems, or transmitted to or from Cloud storage, could be intentionally or unintentionally compromised, lost, and/or stolen. While we have implemented security procedures and virus protection software, intrusion prevention systems, access control, and emergency recovery processes to mitigate risks like these with respect to information systems that are under our control, they are not fail-safe and may be subject to breaches. Further, we cannot assure that third parties upon whom we rely for various IT services will maintain sufficient vigilance and controls over their systems. Our inability to use or access these information systems at critical points in time, or unauthorized releases of personal or confidential information, could unfavorably impact the timely and efficient operation of our business, including our results of operations, and our reputation, as well as our relationships with our employees or other individuals whose information may have been affected by such cybersecurity incidents.
In addition, regulatory authorities have increased their focus on how companies collect, process, use, store, share and transmit personal data. Privacy security laws and regulations, including the United Kingdom's Data Protection Act 2018 and the EU General Data Protection Regulation 2016, and similar laws in countries such as Korea and Taiwan, among others, pose increasingly complex compliance challenges, which may increase compliance costs, and any failure to comply with data privacy laws and regulations could result in significant penalties that could adversely affect our business and results of operations.
OUR ABILITY TO RAISE CAPITAL IN THE FUTURE MAY BE LIMITED, WHICH COULD PREVENT US FROM GROWING, AND OUR EXISTING CREDIT AGREEMENT COULD RESTRICT OUR BUSINESS ACTIVITIES
In the future we may be required to raise capital through public or private financing or other arrangements. Such financing may not be available on acceptable terms, or at all, and our failure to raise capital when needed could harm our business. During the first quarter of fiscal 2020, the Company amended its credit agreement ("Amended Credit Agreement") to reduce the interest rate on term loan borrowings, under the Senior Secured Term Loan Facility under the Amended Credit Agreement ("Term Loan Facility"). Our Amended Credit Agreement contains financial and other covenants that may restrict our business activities or our ability to execute our strategic objectives, and our failure to comply with these covenants could result in a default under it. Furthermore, additional equity financing may dilute the interests of our common stockholders, and debt financing, if available, may involve restrictive covenants that could further restrict our business activities or our ability to execute our strategic objectives and could reduce our profitability. If we raise or borrow funds on acceptable terms, we may not be able to grow our business or respond to competitive pressures.
In addition, borrowings under our Amended Credit Agreement generally bear interest based on (a) a London Inter-bank Offered Rate (“LIBOR”), subject to a 0.00% floor, or (b) a base rate, in each case plus an applicable margin of, in the case of borrowings under the Term Loan Facility, 2.00% for LIBOR loans and 1.00% for base rate loans and, in the case of borrowings under the Amended Credit Agreement's revolving credit facility ("Revolving Credit Facility"), initially, 1.50% for LIBOR loans and 0.50% for base rate loans. On July 27, 2017, the Financial Conduct Authority (the authority that regulates LIBOR) announced that it intends to stop compelling banks to submit rates for the calculation of LIBOR after 2021. In the U.S., the Alternative Reference Rates Committee, the working group formed to recommend an alternative rate to LIBOR, has identified the Secured Overnight Financing Rate as its preferred alternative rate for USD LIBOR. When LIBOR ceases to exist after 2021, any calculation of interest based upon the Alternate Base Rate (or any comparable or replacement formulation), may result in higher interest rates. To the extent that these interest rates increase, our Interest expense will increase, which could adversely affect our financial condition, operating results and cash flows.
20

INDEX
THE MARKET PRICE FOR OUR COMMON STOCK MAY FLUCTUATE SIGNIFICANTLY AND RAPIDLY
The market price of our common stock has fluctuated and could continue to fluctuate significantly as a result of factors such as: economic, geopolitical, global public health, political and stock market conditions generally and specifically as they may impact participants in the semiconductor and related industries; and/or participants in oil and gas related industries; changes in financial estimates and recommendations by securities analysts who follow our stock; earnings and other announcements, and changes in market evaluations, by securities analysts, investors, market participants or others, of or related to, us or participants in the semiconductor and related industries; changes in business, trade or regulatory conditions affecting us or participants in the semiconductor and related industries; announcements or implementation by us, our competitors, or our customers of technological innovations, new products or different business strategies; changes in our capital deployment strategy, issuances of shares of our capital stock or entering into a business combination or other strategic transaction; and trading volume of our common stock. This has been evident since approximately March of 2020 in the wake of the significant adverse impact to global economic conditions of the Pandemic and also dislocation in the oil and gas sector.
ANTI-TAKEOVER PROVISIONS UNDER OUR CERTIFICATE OF INCORPORATION AND BYLAWS MAY DISCOURAGE THIRD PARTIES FROM MAKING AN UNSOLICITED BID FOR OUR COMPANY
Our certificate of incorporation and bylaws, and various provisions of the Delaware General Corporation Law may make it more difficult or expensive to effect a change in control of our Company. For instance, our amended and restated certificate of incorporation provides for the division of our Board of Directors into three classes as nearly equal in size as possible with staggered three-year terms.
We have adopted change in control arrangements covering our executive officers and other key employees. These arrangements provide for a cash severance payment, continued medical benefits and other ancillary payments and benefits upon termination of service of a covered employee's employment following a change in control, which may make it more expensive to acquire our Company.

ITEM 1B. UNRESOLVED STAFF COMMENTS
None.

ITEM 2. PROPERTIES
Our global headquarters and research and development facilities are located in Aurora, Illinois. As of September 30, 2020, we operated 46 facilities globally, of which 20 facilities are owned by the company and 26 are leased. The Company operates in 18 facilities located in the U.S. and 28 are outside the U.S. These facilities outside the Unites States include locations in Taiwan, Japan, South Korea, Singapore, China, Canada, Mexico, Italy, France, and the United Kingdom.
We believe that our facilities are suitable and adequate for their intended purpose and provide us with sufficient capacity and capacity expansion opportunities and technological capability to meet our current and expected demand in the foreseeable future. We intend to expand certain of our facilities to meet our anticipated business needs.

ITEM 3. LEGAL PROCEEDINGS
We periodically become a party to legal proceedings, arbitrations, regulatory proceedings, inquiries and investigations (“contingencies”) arising in the ordinary course of our business operations. The ultimate resolution of these contingencies is subject to significant uncertainty, and should we fail to prevail in any of them or should several of them be resolved against us in the same reporting period, these matters could, individually or in the aggregate, be material to our consolidated financial statements. The information set forth in Note 20 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K is incorporated by reference into this Item 3.

ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
21

INDEX

INFORMATION ABOUT OUR EXECUTIVE OFFICERS
Set forth below is information of our executive officers and their ages as of October 31, 2020.
NameAgePresent PositionFiscal Year Appointed to Current Position
Other Positions Held Between Fiscal 2016-20201
David H. Li47President and Chief Executive Officer2015
Scott D. Beamer49Vice President and Chief Financial Officer2018Vice President and Chief Financial Officer, Stepan Company, 2013-2018
H. Carol Bernstein60Vice President, Secretary and General Counsel2000
Jeffrey M. Dysard47Vice President and President, Performance Materials2019General Manager of CMP Slurries, 2018-2019; General Manager of CMP Pads, 2016-2018
Colleen E. Mumford44Vice President, Communications and Marketing2020Corporate Relations Director, 2018-2019; various other roles within the Company 1997-2018
Eleanor K. Thorp46Vice President, Human Resources2018Head of Human Resources and Recruiting at Sephora Digital SEA, 2015-2018
Daniel D. Woodland50Vice President and President, Electronic Materials2019Vice President and Chief Marketing and Operations Officer, 2017-2019; Vice President of Marketing, 2015-2017
Jeanette A. Press45Corporate Controller and Principal Accounting Officer2020Vice President and Principal Accounting Officer, Univar Solutions, 2019-2020; Vice President and Principal Accounting Officer, USG Corporation, 2014-2019

1Fiscal years for other positions held include partial years if held for any portion of that fiscal year
22

INDEX
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Our common stock is listed on the NASDAQ Global Select Market under the symbol “CCMP.” As of October 31, 2020, there were approximately 598 holders of record of our common stock. In January 2016, we announced that our Board of Directors authorized the initiation of a regular dividend program under which the Company intends to pay quarterly cash dividends on our common stock. The declaration and payment of future dividends is subject to the discretion and determination of the Company's Board of Directors and management, based on a variety of factors, and the program may be suspended, terminated or modified at any time for any reason.
ISSUER PURCHASES OF EQUITY SECURITIES
In January 2016, our Board of Directors authorized an increase in the amount available under our share repurchase program from the previously remaining $75.0 million to $150.0 million. Under this program, we repurchased 318 thousand shares for $35.0 million in fiscal 2020. There were no share repurchases under the share repurchase program in the fourth quarter of 2020. As of September 30, 2020, $36.3 million remained available under our share repurchase program. The manner in which the Company repurchases its shares is discussed in Part II, Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, under the heading "Liquidity and Capital Resources", of this Annual Report on Form 10-K. To date, we have funded share purchases under our share repurchase program from our available cash balance, and currently anticipate we will continue to do so.
Separate from this share repurchase program, a total of 25 thousand shares were withheld from equity award recipients to cover payroll taxes on the vesting of shares of restricted stock or restricted stock units during fiscal 2020 pursuant to the terms of our 2012 Omnibus Incentive Plan, as amended (“OIP”).
EQUITY COMPENSATION PLAN INFORMATION
See Part III, Item 12 of this Annual Report on Form 10-K for information regarding shares of common stock that may be issued under the Company's existing equity compensation plans.
23

INDEX
STOCK PERFORMANCE GRAPH
The following graph illustrates the cumulative total stockholder return on our common stock during the period from September 30, 2015 through September 30, 2020 and compares it with the cumulative total return on the NASDAQ Composite Index and the Philadelphia Semiconductor Index (PHLX). The comparison assumes $100 was invested on September 30, 2015 in our common stock and in each of the foregoing indices and assumes reinvestment of the quarterly cash dividends declared in each fiscal year from 2016 to 2020. The performance shown is not necessarily indicative of future performance. See "Risk Factors" in Part I, Item 1A above.


ccmp-20200930_g1.jpg

9/1512/153/166/169/1612/163/176/179/1712/173/18
CMC Materials, Inc.$100.00 $113.01 $106.08 $110.24 $138.24 $165.51 $201.28 $194.50 $211.12 $249.02 $284.53 
NASDAQ Composite$100.00 $108.71 $106.07 $105.82 $116.42 $118.35 $130.34 $135.77 $144.00 $153.43 $157.40 
PHLX Semiconductor$100.00 $110.57 $113.37 $116.60 $141.43 $154.05 $172.53 $177.48 $201.69 $216.50 $230.47 

6/189/1812/183/196/199/1912/193/206/209/20
CMC Materials, Inc.$286.77 $275.07 $256.40 $302.19 $298.28 $382.64 $393.45 $312.68 $383.49 $392.47 
NASDAQ Composite$167.81 $180.24 $149.07 $174.13 $180.86 $181.19 $203.77 $175.34 $229.60 $255.40 
PHLX Semiconductor$229.14 $239.39 $203.41 $246.85 $259.64 $278.63 $332.10 $272.48 $361.77 $408.20 

24

INDEX
ITEM 6. SELECTED FINANCIAL DATA
The following selected financial data for each year of the five-year period ended September 30, 2020 has been derived from the audited consolidated financial statements.

(In thousands, except per share amounts)Year Ended September 30,
20201,2,3
20191,2,3
20183
20172016
Consolidated Statements of Income:
Revenue$1,116,270 $1,037,696 $590,123 $507,179 $430,449 
Gross profit488,601 442,653 314,105 254,129 210,202 
Operating income216,905 110,496 160,118 111,988 74,508 
Net income142,828 39,215 110,043 86,952 59,849 
Diluted earnings per share$4.83 $1.35 $4.19 $3.40 $2.43 
Dividends declared per share$1.74 $1.66 $1.40 $0.78 $0.54 
Consolidated Balance Sheets:
Cash and cash equivalents$257,354 $188,495 $352,921 $397,890 $287,479 
Property, plant and equipment, net362,067 276,818 111,403 106,361 106,496 
Total assets4
2,376,467 2,261,766 780,973 834,100 727,230 
Long-term debt910,764 928,463 — 132,997 146,961 
Stockholders' equity1,074,313 980,377 666,692 595,037 497,648 
Total liabilities and stockholders' equity4
2,376,467 2,261,766 780,973 834,100 727,230 
Consolidated Statement of Cash Flows:
Net cash provided by operating activities$287,284 $174,981 $168,865 $141,369 $95,211 
Net cash used in investing activities(124,252)(1,232,976)(22,751)(19,783)(144,429)
Net cash provided by (used in) financing activities(97,656)894,432 (197,562)(7,015)(24,409)
Other Financial Data:
Adjusted EBITDA5
$357,801 $333,418 
Adjusted EBITDA margin5
32.1 %32.1 %
1 The results of the Acquisition have been included in the financial results since the Acquisition Date. In addition, as part of the Acquisition, the Company entered into a new credit agreement, which was amended in fiscal 2020. See Notes 4 and 13 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for a discussion of the Acquisition and Debt, respectively.
2 The results of fiscal 2020 and 2019 have been impacted by the impairment of the wood treatment reporting unit. See Note 10 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for a discussion of the impact of the impairments.
3 The Tax Act was passed in December 2017 and has impacted the effective tax rates for our fiscal years beginning in 2018. See Note 19 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for a discussion of the impact of the Tax Act.
4 The new accounting standards for Leases, adopted 10/1/2019, brought operating leases onto the balance sheet. See Note 14 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for a discussion of the impact of this new accounting standard.
5 See “Use of Certain GAAP and Non-GAAP Financial Information” later in Item 7 of this Report on Form 10-K for definitions and reconciliations of adjusted EBITDA and adjusted EBITDA margin. Prior to fiscal 2019, the Company did not provide these financial metrics.
25

INDEX
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following "Management's Discussion and Analysis of Financial Condition and Results of Operations" (MD&A) should be read in conjunction with our historical financial statements and "Notes to the Consolidated Financial Statements," which are included in Item 8 of Part II of this Annual Report on Form 10-K. For management's discussion and analysis of our results of operations for fiscal 2019 as compared to fiscal 2018 please refer to Part II, Item 7 "Management's discussion and analysis of financial condition and results of operations" on Form 10-K for our fiscal year ended September 30, 2019, filed with the SEC on November 27, 2019, which is incorporated herein by reference.

OVERVIEW
CMC is a leading global supplier of consumable materials to semiconductor manufacturers and pipeline companies. The Company’s electronic materials products play a critical role in the production of advanced semiconductor devices, helping to enable the manufacture of smaller, faster and more complex devices by its customers. The Company’s PIM products and services provide solutions for optimizing pipeline throughput and maximizing performance and safety.
Recent Developments and Items Impacting Comparability
The Company completed the Acquisition on the Acquisition Date and the Consolidated Financial Statements included in this Annual Report on Form 10-K include the financial results of KMG since that date. For additional information, refer to Part 1, Item 1, “Business”, in this Annual Report on Form 10-K.
In the fourth quarter of fiscal 2019, we made a decision to close KMG-Bernuth’s Matamoros, Mexico and Tuscaloosa, Alabama wood treatment facilities and cease participating in the wood treatment business by approximately the end of calendar year 2021, and focus our strategy and future capital investments on our core businesses.Until the planned closure of the Matamoros and Tuscaloosa facilities, we intend to continue to operate the existing facilities and serve our wood treatment customers.
The global spread of the Pandemic has created significant uncertainty and economic disruption worldwide and in the countries and locations in which we and our customers and suppliers operate. Our primary focus has been and continues to be on the health and well-being of our employees and the ongoing operation of our facilities worldwide according to our business continuity plans, which we update on an ongoing basis.
To date, we have not seen a meaningful impact from the Pandemic on our ability to manufacture and deliver products to our customers, but the Pandemic has negatively impacted some of the industries we serve, primarily the oil and gas industry. The Pandemic has exacerbated the impact of the continued geopolitical factors within the oil and gas industry, resulting in lower demand for our PIM products. Demand from our semiconductor industry customers, which represents approximately 80% of our revenue, remained stable in our fourth fiscal quarter as the work-from-home and remote learning environments benefited certain areas such as cloud, PCs and servers, offsetting weakness in industrial and automotive sectors of the industry.
The extent to which the Pandemic may further impact our business, operations, results of operations and financial condition going forward is uncertain and difficult to estimate, and depends on numerous evolving and potentially unknown factors.


26

INDEX
RESULTS OF OPERATIONS
The following table sets forth, for the periods indicated, the changes in balances on the consolidated statement of income along with the percentage of revenue of certain line items included in our historical statements of income:
Year Ended September 30,
(In thousands)20202019$ Change% Change
Revenue$1,116,270 100.0 %$1,037,696 100.0 %$78,574 7.6 %
Cost of sales627,669 56.2 %595,043 57.3 %32,626 5.5 %
Gross profit488,601 43.8 %442,653 42.7 %45,948 10.4 %
Research, development and technical52,311 4.7 %51,707 5.0 %604 1.2 %
Selling, general and administrative217,071 19.4 %213,078 20.5 %3,993 1.9 %
Asset impairment charges2,314 0.2 %67,372 6.5 %(65,058)(96.6)%
Total operating expenses271,696 24.3 %332,157 32.0 %(60,461)(18.2)%
Operating income216,905 19.4 %110,496 10.6 %106,409 96.3 %
Interest expense42,510 3.8 %45,681 4.4 %(3,171)(6.9)%
Interest income670 0.1 %2,346 0.2 %(1,676)(71.4)%
Other income (expense), net(1,718)(0.2)%(4,055)(0.4)%2,337 57.6 %
Income before income taxes173,347 15.5 %63,106 6.1 %110,241 174.7 %
Provision for income taxes30,519 2.7 %23,891 2.3 %6,628 27.7 %
Net income$142,828 12.8 %$39,215 3.8 %$103,613 264.2 %


27

INDEX
YEAR ENDED SEPTEMBER 30, 2020, AS COMPARED TO YEAR ENDED SEPTEMBER 30, 2019
REVENUE
Revenue was $1,116.3 million in fiscal 2020, which represented an increase of 7.6%, or $78.6 million, from fiscal 2019. The increase in revenue was primarily driven by the Acquisition. The increase was primarily due to the addition of the KMG businesses for the full period in fiscal 2020, selected price increases, and increased revenue from CMP slurries, offset by lower revenue from CMP pads.
COST OF SALES
Total Cost of sales was $627.7 million in fiscal 2020, which represented an increase of 5.5%, or $32.6 million, from fiscal 2019. The increase was primarily due to addition of the KMG businesses for the full period in fiscal 2020.
GROSS MARGIN
Our gross margin was 43.8% in fiscal 2020 compared to 42.7% in fiscal 2019. The increase was primarily due to price increases for our wood treatment products.
SELLING, GENERAL AND ADMINISTRATIVE
Selling, general and administrative expenses were $217.1 million in fiscal 2020, which represented an increase of 1.9%, or $4.0 million, from fiscal 2019. This was primarily due to a $24.7 million increase in amortization expense associated with re-valuing KMG assets to fair value during fiscal 2019 and $3.3 million increase in staffing-related costs, including incentive compensation costs primarily resulting from higher expense from the Short-Term Incentive Program (“STIP”), our annual cash incentive program, partially offset by a $24.4 million decrease in Acquisition and integration related expenses, as well as a $3.3 million decrease in travel expenses.
ASSET IMPAIRMENT CHARGES
Asset impairment charges were $2.3 million in fiscal 2020 compared to $67.4 million in fiscal 2019 due to impairment of the long-lived assets and intangible assets in the wood treatment asset group as a result of the planned closure of its facilities. See Note 10 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K.
INTEREST EXPENSE
Interest expense was $42.5 million in fiscal 2020, which represented a decrease of $3.2 million, from fiscal 2019. The decrease was primarily due to a decline in the LIBOR rate for the unhedged portion of the Company's Term Loan Facility, a lower outstanding term loan balance due to repayments, and a lower interest rate on our borrowings resulting from the refinancing of our Amended Credit Agreement in the first quarter of fiscal 2020. The decrease was partially offset by the longer period of time during which the Term Loan Facility was outstanding within the twelve months ended September 30, 2020 compared to the twelve months ended September 30, 2019.
PROVISION FOR INCOME TAXES
Our effective income tax rate was 17.6% in fiscal 2020 compared to 37.9% in fiscal 2019. The decrease in the effective tax rate during fiscal 2020 was primarily due to the absence of a discrete charge recorded in fiscal 2019 related to the final regulations issued under the Tax Act and the absence of unfavorable tax treatment of certain non-deductible costs related to the Acquisition.
NET INCOME
Net income was $142.8 million in fiscal 2020, which represented an increase of 264.2%, or $103.6 million, from fiscal 2019.  Net income benefited from the addition of the KMG businesses for the full period in fiscal 2020, lower Acquisition and integration-related expenses, and lower Asset impairment charges related to the wood treatment business, partially offset by amortization associated with re-valuing KMG assets to fair value.

28

INDEX
SEGMENT COMPARISON FOR THE FISCAL YEARS ENDED SEPTEMBER 30, 2020 AND SEPTEMBER 30, 2019
Revenue from external customers by segment and adjusted EBITDA/Margin are as follows:
(In thousands)Year Ended September 30,
20202019$ Change% Change
Segment Revenue:
Electronic Materials$882,824 $833,051 $49,773 6.0 %
Performance Materials233,446 204,645 28,801 14.1 %
Total Revenues$1,116,270 $1,037,696 $78,574 7.6 %
Adjusted EBITDA:
Electronic Materials$299,037 $294,902 $4,135 1.4 %
Performance Materials106,797 91,372 15,425 16.9 %
Unallocated corporate expenses(48,033)(52,856)4,823 9.1 %
Consolidated Adjusted EBITDA$357,801 $333,418 $24,383 7.3 %
Adjusted EBITDA Margin:
Electronic Materials33.9 %35.4 %-150 bpts
Performance Materials45.7 %44.6 %110 bpts


ELECTRONIC MATERIALS

The $49.8 million increase in Electronic Materials revenue was driven by a full year of KMG’s electronic chemicals business post-Acquisition and increased sales volume of CMP slurries, partially offset by lower CMP pads sales. The $4.1 million increase in adjusted EBITDA for Electronic Materials was driven by the revenue increases, as well as stronger profitability in CMP slurries, partially offset by higher fixed manufacturing costs. The 150 basis points decrease in adjusted EBITDA margin was primarily due to product mix.

PERFORMANCE MATERIALS

The $28.8 million increase in Performance Materials revenue was driven by higher selling prices for our wood treatment products and a full year of KMG’s performance materials businesses post-Acquisition. The $15.4 million increase in Performance Materials adjusted EBITDA and 110 basis points increase in Performance Materials adjusted EBITDA margin were primarily driven by higher selling prices for wood treatment products.
29

INDEX

USE OF CERTAIN GAAP AND NON-GAAP FINANCIAL INFORMATION
Certain financial measures contained in this Annual Report on Form 10-K adjust for the impact of specified items and are not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”). We provide certain non-GAAP financial measures, such as adjusted EBITDA and adjusted EBITDA margin, to complement reported GAAP results because we believe that analysis of our financial performance is enhanced by an understanding of these non-GAAP financial measures. We exclude certain items from earnings when presenting our adjusted EBITDA measure because we believe they will be incurred infrequently and/or are otherwise not indicative of the Company’s regular, ongoing operating performance. Accordingly, we believe that they aid in evaluating the underlying operational performance of our business, and facilitate comparisons between periods. In addition, adjusted EBITDA is used as one of the performance goals of our fiscal 2020 Short-Term Incentive Program. A similar adjusted EBITDA calculation is also used by our lenders for a key debt compliance ratio.

Adjusted EBITDA margin is defined as adjusted EBITDA as a percentage of revenue. Adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, adjusted for certain items that affect comparability from period to period. These adjustments include items related to the Acquisition, such as expenses incurred to complete the Acquisition and integration related expenses, costs of restructuring and asset impairment related to the wood treatment business and related adjustments, costs related to the KMG-Bernuth warehouse fire net of insurance recovery, costs related to the Pandemic net of grants received, and impact of fair value adjustments to inventory acquired from KMG.

The non-GAAP financial measures provided are a supplement to, and not a substitute for, the Company’s financial results presented in accordance with U.S. GAAP. Management strongly encourages investors to review the Company’s consolidated financial statements in their entirety and to not rely on any single financial measure. A reconciliation table of GAAP to non-GAAP financial measures is contained below.

Adjusted EBITDA for the Electronic Materials and Performance Materials segments is presented in conformity with Accounting Standards Codification Topic 280, Segment Reporting. This measure is reported to the chief operating decision maker for purposes of making decisions about allocating resources to the segments and assessing their performance. For these reasons, this measure is excluded from the definition of non-GAAP financial measures under the SEC Regulation G and Item 10(e) of Regulation S-K.

30

INDEX

RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA

The table below presents the reconciliation of Net income to adjusted EBITDA. Adjusted EBITDA is not a measurement of our financial performance under GAAP and should not be considered as an alternative to Net income. Adjusted EBITDA may have limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of our results as reported under GAAP.

(In thousands)Year Ended September 30,
202020192018
Net income$142,828 $39,215 $110,043 
Interest expense42,510 45,681 2,905 
Interest income(670)(2,346)(4,409)
Income taxes30,519 23,891 51,668 
Depreciation and amortization127,737 98,592 25,876 
EBITDA342,924 205,033 186,083 
Acquisition and integration related expense10,852 34,709 3,861 
Charges related to asset impairment of wood treatment business2,314 67,372 — 
Cost related to KMG-Bernuth warehouse fire, net of insurance recovery1,083 9,905 — 
Costs related to the Pandemic, net of grants received849 — — 
Charge for fair value write-up of acquired inventory sold— 14,869 — 
Net costs related to restructuring of the wood treatment business1
(221)1,530 — 
Adjusted EBITDA$357,801 $333,418 $189,944 
1 Represents adjustments to previously recorded severance liability related to the wood treatment business.


(In thousands)Year Ended September 30,
202020192018
Adjusted EBITDA
Electronic Materials$299,037 $294,902 $222,019 
Performance Materials106,797 91,372 7,191 
Unallocated Corporate Expenses(48,033)(52,856)(39,266)
Consolidated Adjusted EBITDA$357,801 $333,418 $189,944 


31

INDEX
LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 2020, we had $257.4 million of cash and cash equivalents compared with $188.5 million as of September 30, 2019. On September 30, 2020, $159.4 million of cash and cash equivalents was held in foreign subsidiaries. Our total liquidity as of September 30, 2020 was $457.4 million compared to $388.5 million as of September 30, 2019 (including $200.0 million of borrowing availability under our Revolving Credit Facility in both periods, which includes our letter of credit sub-facility). The increase in liquidity reflects the cash flow provided by operating activities, partially offset by the cash used by additions of property, plant and equipment, the repurchases of our common stock, and payments of quarterly cash dividends.
Total debt, consisting of principal outstanding on our Term Loan Facility, amounted to $921.4 million ($936.4 million in aggregate principal amount less $14.9 million of debt issuance costs) as of September 30, 2020 and $941.8 million ($959.7 million in aggregate principal amount less $17.9 million of debt issuance costs) as of September 30, 2019.
In March 2020, the Company drew $150.0 million under the Revolving Credit Facility as a precautionary measure in order to increase its cash position and preserve financial flexibility in light of uncertain global economic conditions resulting from the Pandemic. In September 2020, the Company repaid the amount outstanding under the Revolving Credit Facility, which had been unused in full, and as of September 30, 2020, had no remaining balance outstanding under the Revolving Credit Facility.
The Revolving Credit Facility requires that the Company maintain a maximum first lien secured net leverage ratio, as defined in the Amended Credit Agreement, of 4.00 to 1.00 as of the last day of each fiscal quarter. As of September 30, 2020, our maximum first lien secured net leverage ratio was 1.81 to 1.00. Additionally, the Amended Credit Agreement contains certain affirmative and negative covenants that limit the ability of the Company, among other things and subject to certain significant exceptions, to incur debt or liens, make investments, enter into certain mergers, consolidations, asset sales and acquisitions, pay dividends and make other restricted payments and enter into transactions with affiliates. We believe we are in compliance with these covenants as of September 30, 2020 and we expect to remain in compliance with our debt covenants during fiscal 2021 and beyond.
In January 2016, our Board of Directors authorized an increase in the amount available under our share repurchase program to $150.0 million. In fiscal 2020, we repurchased 318 thousand shares under this program, and $36.3 million authorization remained at the end of the year. The timing, manner, price and amounts of repurchases are determined at the Company's discretion, and the share repurchase program may be suspended, terminated or modified at any time for any reason. The repurchase program does not obligate the Company to acquire any specific number of shares. To date, we have funded share purchases under our share repurchase program from our available cash on hand, and anticipate we will continue to do so.
Our Board of Directors authorized the initiation of our regular quarterly cash dividend program in January 2016, and since that time has increased the dividend to its current level of $0.44 per share.  The declaration and payment of future dividends is subject to the discretion and determination of the Board of Directors and management, based on a variety of factors, and the program may be suspended, terminated or modified at any time for any reason.
We believe that cash on hand, cash available from future operations, and available borrowing capacity under our Amended Credit Agreement will be sufficient to fund our operations, expected capital expenditures, dividend payments, and share repurchases for at least the next twelve months. However, the current macroeconomic dislocation caused by the Pandemic has created uncertainty in worldwide economic conditions and in those of the industries in which we participate, and whether with respect to the impact of the Pandemic or in pursuit of corporate development or other initiatives, we may need to raise additional funds in the future through equity or debt financing, or other arrangements.  Depending on future conditions in the capital and credit markets, we could encounter difficulty securing additional financing in the type or amount necessary to pursue these objectives.
32

INDEX
Operating Activities
We generated $287.3 million in cash flows from operating activities in fiscal 2020, $175.0 million in fiscal 2019 and $168.9 million in fiscal 2018. Our cash provided by operating activities in fiscal 2020 reflected Net income of $142.8 million, $137.8 million in non-cash reconciling items, and decreases in working capital of $6.7 million. Non-cash reconciling items in fiscal 2020 included $127.7 million of depreciation and amortization expense, $16.4 million of share-based compensation expense, partially offset by $11.3 million of deferred income tax benefit. Our cash provided by operating activities in fiscal 2019 reflected Net income of $39.2 million and $175.2 million in non-cash reconciling items, partially offset by increases in working capital of $39.4 million. Non-cash reconciling items in fiscal 2019 included $98.6 million of depreciation and amortization expense, $67.4 million of wood treatment asset impairment charges, $18.2 million of share-based compensation expense, and $14.9 million of inventory step-up on acquired inventory sold, partially offset by $27.2 million of deferred income tax benefit. Our cash provided by operating activities in fiscal 2018 reflected Net income of $110.0 million and $66.8 million in non-cash reconciling items, partially offset by increases in working capital of $7.9 million. Non-cash reconciling items in fiscal 2018 included $25.9 million of depreciation and amortization expense, $18.5 million of share-based compensation expense, $11.3 million of deemed repatriation transition tax, and $10.8 million deferred income tax expense.
Investing Activities
In fiscal 2020, cash flows used in investing activities were $124.3, representing property, plant and equipment additions of $125.8 million, net of cash inflows of $1.6 million from the disposition of property. In fiscal 2019, cash flows used in investing activities were $1,233.0 million, representing property, plant and equipment additions of $56.0 million and $1,182.2 million used for the Acquisition, net of cash inflows of $5.2 million from insurance policies and disposition of property. The remainder of the Acquisition was satisfied with the issuance of common stock.  In fiscal 2018, cash flows used in investing activities were $22.8 million for purchases of property, plant and equipment.
Financing Activities
In fiscal 2020, cash flows used in financing activities were $97.7 million, which included $50.4 million of dividend payments, $38.2 million of cash used in stock repurchases, and $23.3 million of repayments on long-term debt. In fiscal 2019, cash flows provided from financing activities were $894.4 million. During the first quarter of fiscal 2019, we received $1,043.6 million in debt proceeds, net of $18.7 million in debt issuance costs and $2.7 million original discount fees, which was used for the Acquisition. This was partially offset by $105.3 million of repayments on this debt and $46.3 million of dividend payments during fiscal 2019. In fiscal 2018, cash used in financing activities were $197.6 million, which included $144.4 million of repayments on long-term debt, $30.7 million of dividend payments, and $44.3 million of cash used in stock repurchases.

OFF-BALANCE SHEET ARRANGEMENTS
At September 30, 2020 and 2019, we did not have any unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which might have been established for the purpose of facilitating off-balance sheet arrangements.

33

INDEX
TABULAR DISCLOSURE OF CONTRACTUAL OBLIGATIONS
The following summarizes our contractual obligations at September 30, 2020, and the effect such obligations are expected to have on our liquidity and cash flow in future periods.
CONTRACTUAL OBLIGATIONS
(In thousands)
TotalLess Than
1 Year
1-3
Years
3-5
Years
After 5
Years
Debt$936,363 $10,650 $21,300 $21,300 $883,113 
Interest expense and fees150,708 33,430 64,411 48,829 4,038 
Purchase obligations71,740 55,964 15,103 673 — 
Operating leases35,515 7,196 12,317 7,741 8,261 
Severance agreements896 891 — — 
Other long-term liabilities 1
27,939 256 13,455 264 13,964 
Total contractual obligations$1,223,161 $108,387 $126,591 $78,807 $909,376 
1We have excluded $112.2 million in deferred tax liabilities and $15.5 million of liabilities for uncertain tax positions from the other long-term liability amounts presented, as the amounts and timing of payments to be settled in cash are not known. We have also excluded $26.0 million related to the fair value of our interest rate swap.
INTEREST AND FEES ON LONG-TERM DEBT
Interest payments on long-term debt reflect interest rates in effect at September 30, 2020. The interest payments reflect LIBOR rates currently in effect on $365.4 million of our outstanding debt, and reflect fixed interest rates on $571.0 million of outstanding debt for which we have executed interest rate swaps. Commitment fees are based on our estimated consolidated leverage ratio in future periods. See Note 13 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for additional information regarding our long-term debt.
PURCHASE OBLIGATIONS
Purchase obligations include contractual commitments related to abrasive particle and non-water-based carrier fluid agreements.
OPERATING LEASES
Operating leases include future lease payments under operating leases.
SEVERANCE AGREEMENTS
Liabilities for severance agreements at September 30, 2020 represent payments to be made to former or to be former employees in accordance with individual agreements.
OTHER LONG-TERM LIABILITIES
Other long-term liabilities at September 30, 2020 primarily consist of $11.8 million asset retirement obligations and $9.3 million of liabilities related to our foreign benefit plans in Japan, South Korea, and France.
34

INDEX
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The Company’s accounting policies are more fully described in Note 2 of "Notes to the Consolidated Financial Statements" included in Part II, Item 8 of this Annual Report on Form 10-K of the Consolidated Financial Statements. As disclosed in Note 2, the preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingencies. Actual results may differ from these estimates under different assumptions or conditions.The Company believes that the following discussion addresses the Company’s most critical accounting policies, which are those that are most important to the portrayal of the Company’s financial condition and results of operations and require management’s most difficult, subjective and complex judgments.
GOODWILL AND OTHER INTANGIBLE ASSETS
We perform an annual impairment assessment of goodwill and other intangible assets at the reporting unit level as of September 30 of each year, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, we determine based on qualitative factors, such as macroeconomic, industry, legal, and financial performance, whether it is more likely than not that an impairment exists. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed.
Qualitative factors include industry and market considerations, overall financial performance, industry, legal and other relevant events and factors affecting the reporting unit. Additionally, as part of this assessment, we may perform a quantitative analysis to support the qualitative factors above by applying sensitivities to assumptions and inputs used in measuring a reporting unit’s fair value.
In our quantitative assessment, estimated fair value is determined using an average of a discounted cash flow model and a market approach based on earnings before interest, taxes, and depreciation for a group of guideline comparable companies. Factors requiring significant judgment include the selection of market comparable companies, projected future revenue and gross margin, discount rates, and terminal growth rates. The wood treatment reporting unit fair value is determined using the discounted cash flow model only. The use of different assumptions, estimates or judgments could significantly impact the estimated fair value of a reporting unit, and therefore, impact the excess fair value above carrying value of the reporting unit. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt.
We test the reasonableness of the inputs and outcomes of our discounted cash flow models against available market data. Two of the Company’s reporting units, wood treatment and PIM, are at risk of failing future impairment tests, as the September 30, 2020 estimates of fair value do not substantially exceed their carrying values. As previously announced, the Company is closing its wood treatment facilities by approximately the end of calendar year 2021. The fair value of the wood treatment asset group was sufficient such that the recognized impairment was limited to long-lived assets and the reporting unit goodwill was not impaired, however, as the Company approaches the closure date of the facilities and there are lower estimated future cash flows, the carrying value of the wood treatment asset group and reporting unit will not be recoverable, resulting in future impairments. The carrying value includes $35.0 million and $3.8 million of goodwill and intangible assets as of September 30, 2020, respectively. There is no excess fair value over the carrying value as of September 30, 2020.
For PIM, the estimated fair value of the reporting unit exceeded the carrying value by approximately 8%. PIM’s carrying value includes $318.2 million of goodwill and $46.0 million of trade-name intangible assets. Key assumptions in the goodwill test include projected future revenue and gross margin, a 10.5% discount rate, and a terminal growth rate of 3%. A 50 basis point change in the projected compound annual revenue growth rate, discount rate, or terminal growth assumption would not result in an impairment. The fair values for all other reporting units substantially exceeded their carrying value. Refer to Note 10 of “Notes to the Consolidated Financial Statements” included in Item 8 of Part II of this Annual Report on Form 10-K for more information regarding wood treatment.
The Flowchem LLC (“Flowchem”) trade name, an indefinite-lived intangible asset, was assessed for impairment using a relief from royalty approach. Factors requiring significant judgment include projected revenue, royalty rates, terminal growth rates, and discount rates.
Significant management judgment is required to estimate projected future revenue. All assumptions used in our impairment valuation for indefinite-lived intangible assets and goodwill are based on best available information and are consistent with internal forecasts and operating plans.
35

INDEX
ACCOUNTING FOR INCOME TAXES
We are subject to income taxes in the U.S. and numerous foreign jurisdictions. Accordingly, the determination of our provision for income taxes requires judgment, the use of estimates in certain cases and the interpretation and application of complex tax laws. Our effective income tax rate is affected by many factors, including changes in our assessment of certain tax contingencies, increases and decreases in valuation allowances, changes in tax law, outcomes of audits, and the mix of earnings among our U.S. and international operations.
We assess whether or not our deferred tax assets will ultimately be realized, and record an estimated valuation allowance on those deferred tax assets that may not be realized. Many factors are considered when assessing whether it is more likely than not that the deferred tax assets will be realized, including recent cumulative earnings, expectations of future taxable income, carryforward periods and other relevant quantitative and qualitative factors. The recoverability of the deferred tax assets is evaluated by assessing the adequacy of future expected taxable income from all sources, including reversal of taxable temporary differences, forecasted operating earnings and available tax planning strategies. This evaluation is based on best available information and are consistent with internal forecasts and operating plans.
We recognize the tax benefit of an uncertain tax position only if it is more likely than not that the tax position will be sustained by the taxing authorities, based on the technical merits of the position. When facts and circumstances change, we reassess these probabilities and record any changes in the financial statements as appropriate. This determination requires the use of judgment in evaluating our tax positions and assessing the timing and amounts of deductible and taxable items. See Note 19 of "Notes to the Consolidated Financial Statements" included in Part II, Item 8 of this Annual Report on Form 10-K for additional information on income taxes.
EFFECTS OF RECENT ACCOUNTING PRONOUNCEMENTS
See Note 2 of "Notes to the Consolidated Financial Statements" included in Part II, Item 8 of this Annual Report on Form 10-K for a description of recent accounting pronouncements.
36

INDEX
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
EFFECT OF CURRENCY EXCHANGE RATES AND EXCHANGE RATE RISK MANAGEMENT
We conduct business operations outside of the U.S. through our foreign operations. Most of our foreign operations maintain their accounting records in their local currencies. Consequently, period to period comparability of results of operations is affected by fluctuations in exchange rates. The primary currencies to which we have exposure are the Korean won, Japanese yen, the New Taiwan dollar, Euro, British pound, and Singapore dollar. Approximately 22% of our revenue is transacted in currencies other than the U.S. dollar. However, outside of the U.S., we also incur expenses that are transacted in currencies other than the U.S. dollar, which mitigates the exposure on the Consolidated Statements of Income. We periodically enter into forward contracts in an effort to manage foreign currency exchange exposure on our Consolidated Balance Sheets. However, we are unlikely to be able to hedge these exposures completely. We do not enter into forward contracts or other derivative instruments for speculative or trading purposes.
Currency fluctuations have not had a material impact on our Consolidated Statements of Income during fiscal years 2020, 2019 and 2018.  While currency fluctuations did not have a significant impact on other comprehensive income on our Consolidated Balance Sheets in fiscal 2018, they did have a significant impact in fiscal 2020 and 2019.  We recorded $19.3 million in currency translation gains and $8.5 million in currency translation losses, net of tax, during fiscal 2020 and 2019, respectively, which was included in other comprehensive income.
MARKET RISK AND SENSITIVITY ANALYSIS RELATED TO FOREIGN EXCHANGE RATE RISK
We have performed a sensitivity analysis assuming a hypothetical 10% additional adverse movement in foreign exchange rates.  As of September 30, 2020, the analysis demonstrated that such market movements would not have a material adverse effect on our consolidated financial position, results of operations or cash flows over a one-year period.  Actual gains and losses in the future may differ materially from this analysis based on changes in the timing and amount of foreign currency rate movements and our actual exposures.
37

INDEX
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS AND FINANCIAL STATEMENT SCHEDULE
Page
Consolidated Financial Statements:
Financial Statement Schedule:
All other schedules are omitted, because they are not required, are not applicable, or the information is included in the consolidated financial statements and notes thereto.
38

INDEX
Report of Independent Registered Public Accounting Firm
To the Board of Directors and Stockholders of CMC Materials, Inc.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of CMC Materials, Inc. and its subsidiaries (the “Company”) as of September 30, 2020 and 2019, and the related consolidated statements of income, of comprehensive income (loss), of changes in stockholders' equity and of cash flows for each of the three years in the period ended September 30, 2020, including the related notes and financial statement schedule listed in the index appearing under Item 15(a)(2) (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of September 30, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of September 30, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended September 30, 2020 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of September 30, 2020, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Change in Accounting Principle
As discussed in Note 2 to the consolidated financial statements, the Company changed the manner in which it accounts for leases as of October 1, 2019.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide
39

INDEX
reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Goodwill Impairment Assessment - Pipeline and Industrial Materials (“PIM”) and CMP Pads Reporting Units
As described in Notes 2 and 9 to the consolidated financial statements, the Company’s consolidated goodwill balance was $718.6 million at September 30, 2020, which included the PIM and CMP Pads reporting units.Goodwill is tested for impairment annually on September 30, or between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The goodwill impairment assessment is performed comparing the estimated fair value of the reporting units to their carrying amounts. Estimated fair values are determined using the average of a discounted cash flow model and a market approach based on earnings before interest, taxes, and depreciation for a group of guideline comparable companies. Factors requiring significant judgment include the selection of valuation approach and assumptions related to future revenue and gross margin, discount rates, and terminal growth rates.
The principal considerations for our determination that performing procedures relating to the goodwill impairment assessment of the PIM and CMP Pads reporting units is a critical audit matter are (i) the significant judgment by management when determining the fair value of the reporting units using the discounted cash flow models; (ii) the high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating the significant assumptions used in management’s fair value estimate related to future revenue, gross margin, terminal growth rate and the discount rate for the PIM reporting unit, and future revenue and gross margin for the CMP Pads reporting unit; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessment, including controls over the valuation of the Company’s PIM and CMP Pads reporting units.These procedures alsoincluded, among others, testing management’s process for determining the fair value estimate of the PIM and CMP Pads reporting units; evaluating the appropriateness of using the average of a discounted cash flow model and a market approach based upon relevant market multiples; testing the completeness and accuracy of underlying data used in the discounted cash flow models; and evaluating the significant assumptions used by management related to future revenue, gross margin, terminal growth rate and the discount rate for the PIM reporting unit, and future revenue and gross margin for the CMP Pads reporting unit. Evaluating management’s assumptions related to future revenue, gross margin, and terminal growth rate involved evaluating whether the assumptions used were reasonable considering (i) the current and past performance of the reporting units, (ii) the consistency with external market and industry data, and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the appropriateness of the discounted cash flow models and market approach and the reasonableness of the PIM discount rate assumption.

/s/ PricewaterhouseCoopers LLP
Chicago, Illinois
November 17, 2020

We have served as the Company’s auditor since 1999.
40

INDEX
CMC MATERIALS, INC
CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
Year Ended September 30,
202020192018
Revenue$1,116,270 $1,037,696 $590,123 
Cost of sales627,669 595,043 276,018 
Gross profit488,601 442,653 314,105 
Operating expenses:
Research, development and technical52,311 51,707 51,950 
Selling, general and administrative217,071 213,078 102,037 
Asset impairment charges2,314 67,372 
Total operating expenses271,696 332,157 153,987 
Operating income216,905 110,496 160,118 
Interest expense42,510 45,681 2,905 
Interest income670 2,346 4,409 
Other income (expense), net(1,718)(4,055)89 
Income before income taxes173,347 63,106 161,711 
Provision for income taxes30,519 23,891 51,668 
Net income$142,828 $39,215 $110,043 
Basic earnings per share (in dollars per share)$4.90 $1.37 $4.31 
Weighted average basic shares outstanding29,136 28,571 25,518 
Diluted earnings per share (in dollars per share)$4.83 $1.35 $4.19 
Weighted average diluted shares outstanding29,580 29,094 26,243 
The accompanying notes are an integral part of these consolidated financial statements.
41

INDEX
CMC MATERIALS, INC
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(In thousands)
Year Ended September 30,
202020192018
Net income$142,828 $39,215 $110,043 
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments19,286 (8,548)679 
Minimum pension liability adjustment1,047 (449)(26)
Net unrealized loss on cash flow hedges(10,711)(18,780)(63)
Other comprehensive income (loss), net of tax9,622 (27,777)590 
Comprehensive income$152,450 $11,438 $110,633 
The accompanying notes are an integral part of these consolidated financial statements.
42

INDEX
CMC MATERIALS, INC
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
September 30,
20202019
ASSETS
Current assets:
Cash and cash equivalents$257,354 $188,495 
Accounts receivable, less allowance for doubtful accounts of $583 at September 30, 2020, and $2,377 at September 30, 2019134,023 146,113 
Inventories159,134 145,278 
Prepaid expenses and other current assets26,558 28,670 
Total current assets577,069 508,556 
Property, plant and equipment, net362,067 276,818 
Goodwill718,647 710,071 
Other intangible assets, net670,964 754,044 
Deferred income taxes7,713 6,566 
Other long-term assets40,007 5,711 
Total assets$2,376,467 $2,261,766 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$49,254 $54,529 
Current portion of long-term debt10,650 13,313 
Accrued expenses, income taxes payable and other current liabilities121,442 103,618 
Total current liabilities181,346 171,460 
Long-term debt, net of current portion910,764 928,463 
Deferred income taxes112,212 121,993 
Other long-term liabilities97,832 59,473 
Total liabilities1,302,154 1,281,389 
Commitments and contingencies (Note 20)
Stockholders’ equity:
Common Stock Authorized: 200,000 shares, $0.001 par value; Issued: 39,914 shares at September 30, 2020 and 39,592 shares at September 30, 201940 40 
Capital in excess of par value of common stock1,019,803 988,980 
Retained earnings553,718 461,501 
Accumulated other comprehensive loss(14,104)(23,238)
Treasury stock at cost, 10,834 shares at September 30, 2020 and 10,491 shares at September 30, 2019(485,144)(446,906)
Total stockholders’ equity1,074,313 980,377 
Total liabilities and stockholders’ equity$2,376,467 $2,261,766 
The accompanying notes are an integral part of these consolidated financial statements.
43

INDEX
CMC MATERIALS, INC
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
Year Ended September 30,
202020192018
Cash flows from operating activities:
Net income$142,828 $39,215 $110,043 
Adjustments to reconcile Net income to net cash provided by operating activities:
Depreciation and amortization127,737 98,592 25,876 
Accretion on Asset Retirement Obligations599 530 
Provision for doubtful accounts443 432 185 
Share-based compensation expense16,396 18,227 18,517 
Deemed repatriation transition tax11,340 
Deferred income tax expense (benefit)(11,267)(27,150)10,835 
Non-cash foreign exchange (gain) loss(266)839 (873)
(Gain) on sale of assets(71)(36)(865)
Impairment of assets2,314 67,372 
Realized loss on the sale of available-for-sale securities96 
Non-cash charge on inventory step up of acquired inventory sold14,869 
Amortization of debt issuance costs3,123 2,884 
Other(1,239)(1,362)1,666 
Changes in operating assets and liabilities:
Accounts receivable13,075 (6,156)(12,068)
Inventories(12,337)(20,993)(442)
Prepaid expenses and other assets8,645 6,830 (5,818)
Accounts payable(2,861)1,163 128 
Accrued expenses, income taxes payable and other liabilities165 (20,275)10,245 
Net cash provided by operating activities287,284 174,981 168,865 
Cash flows from investing activities:
Additions to property, plant and equipment(125,839)(55,972)(21,308)
Proceeds from the sale of assets1,587 1,224 3,027 
Acquisition of a business, net of cash acquired(1,182,187)
Cash settlement of life insurance policy3,959 
Purchases of available-for-sale securities(209,048)
Proceeds from the sale and maturities of available-for-sale securities214,460 
Settlement of net investment hedge(9,882)
Net cash used in investing activities(124,252)(1,232,976)(22,751)
Cash flows from financing activities:
Repayment of long-term debt(23,313)(105,326)(144,375)
Dividends paid(50,383)(46,324)(30,730)
Repurchases of common stock(38,238)(14,720)(44,288)
Proceeds from issuance of stock14,427 17,210 23,031 
Proceeds from issuance of long-term debt1,062,337 
Proceeds from revolving line of credit150,000 
Repayment on revolving line of credit(150,000)
44

INDEX
Debt issuance costs(18,745)
Other financing activities(149)(1,200)
Net cash provided by (used in) financing activities(97,656)894,432 (197,562)
Effect of exchange rate changes on cash3,483 (863)6,479 
Increase (decrease) in cash and cash equivalents68,859 (164,426)(44,969)
Cash and cash equivalents at beginning of year188,495 352,921 397,890 
Cash and cash equivalents at end of year$257,354 $188,495 $352,921 
Supplemental disclosure of cash flow information:
Cash paid for income taxes (net of refunds received)$44,535 $35,432 $20,345 
Cash paid for interest45,281 39,181 2,464 
Purchases of property, plant and equipment in accrued liabilities and accounts payable at the end of the period5,365 8,690 1,975 
Equity consideration related to the acquisition of KMG Chemicals, Inc331,048 
Cash paid during the period for lease liabilities7,554 
Right of use asset obtained in exchange for lease liabilities7,435 
The accompanying notes are an integral part of these consolidated financial statements.
45

INDEX
CMC MATERIALS, INC
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY
(In thousands, except per share amounts)
Common
Stock
(shares)
Treasury
Stock
(shares)
Common
Stock
Capital
In Excess
of Par
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Stock
Total
Balance at September 30, 201735,231 9,948 $35 $580,938 $397,881 $3,949 $(387,766)$595,037 
Share-based compensation expense18,518 18,518 
Repurchases of common stock under Share Repurchase Program370 (40,726)(40,726)
Repurchases of common stock - other38 (3,562)(3,562)
Exercise of stock options488 19,278 19,279 
Issuance of restricted stock under Deposit Share Program93 300 300 
Issuance of stock under Employee Stock Purchase Plan50 3,464 3,464 
Net income110,043 110,043 
Dividends ($1.40 per share in dollars)(36,251)(36,251)
Foreign currency translation adjustment679 679 
Cash flow hedges(63)(63)
Minimum pension liability adjustment(26)(26)
Balance at September 30, 201835,862 10,356 $36 $622,498 $471,673 $4,539 $(432,054)$666,692 
Share-based compensation expense18,227 18,227 
Repurchases of common stock under Share Repurchase Program88 (10,002)(10,002)
Repurchases of common stock - other47 (4,850)(4,850)
Exercise of stock options313 13,194 13,195 
Issuance of common stock in connection with acquisition of KMG Chemicals, Inc.3,237 331,045 331,048 
Issuance of restricted stock under Deposit Share Program131 75 75 
Issuance of stock under Employee Stock Purchase Plan49 3,941 3,941 
Net income39,215 39,215 
Dividends ($1.66 per share in dollars)(48,454)(48,454)
Effect of the adoption of revenue recognition accounting standard(933)(933)
Foreign currency translation adjustment(8,548)(8,548)
Cash flow hedges(18,780)(18,780)
Minimum pension liability adjustment(449)(449)
Balance at September 30, 201939,592 10,491 $40 $988,980 $461,501 $(23,238)$(446,906)$980,377 
46

INDEX
Common
Stock
(shares)
Treasury
Stock
(shares)
Common
Stock
Capital
In Excess
of Par
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Treasury
Stock
Total
Balance at September 30, 201939,592 10,491 $40 $988,980 $461,501 $(23,238)$(446,906)$980,377 
Share-based compensation expense16,396 16,396 
Repurchases of common stock under Share Repurchase Program318 (35,009)(35,009)
Repurchases of common stock - other25 (3,229)(3,229)
Exercise of stock options181 9,491 9,491 
Issuance of restricted stock under Deposit Share Program95 150 150 
Issuance of stock under Employee Stock Purchase Plan46 4,786 4,786 
Net income142,828 142,828 
Dividends ($1.74 per share in dollars)(51,099)(51,099)
Effect of the adoption of the stranded tax effect accounting standard488 (488)
Foreign currency translation adjustment19,286 19,286 
Cash flow hedges(10,711)(10,711)
Minimum pension liability adjustment1,047 1,047 
Balance at September 30, 202039,914 10,834 $40 $1,019,803 $553,718 $(14,104)$(485,144)$1,074,313 
The accompanying notes are an integral part of these consolidated financial statements.
47

INDEX
CMC MATERIALS, INC
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
(In thousands, except per share amounts)
1. BACKGROUND AND BASIS OF PRESENTATION
On October 1, 2020, Cabot Microelectronics Corporation changed its name to CMC Materials, Inc. (“CMC”, “the Company”, “us”, “we”, or “our”'). CMC is a leading global supplier of consumable materials to semiconductor manufacturers and pipeline companies. The Company's products play a critical role in the production of advanced semiconductor devices, helping to enable the manufacture of smaller, faster and more complex devices by its customers. The Consolidated Financial Statements included in this Annual Report on Form 10-K include the financial results of KMG Chemicals, Inc. (“KMG”) since the Company’s acquisition of 100% of the outstanding stock of KMG (the “Acquisition”) on November 15, 2018 (the “Acquisition Date”).
Since the Acquisition, we operate our business within 2 reportable segments: Electronic Materials and Performance Materials. The Electronic Materials segment consists of our chemical mechanical planarization (“CMP”) slurries business, CMP pads business, and electronic chemicals business. The Performance Materials segment consists of our pipeline and industrial materials (“PIM”) business, wood treatment business and QED Technologies International, Inc. (“QED”) business.
The audited consolidated financial statements have been prepared by CMC pursuant to the rules of the Securities and Exchange Commission (“SEC”) and accounting principles generally accepted in the United States of America (“U.S. GAAP” or “GAAP”). 
In Note 19. Income Taxes of this Annual Report on Form 10-K, the presentation for the table with the reconciliation between the Federal statutory rate and the Provision for income taxes at our effective tax rate has been updated for the fiscal year’s 2019 and 2018 to conform to the current year’s presentation. The amounts for those fiscal years that related to a change in reserve position and included in “U.S. benefits from research and experimentation activities” and “Other, net” previously, are now presented separately under “Change in reserve positions.”

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
PRINCIPLES OF CONSOLIDATION
The Consolidated Financial Statements include the accounts of CMC Materials, Inc. and its subsidiaries. All intercompany transactions and balances between the companies have been eliminated.
USE OF ESTIMATES
The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience, current conditions, and on various other assumptions that we believe are reasonable under the circumstances. However, future events are subject to change and estimates and judgments routinely require adjustment.  Actual results may differ from these estimates under different assumptions or conditions.
CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
We consider investments in all highly liquid financial instruments with original maturities of three months or less to be cash equivalents. Short-term investments include securities generally having maturities of 90 days to one year. We did not own any securities that were considered short-term investments as of September 30, 2020 or 2019.
ACCOUNTS RECEIVABLE AND ALLOWANCE FOR DOUBTFUL ACCOUNTS
Trade accounts receivable are recorded at the invoiced amount and do not bear interest. We maintain an allowance for doubtful accounts for estimated losses resulting from the potential inability of our customers to make required payments. Our allowance for doubtful accounts is based on historical collection experience, adjusted for any specific known conditions or circumstances such as customer bankruptcies and increased risk due to economic conditions. Uncollectible account balances are charged against the allowance when we believe that it is probable that the receivable will not be recovered. Amounts charged to bad debt expense are recorded in Selling, general and administrative expenses.
48

INDEX
Our allowance for doubtful accounts changed during the fiscal year ended September 30, 2020 and 2019 as follows:

20202019
Beginning Balance$2,377 $1,900 
Amount of charge (benefit) to expense(1,122)432 
Deductions and adjustments(672)45 
Ending Balance at September 30$583 $2,377 
CONCENTRATION OF CREDIT RISK
Financial instruments that subject us to concentrations of credit risk consist principally of accounts receivable. We perform ongoing credit evaluations of our customers' financial conditions and generally do not require collateral to secure accounts receivable. Our exposure to credit risk associated with nonpayment is affected principally by conditions or occurrences within the semiconductor industry, pipeline and adjacent industries, and the global economy. We have not experienced significant losses relating to accounts receivable from individual customers or groups of customers.
Customers who represented more than 10% of consolidated revenue, all of which are in the Electronic Materials segment, are as follows:
Year Ended September 30,
202020192018
Intel15 %14 %*
Samsung Group (Samsung)11 %11 %18 %
Taiwan Semiconductor Manufacturing Co. (TSMC)**12 %
SK Hynix Inc.**10 %
* Customer did not represent more than 10% of consolidated revenue.
Of those customers who represented more than 10% of consolidated revenue, their net accounts receivable as a percentage of total net accounts receivable are as follows:
September 30,
20202019
Intel8.5 %8.1 %
Samsung Group (Samsung)7.0 %5.5 %

FAIR VALUES OF FINANCIAL INSTRUMENTS
The recorded amounts of cash, accounts receivable, and accounts payable approximate their fair values due to their short-term, highly liquid characteristics. Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The Financial Accounting Standards Board ("FASB") established a three-level hierarchy for disclosure based on the extent and level of judgment used to estimate fair value.  Level 1 inputs consist of valuations based on quoted market prices in active markets for identical assets or liabilities.  Level 2 inputs consist of valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in an inactive market, or other observable inputs.  Level 3 inputs consist of valuations based on unobservable inputs that are supported by little or no market activity.
INVENTORIES
Inventories are recorded on the first-in, first-out (FIFO) basis and are stated at the lower of cost or net realizable value. Finished goods and work in process inventories include material, labor and manufacturing overhead costs. We regularly review and write down the value of inventory as required for estimated obsolescence or lack of marketability. 
49

INDEX
PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment are recorded at cost. Depreciation is based on the following estimated useful lives of the assets using the straight-line method:

Land Improvements10-20 years
Buildings15-30 years
Machinery and equipment3-20 years
Furniture and fixtures5-10 years
Vehicles5-8 years
Information systems3-5 years
Assets under financing leasesThe shorter of the term of the lease or estimated useful life
Expenditures for repairs and maintenance are charged to expense as incurred.
LEASES
Effective October 1, 2019, the Company adopted the new lease accounting guidance which requires the recognition of a right of use asset and a corresponding lease liability for operating leases. The Company applies provisions of the guidance to operating leases with terms of more than twelve months for all lease classes except for real estate leases for which the guidance is applied to all leases. Additionally, the Company elected to account for non-lease components and lease components together as a single lease component for all asset classes. The Company’s lease transactions primarily consist of leases for facilities, equipment, and vehicles under operating leases. The Company does not have any material finance leases. Certain of the Company’s leases have an option to extend the lease term and the renewal period is included in determining the lease term for leases where the renewal option is reasonably certain to be exercised.
The new standard was adopted in our first quarter of fiscal 2020 using the modified retrospective transition method; however, we applied the optional transition adjustment that permits us to continue applying Topic 840 within the comparative periods disclosed.
ASSET RETIREMENT OBLIGATIONS
Our asset retirement obligations (“AROs”) include reclamation requirements as regulated by government authorities or contractual obligations for the removal or storage of hazardous materials, decontamination or demolition of above ground storage tanks, and certain restoration and decommissioning obligations related to certain of our owned and leased properties. The Company recognizes an ARO in the period in which it is incurred, if a reasonable estimate can be made. The accounting for ARO requires estimates by management about when and how the assets will be retired, the cost of retirement obligations, discount and inflation rates used in determining fair values and the methods of remediation associated with our AROs. We generally use assumptions and estimates that reflect the most likely remediation method. Our estimated liability for AROs is revised annually, and whenever events or changes in circumstances indicate that a revision to the estimate is necessary.
In subsequent periods, the Company recognizes accretion expense in Cost of sales increasing the ARO balances, such that the balance will ultimately equal the expected cash flows at the time of settlement. AROs are included in Other long-term liabilities on the Consolidated Balance Sheets.
The Company has multiple production facilities with an indeterminate useful life and there is insufficient information available to estimate a range of potential settlement dates for the obligation. Therefore, the Company cannot reasonably estimate the fair value of the liability. When a reasonable estimate can be made, an asset retirement obligation will be recorded, and such amounts may be material to the consolidated financial statements in the period in which they are recorded.
IMPAIRMENT OF LONG-LIVED ASSETS
We assess the recoverability of the carrying value of long-lived assets to be held and used, whenever events or changes in circumstances indicate that the carrying value may not be recoverable. For purposes of recognition and measurement of an impairment loss, long-lived assets are either individually identified or grouped with other assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities. When a long-lived asset is considered impaired a loss is recognized based on the amount by which the carrying value exceeds the fair value of the long-lived asset.
50

INDEX
GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill represents the excess of the aggregate purchase price over the fair value of the net assets acquired in business combinations. Goodwill and Intangible assets that have indefinite lives are tested for impairment annually on September 30, or between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company’s reporting units are CMP slurries, CMP pads, electronic chemicals, PIM, wood treatment, and QED.
Intangible assets that have finite lives are amortized over their respective useful lives of 2 to 20 years. Intangible assets are tested for impairment if an event occurs or circumstances change that indicates the carrying value may not be recoverable.
For each reporting unit, the Company has the option to perform either the qualitative analysis ("step zero") or a quantitative analysis ("step one"). In the event a reporting unit fails the qualitative assessment, it is required to perform the quantitative test. The goodwill impairment assessment is performed by comparing the estimated fair value of the reporting units to their carrying amounts. Estimated fair values are determined using the average of a discounted cash flows model and a market approach based on earnings before interest, taxes, and depreciation for a group of guideline comparable companies. Factors requiring significant judgment include the selection of valuation approach and assumptions related to future revenue and gross margin, discount rates, and terminal growth rates. If the fair value of the reporting unit is less than its carrying value, the reporting unit will recognize an impairment for the lesser of either the amount by which the reporting unit's carrying amount exceeds the fair value of the reporting unit or the reporting unit’s goodwill carrying value. We used a step zero qualitative analysis for the CMP slurries reporting unit in fiscal 2018, 2019 and 2020, and for precision optics in fiscal 2019 and 2020. Aside from those previously noted, all other reporting units were assessed for goodwill impairment using a step one approach.
The Flowchem LLC (“Flowchem”) trade name, an indefinite-lived intangible asset, was assessed for impairment using a relief from royalty approach. Factors requiring significant judgment include projected revenue, royalty rates, terminal growth rates, and discount rates.
The Company provides disclosure of the potential risk of impairment when a reporting unit’s fair value exceeds its carrying value by less than ten percent.
REVENUE RECOGNITION
Performance Obligations and Material Rights
The Company recognizes revenue using the five-step process of 1) identifying the contract, 2) identifying the performance obligation within the contract, 3) determining the transaction price, 4) allocating the transaction price to the performance obligations, and 5) recognizing the revenue as the performance obligations are satisfied through the transfer of control. A majority of the Company’s contracts have a single performance obligation which represents, in most cases, the products, equipment or services being sold to the customer. Some contracts include delivery of free product that we have concluded represents a material right.
Contracts vary in length and payment terms vary depending on the products or services offered, however, the period of time between invoicing and when payment is due is typically not significant. As a result, we do not have significant financing components. Transaction price is determined upon establishment of the contract that contains the final terms of the sale, including the description, quantity, and price of goods or services purchased. In instances where we receive consideration from a customer prior to transferring goods or services to the customer under the terms of a sales contract, we record a contract liability until the performance obligation is satisfied. Contracts with prospective tiered price discounts require judgment in determining the transaction price. For sales contracts that contain multiple performance obligations, the Company allocates the transaction price to each performance obligation identified in the contract based on relative standalone selling prices or estimates of such prices. When we invoice for products shipped under contracts with multiple performance obligations, we defer a portion of the revenue associated2021, filed with the material rightsSecurities and Exchange Commission (the “SEC”) on the balance sheet as a contract liability.
The Company recognizes revenue related to product sales at a point in time following the transfer of control of such products to the customer, which generally occurs upon shipment, or delivery depending on the terms of the underlying contracts. RevenueNovember 12, 2021 (the “Original Form 10-K”) is recognized on consignment sales when control transfers to the customer, generally at the point of customer usage of the product. For services provided to customers in the pipeline and adjacent industries, including preventive maintenance, repair, and specialized isolation sealing on pipelines and training, revenue is recorded at a point in time when the services are completed as this is when right to payment and customer acceptance occurs.
51

INDEX
Costs to Obtain and Fulfill a Contract
For certain contracts within the Performance Materials segment, commissions are paid to sales agents based upon a percentage of end-customer invoice value after funds are received by the Company from its customers. As a practical expedient, the Company does not capitalize commissions as the associated contracts are generally one year or less in duration. For shipping and handling activities performed after a customer obtains control of the goods, the Company has elected to account for these costs as activities to fulfill the promise to transfer the goods and included in Cost of sales.
RESEARCH, DEVELOPMENT AND TECHNICAL
Research, development and technical costs are expensed as incurred and consist primarily of staffing costs, materials and supplies, depreciation, utilities and other facilities costs.
LEGAL COSTS
Legal costs are expensed as incurred.
INCOME TAXES
Current income taxes are determined based on estimated taxes payable or refundable on tax returns for the current year. Deferred income taxes are determined using enacted tax rates for the effect of temporary differences between the book and tax bases of recorded assets and liabilities. The effect on deferred tax assets and liabilities of changes in tax rates is recognized in income in the period that includes the enactment date. Provisions are made for both U.S. and any foreign deferred income tax liability or benefit. We assess whether or not our deferred tax assets will ultimately be realized and record an estimated valuation allowance on those deferred tax assets that may not be realized. We recognize the tax benefit of an uncertain tax position only if it is more likely than not that the tax position will be sustained by the taxing authorities, based on the technical merits of the position.
The Company recognizes interest and penalties related to unrecognized tax benefits within the Provision for income taxes. Accrued interest and penalties are included in Other long-term liabilities.
DERIVATIVES AND HEDGING
The Company is exposed to various market risks, including risks associated with interest rates and foreign currency exchange rates. We enter into certain derivative transactions to mitigate the volatility associated with these exposures. We have policies in place that define acceptable instrument types we may enter into and we have established controls to limit our market risk exposure. We do not use derivative financial instruments for trading or speculative purposes. In addition, all derivatives, whether designated in hedging relationships or not, are recorded on the Consolidated Balance Sheets at fair value on a gross basis.
Interest Rate Swaps
During the second quarter of fiscal 2019, we entered into a floating-to-fixed interest rate swap agreement to hedge the variability in London Inter-bank Offered Rate (“LIBOR”) based interest payments on a portion of our outstanding variable rate debt. The fair value of our interest rate swaps is estimated using standard valuation models using market-based observable inputs over the contractual term, including one-month LIBOR-based yield curves, among others. We consider the risk of nonperformance, including counterparty credit risk, in the calculation of the fair value. We have designated these swap agreements as cash flow hedges. As cash flow hedges, unrealized gains are recognized as assets and unrealized losses are recognized as liabilities. Unrealized gains and losses are designated as effective or ineffective based on a comparison of the changes in fair value of the interest rate swaps and changes in fair value of the underlying exposures being hedged. The effective portion is recorded as a component of accumulated other comprehensive income or loss, while the ineffective portion is recorded as a component of Interest expense. Changes in the method by which we pay interest from one-month LIBOR to another rate of interest could create ineffectiveness in the swaps, and result in amounts being reclassified from other comprehensive income into Net income. Hedge effectiveness is tested quarterly to determine if hedge treatment is appropriate. Realized gains and losses are recorded on the same financial statement line as the hedged item, which is Interest expense.
52

INDEX
Foreign Currency Contracts Not Designated as Hedges
On a regular basis, we enter into forward foreign exchange contracts in an effort to mitigate the risks associated with currency fluctuations on certain foreign currency balance sheet exposures. These foreign exchange contracts do not qualify for hedge accounting; therefore, the gains and losses resulting from the impact of currency exchange rate movements on our forward foreign exchange contracts are recognized as Other income (expense), net in the accompanying Consolidated Statements of Income in the period in which the exchange rates change.
SHARE-BASED COMPENSATION
The Company’s long-term equity incentive plan authorizes the Compensation Committee of the Board of Directors to provide equity-based compensation in the form of stock options, restricted stock, restricted stock units (“RSUs”), and performance share units (“PSUs”)filed solely for the purpose of providing our employees, officers, and non-employee directors incentives and rewards for performance. We also have an employee stock purchase plan (“ESPP”). All grants under share-based payment plans are accounted for at fair value atincluding the dateinformation required by Part III of grant. We recognize expenseForm 10-K. This information was previously omitted from the Original Form 10-K in reliance on share-based awardsGeneral Instruction G(3) to employees expected to vest overForm 10-K, which permits the service period, which is the shorter of the period until the employees’ retirement eligibility dates or the service period of the award.
EARNINGS PER SHARE
Basic earnings per share (“EPS”) is calculated by dividing Net income available to common stockholders by the weighted-average number of common shares outstanding during the period, excluding the effects of unvested restricted stock awards with a right to receive non-forfeitable dividends, which are considered participating securities and are includedinformation in the calculation usingabove referenced items to be incorporated in the two-class method.  Diluted EPSForm 10-K by reference from our definitive proxy statement if such statement is calculated in a similar manner, but the weighted-average number of common shares outstanding during the period is increasedfiled no later than 120 days after our fiscal year-end. We are filing this Amendment No. 1 to include the weighted-average dilutive effect of "in-the-money" stock options and unvested restricted stock shares using the treasury stock method.
EFFECTS OF RECENT ACCOUNTING PRONOUNCEMENTS
Recently Adopted Accounting Pronouncements
Accounting Standards Update ("ASU") 2016-02 “Leases” (Topic 842) changed the criteria for recognizing leasing transactions. The provisions of this guidance require a lessee to recognize a right of use asset and a corresponding lease liability for operating leases. Under this guidance, rental expense for operating leases, continues to be recognized on a straight-line basis over the non-cancelable lease term. As of October 1, 2019, the Company began applying the provisions of this standard prospectively for all lease transactions as of and after the effective date. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed the historical lease classification to carry forward. We did not elect the hindsight practical expedient. Upon adoption, the Company recorded a lease liability of $30,881 and a right of use asset of $30,115. The difference between the right of use asset and lease liability primarily relates to deferred rent recorded prior to adoption. The new guidance did not have a material impact onPart III information in our results of operations or cash flows for the year ended September 30, 2020. Refer to Note 14 of this Annual Report on Form 10-K for additionalbecause we will not file a definitive proxy statement containing such information regarding the Company’s lease transactions.
ASU No. 2018-02 “Income Statement – Reporting Comprehensive Income” (Topic 220) allows for an optional one-time reclassification of the stranded tax effects resulting from the change in the U.S. federal corporate income tax rate under the Tax Cuts and Jobs Act (the "Tax Act") from Accumulated other comprehensive income to Retained earnings. The Company adopted this standard effective October 1, 2019, which resulted in an increase of $488 to both Retained earnings and Accumulated other comprehensive loss.
Accounting Pronouncements Issued But Not Yet Adopted
ASU No. 2016-13, "Measurement of Credit Losses on Financial Instruments" (Topic 326) requires financial assets measured at amortized cost to be presented at the net amount expected to be collected using an allowance account and provides that credit losses relating to available-for-sale debt securities should be recorded through an allowance for credit losses. The guidance was amended through various ASU's subsequent to ASU 2016-13, all of which is effective for the Company beginning October 1, 2020. We are finalizing the impact of this standard on our financial statements and it is not expected to have a material impact to the Company’s results of operations or financial condition.
53

INDEX
ASU No. 2018-13 “Fair Value Measurement” (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement provides specific guidance on various disclosure requirements in Topic 820, including removal, modification and addition to current disclosure requirements. ASU 2018-13 will be effective for us beginning October 1, 2020. We are finalizing the impact of this standard on our disclosures and do not expect the adoption to have a material impact in our disclosures.
ASU No. 2018-15 “Intangibles—Goodwill and Other—Internal-Use Software” (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force) requires an entity (customer) in a hosting arrangement that is a service contract to follow the guidance in Subtopic 350-40 to determine which implementation costs to capitalize as an asset related to the service contract and which costs to expense. ASU 2018-15 will be effective for us beginning October 1, 2020. We are finalizing the impact of this standard on our financial statements and do not expect the adoption to have a material impact.
ASU No. 2019-12 “Income Taxes” (Topic 740): Simplifying the Accounting for Income Taxes was issued to simplify Topic 740 through improving consistency and removing certain exceptions to general principles. ASU 2019-12 will be effective for us beginning October 1, 2021. We are currently evaluating the impact of implementing this standard on our financial statements.
ASU No. 2020-04 “Reference Rate Reform” (Topic 848) - Facilitation of the Effects of Reference Rate Reform on Financial Reporting provides optional guidance for accounting for contracts, hedging relationships, and other transactions affected by the reference rate reform, if certain criteria are met. The provisions of this standard are available for election through December 31, 2022. We are currently evaluating the impact of the reference rate reform on our contracts and the resulting impact of adopting this standard on our financial statements.

3.  REVENUE FROM CONTRACTS WITH CUSTOMERS
Disaggregated Revenue
The Company disaggregates revenue by product area and segment as it best depicts the nature and amount of the Company’s revenue. See Note 23 of this Annual Report on Form 10-K for more information.
Contract Balances
The following table provides information about contract liability balances:
Consolidated Balance Sheet LocationSeptember 30, 2020September 30, 2019
Contract liabilities (current)Accrued expenses, income taxes payable and other current liabilities$8,501 $5,008 
Contract liabilities (noncurrent)Other long-term liabilities1,288 1,130 
The amount of revenue recognized during the year ended September 30, 2020 and 2019 that was included in the opening current contract liability balances in our Performance Materials segment was $3,576 and $4,989, respectively. The amount of revenue recognized during the year ended September 30, 2020 and 2019 that was included in our opening contract liability balances in our Electronic Materials segment was not material.
Transaction Price Allocated to Remaining Performance Obligations
The table below discloses (1) the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied (or partially unsatisfied) as ofwithin 120 days after the end of the reporting period for contracts with an original duration of greater than onefiscal year and (2) whencovered by the Company expects to recognizeOriginal Form 10-K. In addition, this revenue.
Less Than 1 Year1-3 Years3-5 YearsTotal
Revenue expected to be recognized on contract liability amounts as of September 30, 2020$1,446 $1,288 $$2,734 

54

INDEX
4. BUSINESS COMBINATION
OnForm 10-K/A deletes the Acquisition Date,reference on the Company completed the Acquisition, and KMG’s results of operations have been included in our Consolidated Statements of Income and Consolidated Statements of Comprehensive Income (Loss) from that date. The Acquisition was accounted for using the acquisition method of accounting and the total purchase consideration was $1,513,235, including consideration transferred of $1,536,452, less cash acquired of $23,217. See below for a summarycover of the different components that comprise the total consideration.
Amount
Total cash consideration paid for KMG outstanding common stock and equity awards$900,756 
Cash provided to payoff KMG debt304,648 
Total cash consideration paid1,205,404 
Fair value of CMC common stock issued for KMG outstanding common stock and equity awards331,048 
Total consideration transferred$1,536,452 

The following table sets forth the components of identifiable intangible assets acquired:
Acquisition Date Fair ValueEstimated Useful Life
(years)
Customer relationships - Flowchem$315,000 20
Customer relationships - Electronic chemicals280,000 19
Customer relationships - all other109,000 15-16
Technology and know-how85,500 9-11
Trade name - Flowchem46,000 Indefinite
Trade name - all other7,000 1-15
EPA product registration rights2,300 15
Total intangible assets$844,800 
The intangible assets subject to amortization have a weighted average useful life of 17.9 years. For intangible assets relatedOriginal Form 10-K to the wood treatment business, the remaining useful lives were limited to the endincorporation by reference of portions of our proxy statement into Part III of the calendar year 2021.Original Form 10-K.
The allocation of goodwill
Pursuant to each of the Electronic Materials and Performance Materials segments as a result of the Acquisition was $259,859 and $353,475, respectively.
The following unaudited supplemental pro forma information summarizes the combined results of operations as if the Acquisition had occurred on October 1, 2017.
Year Ended September 30,
20192018
Revenue$1,099,674 $1,063,563 
Net income67,722 50,055 
Earnings per share - basic$2.34 $1.74 
Earnings per share - diluted$2.30 $1.70 
The following costs are included in the years ended September 30, 2019 and 2018:
Non-recurring transaction costs of $2,495 and $33,208, respectively.
Non-recurring transaction-related employee costs, such as accelerated stock compensation costs, retention and severance expense of $427 and $38,132, respectively.
Non-recurring charge for fair value write-up of inventory sold of $0 and $14,869, respectively.

55

INDEX
The historical financial information has been adjusted by applying the Company’s accounting policies and giving effect to the pro forma adjustments, which consist of (i) amortization expense associated with identified intangible assets; (ii) depreciation of fixed asset step-up (for pre-Acquisition periods only); (iii) accretion of inventory step-up value; (iv) the elimination of Interest expense on pre-Acquisition KMG debt and replacement of Interest expense related to the Acquisition-related financing; (v) transaction-related costs; (vi) accelerated share-based compensation expense (pre-Acquisition periods only); (vii) retention and severance expense incurred as a direct result of the Acquisition; and (viii) an adjustment to tax-effect the aforementioned unaudited pro forma adjustments using an estimated weighted-average effective income tax rate of each entity and the jurisdictions to which the above adjustments relate. The pro forma consolidated results are not necessarily indicative of what the consolidated results actually would have been had the Acquisition been completed on October 1, 2017. The pro forma consolidated results do not purport to project future results of combined operations, nor do they reflect the expected realization of any revenue or cost synergies associated with the Acquisition.

5. FAIR VALUE OF FINANCIAL INSTRUMENTS
The following table presents financial instruments, other than debt, that we measured at fair value on a recurring basis at September 30, 2020 and 2019.  See Note 13 of this Annual Report on Form 10-K for a discussion of our debt. In instances where the inputs used to measure the fair value of an asset fall into more than one level of the hierarchy, we have classified them based on the lowest level input that is significant to the determination of the fair value.
September 30, 2020Level 1Level 2Level 3Total
Fair Value
Assets:
Cash and cash equivalents$257,354 $$$257,354 
Other long-term investments1,214 1,214 
Derivative financial instruments27 27 
Liabilities:
Derivative financial instruments$$38,157 $$38,157 

September 30, 2019Level 1Level 2Level 3Total
Fair Value
Assets:
Cash and cash equivalents$188,495 $$$188,495 
Other long-term investments980 980 
Liabilities:
Derivative financial instruments$$24,244 $$24,244 
Our cash and cash equivalents consist of various bank accounts used to support our operations and investments in institutional money-market funds that are traded in active markets. We invest only in AAA-rated, prime institutional money market funds, comprised of high quality, short-term fixed income securities. Our other long-term investments represent the fair value of investments under our supplemental employee retirement plan (“SERP”), which is a non-qualified supplemental savings plan. The fair value of the investments is determined through quoted market prices within actively traded markets. Although the investments are allocated to individual participants and investment decisions are made solely by those participants, the SERP is a non-qualified plan. Consequently, the Company owns the assets and the related offsetting liability for disbursement until such time as a participant makes a qualifying withdrawal. 
Our derivative financial instruments include foreign exchange contracts and an interest rate swap contract. During the second quarter of fiscal 2019, we entered into a floating-to-fixed interest rate swap contract to hedge the variability in LIBOR-based interest payments on a portion of our outstanding variable rate debt. The fair value of our derivative instruments is estimated using standard valuation models and market-based observable inputs over the contractual term, including one-month LIBOR-based yield curves for the interest rate swap, and forward rates and/or the Overnight Index Swap curve for forward foreign exchange contracts, among others. We consider the risk of nonperformance, including counterparty credit risk, in the calculation of the fair value of derivative financial instruments. See Note 15 of this Annual Report on Form 10-K for more information on our use of derivative financial instruments.
56

INDEX

6. INVENTORIES
Inventories consisted of the following:
September 30,
20202019
Raw materials$66,591 $60,157 
Work in process15,148 12,940 
Finished goods77,395 72,181 
Total$159,134 $145,278 

7. PROPERTY, PLANT AND EQUIPMENT
Property, plant and equipment consisted of the following:
September 30,
20202019
Land$36,775 $36,276 
Buildings166,907 142,585 
Machinery and equipment280,432 257,706 
Vehicles18,719 13,497 
Furniture and fixtures9,865 9,615 
Information systems56,573 46,516 
Finance leases2,514 1,200 
Construction in progress123,441 63,636 
Total property, plant and equipment695,226 571,031 
Less: accumulated depreciation(333,159)(294,213)
Net property, plant and equipment$362,067 $276,818 
Depreciation expense was $39,929, $37,584 and $17,255 for the years ended September 30, 2020, 2019 and 2018, respectively.
In fiscal 2020 and 2019, we recorded impairment charges of $450 and $4,063, respectively, of property, plant and equipment related to the wood treatment asset group, and adjusted the remaining useful lives such that they do not extend beyond the announced plant closures around the end of the calendar year 2021. See Note 10 of this Annual Report on Form 10-K for further information. We did 0t record any impairment expense on property, plant and equipment in fiscal 2018.

8. ASSET RETIREMENT OBLIGATIONS
The following table provides a roll-forward of the AROs reflected in the Company’s Consolidated Balance Sheets:
20202019
Beginning Balance$12,675 $
Purchase Accounting in connection with the Acquisition(860)12,145 
Liabilities settled
Accretion of discount599 530 
Estimate revision(655)
Ending Balance at September 30$11,759 $12,675 


57

INDEX
9. GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill activity for each of the Company’s reportable segments for the years ended September 30, 2020 and 2019 is shown below:

Electronic MaterialsPerformance MaterialsTotal
Balance at September 30, 2018$96,083 $5,000 $101,083 
Foreign currency translation impact(3,145)(3,141)
Goodwill arising from the Acquisition259,859 352,270 612,129 
Balance at September 30, 2019$352,797 $357,274 $710,071 
Foreign currency translation impact7,628 (257)7,371 
Other1,205 1,205 
Balance at September 30, 2020$360,425 $358,222 $718,647 
The components of other intangible assets are as follows:

September 30, 2020September 30, 2019
Gross Carrying
Amount
Accumulated
Amortization
NetGross Carrying
Amount
Accumulated
Amortization
Net
Other intangible assets subject to amortization:
Customer relationships, trade names, and distribution rights$690,716 $140,037 $550,679 $684,764 $64,471 $620,293 
Product technology, trade secrets and know-how122,135 49,228 72,907 123,948 37,993 85,955 
Acquired patents and licenses8,921 8,713 208 9,023 8,397 626 
Total other intangible assets subject to amortization821,772 197,978 623,794 817,735 110,861 706,874 
Other intangible assets not subject to amortization:
Other indefinite-lived intangibles*47,170 — 47,170 47,170 — 47,170 
Total other intangible assets not subject to amortization47,170 — 47,170 47,170 — 47,170 
Total other intangible assets$868,942 $197,978 $670,964 $864,905 $110,861 $754,044 
*Other indefinite-lived intangibles not subject to amortization primarily consist of trade names.
58

INDEX

Gross Carrying Amount
Balance at September 30, 2019
Impairment1
FX and OtherBalance at September 30, 2020Accumulated AmortizationNet at September 30, 2020
Other intangible assets subject to amortization:
Customer relationships, trade names, and distribution rights$684,764 $(1,419)$7,371 $690,716 $140,037 $550,679 
Product technology, trade secrets and know-how123,948 (343)(1,470)122,135 49,228 72,907 
Acquired patents and licenses9,023 (102)8,921 8,713 208 
Total other intangible assets subject to amortization817,735 (1,864)5,901 821,772 197,978 623,794 
Other intangible assets not subject to amortization:
Other indefinite-lived intangibles*47,170 — — 47,170 — 47,170 
Total other intangible assets not subject to amortization47,170 — — 47,170 — 47,170 
Total other intangible assets$864,905 $(1,864)$5,901 $868,942 $197,978 $670,964 
1 Refer to Note 10 of this Annual Report on Form 10-K for additional information regarding the impairment.
Amortization expense was $85,557, $59,931 and $7,495 for fiscal 2020, 2019 and 2018, respectively.  Estimated future amortization expense of intangible assets as of September 30, 2020 for the five succeeding fiscal years is as follows:

Fiscal YearEstimated
Amortization
Expense
2021$81,985
202274,695
202362,879
202455,664
202550,526
As of September 30, 2020, the estimated fair value of the PIM reporting unit exceeded the carrying value by approximately 8% and 0 impairment was recognized. In estimating the fair value, the Company used the average of a discounted cash flows model and a market approach based on earnings before interest, taxes, and depreciation for a group of guideline comparable companies. The most significant estimates and assumptions inherent in the discounted cash flows model are the forecasted revenue growth rate, forecasted gross margin, the discount rate and the terminal growth rate. These assumptions are classified as level 3 inputs. The Company’s projections for revenue and gross margin are based on the Company’s multiyear forecast which reflects a recovery from the COVID-19 pandemic (“Pandemic”) during the forecast period. The discount rate was based on an estimated weighted average cost of capital (“WACC”) for the PIM reporting unit. The components of WACC are the cost of equity and the cost of debt, each of which requires judgment by management to estimate. The company developed its cost of equity estimate based on perceived risks and predictability of future cash flows.
The extent to which the Pandemic or future geopolitical events in the oil and gas industry may further impact our PIM business, operations, results of operations and financial condition is uncertain and difficult to estimate, however the impact could negatively affect future revenue and gross margin. The carrying value of the PIM reporting unit includes $318.2 million of goodwill and $46.0 million of trade-name intangible assets. Potential future impairments could be material to the Company’s Consolidated Balance Sheets and to the Consolidated Statements of Income, but we do not expect them to affect the Company’s reported Net cash provided by operating activities. NaN impairment charges to goodwill were recognized in any periods presented.
59

INDEX

10. LONG-LIVED ASSET IMPAIRMENT - WOOD TREATMENT
As a result of to the previously announced planned closure of the Company's wood treatment business' facilities by approximately the end of calendar year 2021, the Company recognized non-cash pre-tax impairment charges in the Performance Materials segment of $2,314 and $67,372, for the years ending September 30, 2020 and 2019, respectively, for the wood treatment asset group which is also a reporting unit, and adjusted the remaining useful lives such that they do not extend beyond the announced plant closures. The Company recognized a tax benefit of $608 and $17,072, for the years ending September 30, 2020 and 2019, respectively in Provision for income taxes in the Consolidated Statements of Income.
The Company tested the recoverability of its long-lived assets and determined the carrying amount of the assets exceeded the sum of the expected undiscounted future cash flows. The resulting impairment charge of $2,314 was recorded to reduce the carrying values of these assets to fair value and was allocated as follows:
September 30,
20202019
Property, plant, and equipment, net$450 $4,063 
Other intangible assets – Product technology343 9,651 
Other intangible assets – Acquired patents and licenses102 1,689 
Other intangible assets – Customer relationships, distribution rights, and other1,419 51,969 
Total$2,314 $67,372 
Testing the assets for recoverability involves developing estimates of future cash flows directly associated with, and that are expected to arise as a direct result of, the use and eventual disposition of the assets. As the inputs for testing recoverability, including estimates of revenue and expenses, not generally observable in active markets, the Company considers such measurements to be Level 3 measurements in the fair value hierarchy. The duration of the revenue and expense estimates are limited to the period through the closure date.
The fair value of the wood treatment asset group was sufficient such that the recognized impairment was limited to long-lived assets and the reporting unit goodwill was not impaired, however, as the Company approaches the closure date of the facilities and there are lower estimated future cash flows, the carrying value of the wood treatment asset group and reporting unit will not be recoverable, resulting in future impairments. The remaining carrying value of the wood treatment business as of September 30, 2020 includes $35.0 million and $3.8 million of goodwill and intangible assets, respectively, which we anticipate will be periodically impaired through the closure date, resulting in no fair value ascribed to the wood treatment business by the date of closure. The amount of the periodic impairments will vary depending on the timing of the remaining future cash flows of the business.

11. OTHER LONG-TERM ASSETS
Other long-term assets consisted of the following:
September 30,
20202019
Long-term right of use assets$30,999 $
Long-term vendor contract assets2,889 1,164 
Long-term SERP investments1,214 980 
Prepaid unamortized debt issuance costs - revolver537 709 
Other long-term assets4,368 2,858 
Total$40,007 $5,711 

60

INDEX
12. ACCRUED EXPENSES, INCOME TAXES PAYABLE AND OTHER CURRENT LIABILITIES
Accrued expenses, income taxes payable and other current liabilities consisted of the following:
September 30,
20202019
Accrued compensation$46,465 $33,809 
Income taxes payable16,216 15,725 
Dividends payable13,669 12,953 
Interest rate swap liability11,992 5,351 
Contract liabilities (current)8,501 5,008 
Current portion of operating lease liability6,513 
Taxes, other than income taxes5,044 6,281 
Goods and services received, not yet invoiced3,957 3,075 
Accrued interest29 3,739 
KMG - Bernuth warehouse fire-related (See Note 20)7,998 
Other9,056 9,679 
Total$121,442 $103,618 

13. DEBT
Total debt consisted of the following:
September 30,
20202019
Senior Secured Term Loan Facility, one-month LIBOR plus 2.00% and 2.25%, respectively$936,363 $959,676 
Less: Unamortized debt issuance costs(14,949)(17,900)
Total debt921,414 941,776 
Less: Current maturities and short-term debt(10,650)(13,313)
Total long-term debt excluding current maturities$910,764 $928,463 
Term Loan Facility
In connection with the Acquisition, we entered into a credit agreement, which provides for senior secured financing of up to $1,265.0 million (“Credit Agreement”), which includes the Senior Secured Term Loan Facility ("Term Loan Facility") in an aggregate principal amount of $1,065.0 million. During the first quarter of fiscal 2020, the Company amended the Credit Agreement ("Amended Credit Agreement") to reduce the interest rate on the Term Loan Facility.Borrowings under the Term Loan Facility bear interest at a rate per annum equal to, at the Company’s option, either (a) a LIBOR, subject to a 0.00% floor, or (b) a base rate, in each case, plus an applicable margin of, in the case of borrowings under the Term Loan Facility, 2.00% for LIBOR loans and 1.00% for base rate loans. The borrowings are guaranteed by each of the Company’s wholly-owned domestic subsidiaries and are secured by substantially all assets of the Company and of each subsidiary guarantor, in each case subject to certain exceptions.
The Term Loan Facility matures on November 15, 2025, and amortizes in equal quarterly installments of 0.25% of the initial principal amount beginning January 1, 2019. In addition, the Company is required to prepay outstanding loans under the Term Loan Facility, subject to certain exceptions, with up to 50% of the Company’s annual excess cash flow, as defined under the Amended Credit Agreement, and 100% of the net cash proceeds of certain recovery events and non-ordinary course asset sales. We made total prepayments on the Term Loan Facility of $10.0 million and $100.0 million during the fiscal years ended September 30, 2020 and 2019, respectively.
At September 30, 2020, the fair value of the Term Loan Facility, using level 2 inputs, approximated its carrying value of $936,363 as the loan bears a floating market rate of interest.
61

INDEX
In the second quarter of fiscal 2019, we entered into a floating-to-fixed interest rate swap contract to hedge the variability in our LIBOR-based interest payments on our Term Loan Facility balance. See Note 15 of this Annual Report on Form 10-K for additional information.
The Amended Credit Agreement contains certain affirmative and negative covenants that limit the ability of the Company, among other things and subject to certain significant exceptions, to incur debt or liens, make investments, enter into certain mergers, consolidations, asset sales and acquisitions, pay dividends and make other restricted payments and enter into transactions with affiliates. We believe we are in compliance with these covenants.
The Amended Credit Agreement contains certain events of default, including relating to a change of control. If an event of default occurs, the lenders under the Credit Facilities will be entitled to take various actions, including the acceleration of amounts due under the Credit Facilities.
As of September 30, 2020, scheduled principal repayments of the Term Loan Facility were:
Fiscal YearPrincipal Repayments
2021$10,650 
202210,650 
202310,650 
202410,650 
202510,650 
Thereafter883,113 
$936,363 
Revolving Credit Facility
The Company has a revolving credit facility under the Amended Credit Agreement ("Revolving Credit Facility") with an aggregate principal amount of up to $200.0 million, including a letter of credit sub-facility of up to $50.0 million. Borrowings under the Revolving Credit Facility bear interest at a rate per annum equal to a base rate in each case, plus an applicable margin of 1.50% for LIBOR loans and 0.50% for base rate loans. The applicable margin for borrowings under the Revolving Credit Facility varies depending on the Company’s first lien secured net leverage ratio. The Revolving Facility matures on November 15, 2023, the five-year anniversary of the Acquisition Date.
During the second quarter of fiscal 2020, the Company drew $150.0 million under the Revolving Credit Facility as a precautionary measure in order to increase its cash position and preserve financial flexibility in light of uncertain global economic conditions resulting from the Pandemic. The entire amount, which was unused in full, was repaid in the fourth quarter of fiscal 2020 and 0 amount remains outstanding as of September 30, 2020.

14. LEASES
We lease certain vehicles, warehouse facilities, office space, machinery, and equipment under cancellable and noncancellable leases, most of which expire in five years and may be renewed at our option.  
The components of lease expense are as follows:
Lease ComponentsYear Ended September 30, 2020
Operating lease cost$7,871 
Variable and short-term costs1,637 
Total lease cost$9,508 
Lease expense for the years ended September 30, 2019 and 2018 totaled $7,975 and $4,307, respectively.
62

INDEX
Supplemental balance sheet information related to leases is as follows:
Lease ComponentsConsolidated Balance Sheet LocationSeptember 30, 2020
Lease right-of-use assetsOther long-term assets$30,999 
Lease liabilities - currentAccrued expenses, income taxes payable and other current liabilities$6,513 
Lease liabilities - non-currentOther long-term liabilities25,967 
Total lease liabilities$32,480 
Weighted-average remaining lease term (in years)7 years
Weighted-average discount rate3.06 %
Future maturities of operating lease liabilities for the years ended September 30 are as follows:

Fiscal YearAmount
2021$7,196 
20226,672 
20235,645 
20244,242 
20253,499 
2026 and future years8,261 
Total future lease payments35,515 
Less: Imputed interest3,035 
Operating lease liability32,480 
Less: Current portion of operating lease liability6,513 
Long-term portion of operating lease liability$25,967 
As of September 30, 2019, minimum lease payments under non-cancellable operating leases in excess of one year are as follows:

Fiscal YearAmount
2020$6,984 
20214,941 
20224,291 
20234,122 
20243,710 
Thereafter12,010 
Total future minimum lease payments$36,058 

15. DERIVATIVE FINANCIAL INSTRUMENTS
We are exposed to various market risks, including risks associated with interest rates and foreign currency exchange rates.  We enter into certain derivative transactions to mitigate the volatility associated with these exposures. 
63

INDEX
Cash Flow Hedges – Interest Rate Swap Contract
We have a floating-to-fixed interest rate swap contract to hedge the variability in LIBOR-based interest payments on a portion of our outstanding variable rate debt.  The notional amount is scheduled to decrease bi-annually and will expire on January 31, 2024. Based on certain quantitative and qualitative assessments, we have determined that the hedge is highly effective and qualifies for hedge accounting. Accordingly, unrealized gains and losses on the hedge are recorded in other comprehensive income. Realized gains and losses are recorded on the same financial statement line as the hedged item, which is Interest expense.
Foreign Currency Contracts Not Designated as Hedges
We enter into forward foreign exchange contracts in an effort to mitigate the risks associated with currency fluctuations on certain foreign currency balance sheet exposures.  These foreign exchange contracts do not qualify for hedge accounting; therefore, the gains and losses resulting from the impact of currency exchange rate movements on our forward foreign exchange contracts are recognized as Other income (expense), net in the accompanying Consolidated Statements of Income in the period in which the exchange rates change. 
The notional amount of our derivative instruments are as follows:
September 30,
20202019
Derivatives designated as hedging instruments
Interest rate swap contract$571,000 $699,000 
Derivatives not designated as hedging instruments
Foreign exchange contracts to purchase U.S. dollars8,054 6,239 
Foreign exchange contracts to sell U.S. dollars25,105 24,270 

The fair value of our derivative instruments included in the Consolidated Balance Sheets was as follows:
Derivative AssetsDerivative Liabilities
September 30,September 30,
Consolidated Balance Sheets Location2020201920202019
Derivatives designated as hedging instruments
Interest rate swap contractAccrued expenses, income taxes payable and other current liabilities$$$11,992 $5,351 
Other long-term liabilities26,000 18,841 
Derivatives not designated as hedging instruments
Foreign exchange contractsPrepaid expenses and other current assets27 
Accrued expenses, income taxes payable and other current liabilities165 52 
64

INDEX
The following table summarizes the effect of our derivative instrument on our Consolidated Statements of Income:
Gain (Loss) Recognized in Consolidated Statements of Income
Fiscal Year Ended September 30,
Consolidated Statements of Income Location 202020192018
Derivatives designated as hedging instruments
Interest rate swap contractInterest expense$(9,360)$524 $515 
Derivatives not designated as hedging instruments
Foreign exchange contractsOther income (expense), net(222)28 (1,569)
The following table summarizes the effect of our derivative instrument on Accumulated other comprehensive income:
Amount of Gain (Loss) Recognized in Other Comprehensive Income
Fiscal Year Ended September 30,
202020192018
Derivatives designated as hedging instruments
Interest rate swap contract$(23,161)$(23,667)$430 
We expect approximately $11,992 to be reclassified from Accumulated other comprehensive (loss) income into Interest expense during the next twelve months related to our interest rate swap based on projected rates of the LIBOR forward curve as of September 30, 2020.

65

INDEX
16. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
The table below summarizes the components of Accumulated other comprehensive income (loss), net of income tax expense (benefit).
Year Ended September 30,
202020192018
Beginning Balance$(23,238)$4,539 $3,949 
Foreign currency translation adjustment19,642 (7,957)(1,730)
Income tax expense (benefit)(356)(591)2,409 
Foreign currency translation adjustment, net of tax19,286 (8,548)679 
Pension and other postretirement891 (479)(25)
Income tax expense (benefit)156 30 (1)
Pension and other postretirement, net of tax1,047 (449)(26)
Unrealized gain (loss) on cash flow hedges:
Change in fair value(23,161)(23,667)430 
Reclassification adjustment into earnings9,360 (524)(515)
Income tax expense3,090 5,411 22 
Unrealized loss on cash flow hedges, net of tax(10,711)(18,780)(63)
Effect of the adoption of the stranded tax effect accounting standard(497)
Income tax expense
Effect of the adoption of the stranded tax effect accounting standard, net of tax(488)
Net Change9,134 (27,777)590 
Ending Balance$(14,104)$(23,238)$4,539 
During the first quarter of fiscal 2020, the Company adopted ASU No. 2018-02 regarding the reclassification of stranded tax effects resulting from the change in the U.S. federal corporate income tax rate under the Tax Act and as a result, we reclassified $488 of stranded tax effects from Accumulated other comprehensive income to Retained earnings.

17. SHARE-BASED COMPENSATION PLANS
We grant share-based compensation to eligible participants under our 2012 Omnibus Incentive Plan (the "OIP"), which was amended as of March 2017, and prior to that under our 2000 Equity Incentive Plan (the “EIP”).  The OIP allows for the granting of 6 types of equity incentive awards: stock options, restricted stock, restricted stock units, stock appreciation rights (“SARs”), performance-based awards, and substitute awards in connection with an acquisition (in the case of the Acquisition, “Replacement Awards”). The OIP authorizes up to 4,978 shares of stock to be granted thereunder, including up to 2,074 shares of stock in the aggregate of awards other than options or SARs and up to 2,539 incentive stock options.  In addition, shares that become available from awards under the EIP and the OIP because of events such as forfeitures, cancellations or expirations will also be available for issuance under the OIP. Shares issued under our share-based compensation plans are issued from new shares rather than from treasury shares.
66

INDEX
In fiscal 2019, in connection with the Acquisition, we awarded a total of 43,443 restricted stock unit awards to certain KMG employees in substitution for certain unvested restricted stock unit awards that KMG had awarded subsequent to the entry into the definitive agreement for the Acquisition, but prior to the Acquisition Date. The Replacement Awards vest in 3 equal installments on the first three anniversaries of the original award date. If the recipient was terminated without cause or resigned with good reason during the 18 months following the Acquisition Date, the Replacement Awards will have vested as of such termination date in a number of shares equal to 150% of the Replacement Award.
STOCK OPTIONS
Non-qualified stock options issued under the OIP are generally time-based and provide for a ten-year term, with options generally vesting equally over a four-year period. Non-qualified stock options granted to non-employee directors on an annual basis vest 100% on the first anniversary of the award date. Under the OIP employees may also be granted incentive stock options to purchase common stock at not less than the fair value on the date of the grant, but to date we have not granted incentive stock options.
The fair value of our share-based awards, as shown below, was estimated using the Black-Scholes model with the following weighted-average assumptions:
Year Ended September 30,
202020192018
Weighted-average grant date fair value$39.68 $27.34 $26.59 
Expected term (in years)6.966.866.68
Expected volatility32 %26 %26 %
Risk-free rate of return1.6 %2.8 %2.4 %
Dividend yield1.3 %1.6 %1.0 %

A summary of stock option activity is as follows:
Stock
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term
(in years)
Aggregate
Intrinsic
Value
(in thousands)
Outstanding at September 30, 2019879 $63.44 
Granted121 129.60 
Exercised(182)51.50 
Forfeited or canceled(11)75.59 
Outstanding at September 30, 2020807 $75.87 6.2$54,078 
Exercisable at September 30, 2020499 $58.27 5.1$42,184 
Expected to vest at September 30, 2020308 $104.39 8.1$11,836 

Year Ended September 30,
202020192018
Intrinsic value of options exercised$19,077 $20,711 $30,345 
Cash received from exercise of options9,350 13,193 19,247 
Tax benefit from exercise of options3,629 4,449 7,503 
Fair value of options vested3,765 4,506 5,008 

As of September 30, 2020, there was $5,267 of total unrecognized share-based compensation expense related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 2.3 years.
67

INDEX
EMPLOYEE STOCK PURCHASE PLAN
The ESPP allows all full-time, and certain part-time, employees of our Company and its designated subsidiaries to purchase shares of our common stock through payroll deductions, subject to a maximum number of shares that a participant may purchase and a maximum dollar expenditure in any six-month offering period, and certain other criteria.  The provisions of the ESPP allow shares to be purchased at a price no less than the lower of 85% of the closing price at the beginning or end of each semi-annual stock purchase period. As of September 30, 2020, a total of 291 shares are available for purchase under the ESPP.
The Black-Scholes model is primarily used in estimating the fair value of short-lived exchange traded options that have no vesting restrictions and are fully transferable.  Because employee stock options and ESPP purchases have certain characteristics that are significantly different from traded options, and because changes in the subjective assumptions can materially affect the estimated value, our use of the Black-Scholes model for estimating the fair value of stock options and ESPP purchases may not provide an accurate measure.  Although the value of our stock options and ESPP purchases are determined in accordance with applicable accounting standards using an option-pricing model, those values may not be indicative of the fair values observed in a willing buyer/willing seller market transaction.

Year Ended September 30,
202020192018
Weighted-average grant date fair value$39.17 $25.16 $20.94 
Shares issued46 49 50 
Expected term (in years)0.50.50.5
Expected volatility52 %34 %26 %
Risk-free rate of return1.7 %2.3 %1.5 %
Dividend yield1.3 %1.6 %1.1 %

RESTRICTED STOCK, RESTRICTED STOCK UNITS, AND PERFORMANCE SHARE UNITS
Under the OIP, employees and non-employees may be awarded shares of restricted stock or RSUs, which generally vest over a four-year period. Restricted shares under the OIP may be purchased and placed "on deposit" by executive officers pursuant to the 2001 Deposit Share Program. Shares purchased under this Deposit Share Program receive a 50% match in restricted shares that vest at the end of a three-year period, and are subject to forfeiture upon early withdrawal of the deposit shares.The fair value of our restricted stock and restricted stock unit awards represents the closing price of our common stock on the date of award. Share-based compensation expense related to restricted stock and RSU awards is recorded net of expected forfeitures.
In December 2017, we began awarding PSU awards to certain employees on an annual basis. These PSUs fully vest upon certification of performance achieved with respect to the PSU following the third anniversary of the performance period tied to the PSU, according to the terms and conditions of the relevant PSU award agreement. Stock-based compensation for the awards is recognized over the requisite service period (three years) beginning on the date of award through the end of the performance period based on the number of PSUs expected to vest under the awards at the end of the performance period. The expected amount of vesting is determined using certain performance measures and is re-evaluated at the end of each fiscal year through the end of the performance period. In addition, the PSUs awarded may be subject to downward or upward adjustment depending on the total shareholder return achieved by the Company during the particular performance period related to the PSUs, relative to the total shareholder return of the S&P SmallCap 600 Index or the S&P MidCap 400 Index, as specified in the respective PSU award agreement. We estimate fair value of the PSUs at award date by using a Monte Carlo simulation model. This model simulates the stock price movements of the Company and relevant Index constituents using certain assumptions, including the stock price of our company and relevant Index constituents, the risk-free interest rate and stock price volatility.
68

INDEX
A summary of the activity of the restricted stock awards, RSU awards, and PSU awards is presented below:
Restricted Stock
Awards and Units
Weighted Average
Grant Date Fair
Value
Nonvested at September 30, 2019275 $87.36 
Granted 1
88 125.14 
Vested(100)74.65 
Forfeited(6)83.65 
Nonvested at September 30, 2020257 $104.83 
1 Includes PSUs awarded

Year Ended September 30,
202020192018
Weighted average grant date fair value$104.83 $87.36 $70.42 

The total fair value of restricted stock awards and RSUs vested during fiscal years 2020, 2019 and 2018 was $7,481, $11,060 and $6,669, respectively.  As of September 30, 2020, there was $14,256 of total unrecognized share-based compensation expense related to unvested restricted stock awards and RSUs, including PSUs, under the OIP.  That cost is expected to be recognized over a weighted-average period of 2.09 years.
SHARE-BASED COMPENSATION EXPENSE
Total share-based compensation expense and the classification of that expense in the Consolidated Statements of Income for the years ended September 30, 2020, 2019 and 2018, is as follows:

Year Ended September 30,
202020192018
Cost of sales$2,863 $2,727 $2,450 
Research, development and technical2,090 2,150 1,940 
Selling, general and administrative11,443 13,350 14,128 
Tax benefit(3,162)(3,767)(4,306)
Total share-based compensation expense, net of tax$13,234 $14,460 $14,212 

Total gross share-based compensation expense is attributable to the following awards:
Year Ended September 30,
202020192018
Stock Options$4,406 $4,267 $6,392 
Restricted stock, restricted stock units, and replacement awards8,259 11,400 9,186 
Performance share units1,957 1,279 2,056 
ESPP1,774 1,281 885 

69

INDEX
18. EMPLOYEE RETIREMENT PLANS
Defined Contribution Plans
The Company has 401(k) defined contribution plans covering employees in the U.S., and the expense for the plans totaled $7,658, $6,698 and $5,562 for the fiscal years ended September 30, 2020, 2019 and 2018, respectively.
The Company’s United Kingdom and Singapore subsidiaries make contributions to retirement plans that function as defined contribution retirement plans. The contributions to those plans were approximately $1,766 and $1,356 for the fiscal years ended September 30, 2020 and 2019, respectively.
Pension Obligations in Foreign Jurisdictions
The Company has defined benefit plans covering employees in Japan, South Korea, and France as required by local law. These plans are unfunded. A summary of these combined plans are:
September 30,
20202019
Projected benefit obligation$11,627 $11,121 
Accumulated benefit obligation8,680 8,314 
Pension cost included in Accumulated other comprehensive income (loss)(764)(1,811)
Weighted average discount rate1.32 %0.73 %
Weighted average rate of increases in future compensation levels3.01 %2.89 %

Benefit costs for the combined plans were $1,403, $1,345 and $1,236 in fiscal years 2020, 2019 and 2018, respectively, consisting primarily of service costs. Net service costs are included in Cost of sales and Operating expenses, and all other costs are recorded in the Other income (expense), net in our Consolidated Statements of Income. Estimated future benefit payments are as follows:
Fiscal YearAmount
2021$519 
2022542 
2023641 
2024661 
20251,209 
2026 to 20305,172 

19. INCOME TAXES
Income before income taxes was as follows:
Year Ended September 30,
202020192018
Domestic$94,002 $(45,364)$46,254 
Foreign79,345 108,470 115,457 
Total$173,347 $63,106 $161,711 
70

INDEX
Taxes on income consisted of the following:
Year Ended September 30,
202020192018
U.S. federal and state:
Current$20,733 $23,461 $14,698 
Deferred(7,048)(23,182)10,347 
Total13,685 279 25,045 
Foreign:
Current21,053 27,580 26,135 
Deferred(4,219)(3,968)488 
Total16,834 23,612 26,623 
Total U.S. and foreign$30,519 $23,891 $51,668 
The Provision for income taxes at our effective tax rate differed from the statutory rate as follows:
Year Ended September 30,
202020192018
Federal statutory rate21.0 %21.0 %24.5 %
U.S. benefits from research and experimentation activities(1.5)(2.9)(0.8)
State taxes, net of federal effect1.1 (4.7)0.1 
Foreign income at other than U.S. rates1.7 10.3 1.2 
Excess compensation0.4 6.4 0.4 
Share-based compensation(2.2)(7.2)(4.3)
U.S. tax reform14.1 11.2 
Global Intangible Low Taxed Income ("GILTI")3.1 
Foreign derived intangible income(3.4)(3.9)
Change in reserve positions1.9 0.3 (0.5)
Other, net(1.4)1.4 0.2 
Provision for income taxes17.6 %37.9 %32.0 %
The decrease in the effective tax rate during fiscal 2020 was primarily attributable to the absence of a discrete charge recorded in fiscal 2019 related to the final regulations issued under the Tax Act and the absence of unfavorable tax treatment of certain non-deductible costs related to the Acquisition. Additionally, the tax rate was favorably impacted by the final tax regulations issued in July 2020, which provided for a high-tax exception for those jurisdictions subject to the GILTI tax, for which the Company qualified.
The increase in the effective tax rate during fiscal 2019 was primarily due to increased tax expense related to the final regulations related to the Tax Act, which impacted our reserves for uncertain tax positions, and the unfavorable tax treatment of certain Acquisition-related costs. Partially offsetting these adverse items, the Tax Act reduced the corporate income tax rate to 21.0% effective January 1, 2018, resulting in a change in our blended tax rate of 24.5% in fiscal 2018 to 21.0% beginning with our fiscal 2019.
The accounting guidance regarding uncertainty in income taxes prescribes a threshold for the financial statement recognition and measurement of tax positions taken or expected to be taken on a tax return. Under these standards, we may recognize the tax benefit of an uncertain tax position only if it is more likely than not that the tax position will be sustained by the taxing authorities, based on the technical merits of the position.
71

INDEX
The following table presents the changes in the balance of gross unrecognized tax benefits during the last three fiscal years:

Balance September 30, 2017$2,270 
Additions for tax positions relating to the current fiscal year263 
Additions for tax positions relating to prior fiscal years116 
Lapse of statute of limitations(1,215)
Balance September 30, 20181,434 
Additions for tax positions relating to the current fiscal year271 
Additions for tax positions relating to prior fiscal years9,839 
Balance September 30, 201911,544 
Additions for tax positions relating to the current fiscal year4,691 
Additions for tax positions relating to prior fiscal years140 
Reduction for tax positions relating to prior fiscal years(1,337)
Balance September 30, 2020$15,038 
The entire balance of unrecognized tax benefits shown above as of September 30, 2020 and 2019, would affect our effective tax rate if recognized.  Additions for tax positions of $4,691 recorded in the current fiscal year are mainly due to liabilities related to mix of jurisdictional earnings from intercompany transactions. Interest accrued on our Consolidated Balance Sheets was $233 and $281 at September 30, 2020 and 2019, respectively, and any interest and penalties charged to expense in fiscal years 2020, 2019 and 2018 was immaterial.
At September 30, 2020, the tax periods open to examination by the U.S. federal, state and local governments include fiscal years 2013 through 2020, and the tax periods open to examination by foreign jurisdictions include fiscal years 2015 through 2020. We do not anticipate a significant change to the total amount of unrecognized tax benefits within the next 12 months.
Significant components of net deferred tax assets and liabilities were as follows:
September 30,
20202019
Deferred tax assets:
Employee benefits$8,920 $5,719 
Inventory4,657 3,811 
Accrued expenses2,615 4,202 
Share-based compensation expense5,709 5,215 
Credit and other carryforwards5,803 9,743 
Interest rate swap8,506 5,412 
Other1,238 1,088 
Valuation allowance(2,948)(2,574)
Total deferred tax assets$34,500 $32,616 
Deferred tax liabilities:
Depreciation and amortization$131,237 $140,092 
Withholding on transition taxes4,156 6,026 
Other3,606 1,926 
Total deferred tax liabilities$138,999 $148,044 
As of September 30, 2020, the Company had foreign and domestic net operating loss carryforwards (“NOLs”) of $11,025, which will expire over the period between fiscal year 2021 and fiscal year 2040. We have recorded a tax-effected valuation allowance of $2,948 against the deferred tax assets related to certain foreign and U.S. federal and state NOLs, as well as on certain federal tax credit carryforwards.  As of September 30, 2020, the Company had a U.S. federal and state tax credit carryforward of $1,131, which will expire beginning in fiscal years 2021 through 2030.
72

INDEX
Prior to enactment of the Tax Act, the Company did not record income tax expense for the undistributed earnings of its international subsidiaries. As a result of the Tax Act, the Company no longer intends to maintain the indefinite reinvestment assertion.

20. COMMITMENTS AND CONTINGENCIES
LEGAL PROCEEDINGS AND OTHER CONTINGENCIES
We periodically become a party to legal proceedings, arbitrations, regulatory proceedings, inquiries and investigations (“contingencies”) arising in the ordinary course of our business operations. The ultimate resolution of these contingencies is subject to significant uncertainty, and should we fail to prevail in any of them or should several of them be resolved against us in the same reporting period, these matters could, individually or in the aggregate, be material to our consolidated financial statements. One of these contingencies, related to Star Lake Canal, which we assumed in connection with the Acquisition, is discussed below. The ultimate outcome of these matters, however, cannot be determined at this time, nor can the amount of any potential loss be reasonably estimated, and as a result except where indicated no amounts have been recorded in our consolidated financial statements.
On May 31, 2019, a fire occurred at the warehouse of the wood treatment facility of KMG’s subsidiary, KMG-Bernuth, Inc.’s (“KMG-Bernuth”), in Tuscaloosa, Alabama, which processes pentachlorophenol (“penta”) for sale to customers in the U.S. and Canada. The warehouse fire, which we believe originated from non-hazardous waste materials temporarily stored in the warehouse for recycling purposes, caused no injuries and was extinguished in less than an hour. Company personnel investigated the incident, and KMG-Bernuth commenced cleanup with oversight from certain local, state and federal authorities. The carrying value of the warehouse and the affected inventory are not material. Applying the accounting guidance under ASC 410-30, Environmental Obligations and ASC 450, Contingencies, we determined that since we had environmental obligations as of the date of the fire, costs for the fire waste cleanup and disposal should be recognized to the extent they are probable and reasonably estimable. We recorded expense of $1,551 and $9,494 for the years ending September 30, 2020 and 2019, respectively. These disposal costs were charged to Cost of sales. Although we believe we have completed cleanup efforts related to the fire incident and the assessment of materials in the warehouse that had been impacted by the incident, there are potential other costs that cannot be reasonably estimated as of this time related to the fire incident due to the nature of federally-regulated penta-related requirements. We incurred significant fire waste cleanup and disposal costs and certain other costs related to the assessment of the impacted warehouse material due to these requirements, and we may incur additional costs related to the fire incident. We intend to continue to update the estimated losses as new information becomes available.
In addition, we are working with our insurance carriers on possible recovery of losses and costs related to the fire incident. We received $468 of insurance recovery during the twelve months ended September 30, 2020 which was recorded in Cost of sales. At this point we cannot reasonably estimate whether we will receive any additional insurance recoveries, or if so, the amount of such recoveries. As such, no additional insurance recoveries have been recognized as of September 30, 2020.
Separately, in 2014, prior to the Acquisition, the United States Environmental Protection Agency (“EPA”) had notified KMG-Bernuth, that the EPA considered it to be a potentially responsible party under the Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended by virtue of its relationship with certain alleged predecessor companies, including Idacon, Inc (f/k/a Sonford Chemical Company) in connection with the Star Lake Canal Superfund Site near Beaumont, Texas. The EPA has estimated that the remediation will cost approximately $22.0 million. KMG-Bernuth and approximately 7 other parties entered into an agreement with the EPA in September 2016 to complete a remedial design phase of the remediation of the site. The remediation work will be performed under a separate future agreement. Although KMG-Bernuth has not conceded liability, a reserve in connection with the remedial design was established, and as of September 30, 2020, the reserve remaining was $553.
We also may face other governmental or third-party claims, or otherwise incur costs, relating to cleanup of, or for injuries resulting from, contamination at sites associated with this or other past and present operations. We accrue for environmental liabilities when a determination can be made that they are probable and reasonably estimable. Other than as described herein, we are not involved in any legal proceedings that we believe could have a material impact on our consolidated financial position, results of operations or cash flows.
73

INDEX
In addition, our Company is subject to extensive federal, state and local laws, regulations and ordinances in the U.S. and in other countries. These regulatory requirements relate to the use, generation, storage, handling, emission, transportation and discharge of certain hazardous materials, substances and waste into the environment. The Company, including its KMG entities, manage Environmental, Health and Safety (“EHS”) matters related to protection of the environment and human health, the cleanup of contaminated sites, the treatment, storage and disposal of wastes, and the emission of substances into the air or waterways, among other EHS concerns. Governmental authorities can enforce compliance with their regulations, and violators may be subject to fines, injunctions or both. The Company devotes significant financial resources to compliance, including costs for ongoing compliance.
Certain licenses, permits and product registrations are required for the Company’s products and operations in the U.S., Mexico and other countries in which it does business. The licenses, permits and product registrations are subject to revocation, modification and renewal by governmental authorities. In the U.S. in particular, producers and distributors of penta, which is a product manufactured and sold by KMG-Bernuth as part of the wood treatment business, are subject to registration and notification requirements under the Federal Insecticide, Fungicide and Rodenticide Act and comparable state law in order to sell this product in the U.S. Compliance with these requirements may have a significant effect on our business, financial condition and results of operations.
We are subject to contingencies, including litigation relating to EHS laws and regulations, commercial disputes and other matters. Certain of these contingencies are discussed above and below. The ultimate resolution of these contingencies is subject to significant uncertainty, and should we fail to prevail in any of them or should several of them be resolved against us in the same reporting period, these matters could, individually or in the aggregate, be material to the consolidated financial statements. The ultimate outcome of these matters cannot be determined at this time, nor can the amount of any potential loss be reasonably estimated, and as a result except where indicated no amounts have been recorded in our consolidated financial statements.
INDEMNIFICATION
In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party with respect to certain matters.  Generally, these obligations arise in the context of agreements entered into by us, under which we customarily agree to hold the other party harmless against losses arising from items such as a breach of certain representations and covenants including title to assets sold, certain intellectual property rights and certain environmental matters.  These terms are common in the industries in which we conduct business.  In each of these circumstances, payment by us is subject to certain monetary and other limitations and is conditioned on the other party making an adverse claim pursuant to the procedures specified in the particular agreement, which typically allow us to challenge the other party's claims.
We evaluate estimated losses for such indemnifications under the accounting standards related to contingencies and guarantees.  We consider such factors as the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of loss. To date, we have not experienced material costs as a result of such obligations and, as of September 30, 2020, have not recorded any liabilities related to such indemnifications in our financial statements as we do not believe the likelihood of such obligations is probable.
PURCHASE OBLIGATIONS
Purchase obligations include take-or-pay arrangements with suppliers, and purchase orders and other obligations entered into in the normal course of business regarding the purchase of goods and services. We have been operating under an abrasive particle supply agreement, the current term of which now runs through December 2022. As of September 30, 2020, purchase obligations include $22,932 of contractual commitments related to this agreement. In addition, we have a purchase commitment of $5,631 to purchase non-water based carrier fluid.

74

INDEX
21. EARNINGS PER SHARE
Basic and diluted earnings per share were calculated as follows:
Year Ended September 30,
202020192018
Numerator:
Net income available to common shares$142,828 $39,215 $110,043 
Less: income attributable to participating securities1
(123)
Net income available to common stockholders$142,828 $39,215 $109,920 
Denominator:
Weighted average common shares29,136 28,571 25,518 
Weighted average effect of dilutive securities444 523 725 
Diluted weighted average common shares29,580 29,094 26,243 
Earnings per share:
Basic$4.90 $1.37 $4.31 
Diluted$4.83 $1.35 $4.19 
1 Beginning in the first quarter of fiscal 2019, the amount of participating securities was no longer material and therefore, we have excluded such securities from our calculation of earnings per share in fiscal 2020 and 2019.
Shares excluded from the calculation of Diluted earnings per share as their inclusion would have been anti-dilutive were as follows:
Year Ended September 30,
202020192018
Outstanding stock options102 196 100 

22. SEGMENT REPORTING
We identify our segments based on our management structure and the financial information used by our chief executive officer, who is our chief operating decision maker, to assess segment performance and allocate resources among our operating units. Historically, we operated in 1 industry segment – the development, manufacture and sale of CMP consumables products. In connection with the Acquisition, we reassessed our operating and reportable segments, and determined that we have the following 2 reportable segments:
Electronic Materials
Electronic Materials includes products and solutions for the semiconductor industry and consists of our CMP slurries business, CMP pads business, and electronic chemicals business.
Performance Materials
Performance Materials consists of our PIM business, wood treatment business, and QED business.
75

INDEX
Beginning in fiscal 2019 and with the Acquisition, our chief operating decision maker evaluates segment performance based upon revenue and segment adjusted EBITDA. Segment adjusted EBITDA is defined as earnings before interest, income taxes, depreciation and amortization, adjusted for certain items that affect comparability from period to period.  These adjustments include items related to the Acquisition, such as Acquisition and integration-related expenses, the impact of fair value adjustments to inventory acquired from KMG, certain costs related to the KMG-Bernuth warehouse fire, net of insurance recovery, asset impairment charges and net restructuring charges related to the wood treatment business and costs related to the Pandemic, net of grants received. We exclude these items from earnings when presenting our adjusted EBITDA measure because we believe they are not indicative of a segment's regular, ongoing operating performance. Adjusted EBITDA is also the basis of a performance metric for our fiscal 2020 Short-Term Incentive Program. In addition, our chief operating decision maker does not use assets by segment to evaluate performance or allocate resources, and therefore, we do not disclose assets by segment.
Since the two segments operate independently and serve different markets and customers, as a result there are no sales between segments.  Revenue from external customers and segment adjusted EBITDA shown for Performance Materials for the year ended September 30, 2018 include the precision optics business. Revenue from external customers by segment are as follows:
Year Ended September 30,
202020192018
Segment Revenue:
Electronic Materials:
CMP Slurries$480,617 $460,053 $476,828 
Electronic Chemicals316,253 278,413 
CMP Pads85,954 94,585 83,117 
Total Electronic Materials882,824 833,051 559,945 
Performance Materials:
PIM141,503 140,553 
Wood Treatment62,655 31,898 
QED29,288 32,194 30,178 
Total Performance Materials233,446 204,645 30,178 
Total$1,116,270 $1,037,696 $590,123 
Capital expenditures by segment are as follows:
Year Ended September 30,
202020192018
Capital Expenditures:
Electronic Materials$26,536 $40,166 $18,668 
Performance Materials84,634 16,367 409 
Corporate11,344 5,663 3,918 
Total$122,514 $62,196 $22,995 
76

INDEX
Adjusted EBITDA by segment is as follows:
Year Ended September 30,
202020192018
Net income$142,828 $39,215 $110,043 
Interest expense42,510 45,681 2,905 
Interest income(670)(2,346)(4,409)
Income taxes30,519 23,891 51,668 
Depreciation and amortization127,737 98,592 25,876 
EBITDA342,924 205,033 186,083 
Acquisition and integration-related expense10,852 34,709 3,861 
Charges related to asset impairment of wood treatment business2,314 67,372 
Costs related to KMG-Bernuth warehouse fire, net of insurance recovery1,083 9,905 
Costs related to the Pandemic, net of grants received849 
Charge for fair value write-up of acquired inventory sold14,869 
Net costs related to restructuring of the wood treatment business(221)1,530 
Consolidated adjusted EBITDA$357,801 $333,418 $189,944 
Segment adjusted EBITDA:
Electronic Materials$299,037 $294,902 $222,019 
Performance Materials106,797 91,372 7,191 
Unallocated corporate expenses(48,033)(52,856)(39,266)
Consolidated adjusted EBITDA$357,801 $333,418 $189,944 
The unallocated portions of corporate functions, including finance, legal, human resources, information technology, and corporate development, are not directly attributable to a reportable segment.

23. FINANCIAL INFORMATION BY GEOGRAPHIC AREA
Revenues are attributed to the U.S. and foreign regions based upon the customer location and not the geographic location from which our products were shipped.  Financial information by geographic area was as follows:
Year Ended September 30,
202020192018
Revenue:
North America$399,993 $372,247 $79,019 
Asia546,866 515,833 471,215 
Europe, Middle East, and Africa169,099 149,305 39,889 
South America312 311 
Total$1,116,270 $1,037,696 $590,123 
Property, plant and equipment, net1:
North America$250,895 $133,682 $60,818 
Asia66,872 68,823 50,573 
Europe44,300 74,313 12 
Total$362,067 $276,818 $111,403 
1 No individual countries other than the U.S. have material Property, plant and equipment
77

INDEX
The following table shows revenue from sales to customers in foreign countries that accounted for more than ten percent of our total revenue in fiscal 2020, 2019 and 2018:
Year Ended September 30,
202020192018
Revenue:
South Korea$127,972 $135,844 $136,403 
Taiwan133,059 125,895 130,500 
China113,570 *97,254 
* Not a country with more than 10% revenue.
78

INDEX
SELECTED QUARTERLY OPERATING RESULTS
The following table presents our unaudited financial information for the eight quarterly periods ended September 30, 2020.  This unaudited financial information has been prepared in accordance with accounting principles generally accepted in the United States of America, applied on a basis consistent with the annual audited financial statements and in the opinion of management, include all necessary adjustments, which consist only of normal recurring adjustments necessary to present fairly the financial results for the periods.  The results for any quarter are not necessarily indicative of results for any future period.

SELECTED QUARTERLY OPERATING RESULTS
(Unaudited and in thousands, except per share amounts)
September 30, 2020June 30,
2020
March 31,
2020
Dec. 31,
2019
September 30, 2019June 30,
2019
March 31,
2019
Dec. 31,
2018
Revenue$274,207 $274,727 $284,193 $283,143 $278,645 $271,882 $265,391 $221,778 
Cost of sales157,144 152,973 163,091 154,461 165,535 156,492 150,571 122,445 
Gross profit117,063 121,754 121,102 128,682 113,110 115,390 114,820 99,333 
Operating income (loss)46,068 57,742 51,663 61,432 (17,623)52,240 51,714 24,165 
Net income (loss)$36,855 $34,525 $32,899 $38,549 $(20,243)$18,878 $27,137 $13,443 
Basic earnings (loss) per share1
$1.27 $1.19 $1.12 $1.32 $(0.70)$0.65 $0.94 $0.50 
Diluted earnings (loss) per share1
$1.25 $1.17 $1.11 $1.30 $(0.70)$0.64 $0.92 $0.48 
1The total of the individual quarters may not equal full year results as quarterly per share information is calculated using the quarterly weighted average shares.

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS
The following table sets forth activities in our allowance for doubtful accounts:
Allowance For Doubtful AccountsBalance At
Beginning of
Year
Amount of Charge
(Benefit) To
Expenses
Deductions
and
Adjustments
Balance At
End
of Year
Year ended:
September 30, 2020$2,377 $(1,122)$(672)$583 
September 30, 20191,900 432 45 2,377 
September 30, 20181,747 185 (32)1,900 
We have provided a valuation allowance on certain deferred tax assets. The following table sets forth activities in our valuation allowance:
Valuation AllowanceBalance At
Beginning
of Year
Amounts
Charged To
Expenses
Deductions
and
Adjustments
Balance At
End
of Year
Year ended:
September 30, 2020$2,565 $658 $(275)$2,948 
September 30, 2019133 2,432 2,565 
September 30, 20182,271 (2,138)133 

79

INDEX
MANAGEMENT RESPONSIBILITY
The accompanying consolidated financial statements were prepared by the Company in conformity with accounting principles generally accepted in the United States of America. The Company's management is responsible for the integrity of these statements and of the underlying data, estimates and judgments.
The Company's management establishes and maintains a system of internal accounting controls designed to provide reasonable assurance that its assets are safeguarded from loss or unauthorized use, transactions are properly authorized and recorded, and that financial records can be relied upon for the preparation of the consolidated financial statements. This system includes written policies and procedures, a code of business conduct and an organizational structure that provides for appropriate division of responsibility and the training of personnel. This system is monitored and evaluated on an ongoing basis by management in conjunction with its internal audit function.
The Company's management assesses the effectiveness of its internal control over financial reporting on an annual basis. In making this assessment, management uses the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control – Integrated Framework (2013). Management acknowledges, however, that all internal control systems, no matter how well designed, have inherent limitations and can provide only reasonable assurance with respect to financial statement preparation and presentation. In addition, the Company's independent registered public accounting firm evaluates the Company's internal control over financial reporting and performs such tests and other procedures as it deems necessary to reach and express an opinion on the fairness of the financial statements.
In addition, the Audit Committee of the Board of Directors provides general oversight responsibility for the financial statements. Composed entirely of Directors who are independent and not employees of the Company, the Committee meets periodically with the Company's management, internal auditors and the independent registered public accounting firm to review the quality of financial reporting and internal controls, as well as results of auditing efforts. The internal auditors and independent registered public accounting firm have full and direct access to the Audit Committee, with and without management present.
/s/ David H. Li
David H. Li
Chief Executive Officer
/s/ Scott D. Beamer
Scott D. Beamer
Chief Financial Officer
/s/ Jeanette A. Press
Jeanette A. Press
Principal Accounting Officer
80

INDEX
ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.

ITEM 9A. CONTROLS AND PROCEDURES
EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES
Our management, with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), has conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e)12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act")Act”), this Form 10-K/A also contains certifications pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, which are attached hereto. Because no financial statements have been included in this Form 10-K/A and this Form 10-K/A does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4, and 5 of the certifications have been omitted.

Except as of September 30, 2020.  Based on that evaluation, our CEOdescribed above, this Form 10-K/A does not modify or update disclosure in, or exhibits to, the Original Form 10-K. Furthermore, this Form 10-K/A does not change any previously reported financial results. Information not affected by this Form 10-K/A remains unchanged and CFO have concluded that our disclosure controls and procedures were effective to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported withinreflects the disclosures made at the time periods specified in the SEC's rules and forms, and to ensure that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.Original Form 10-K was filed.
While we believe the present design of our disclosure controls and procedures is effective enough to make known to our senior management in a timely fashion all material information concerning our business, we intend to continue to improve the design and effectiveness of our disclosure controls and procedures to the extent necessary in the future to provide our senior management with timely access to such material information, and to correct any deficiencies that we may discover in the future, as appropriate.
MANAGEMENT'S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Our management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. Internal control over financial reporting is defined in Rule 13a-15(f) or Rule 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, the Company's CEO and CFO, or person’s performing similar functions, and effected by the Company’s board of directors, management and other personnel to provide reasonable assurance regarding the reliability of our financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles in the United States of America. Internal control over financial reporting includes policies and procedures that: pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of the Company's assets; provide reasonable assurance that transactions are recorded as necessary for preparation of our financial statements in accordance with generally accepted accounting principles; provide reasonable assurance that receipts and expenditures of Company assets are made in accordance with management authorization; and provide reasonable assurance that unauthorized acquisition, use or disposition of Company assets that could have a material effect on our financial statements would be prevented or detected on a timely basis. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Our management evaluated the effectiveness of our internal control over financial reporting based on the framework in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this evaluation, our management concluded that the Company's internal control over financial reporting was effective as of September 30, 2020.  The effectiveness of the Company's internal control over financial reporting as of September 30, 2020 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears under Item 8 of this Annual Report on Form 10-K.
CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING
There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
81
 

PART III.
Item 10.5
Item 11.6
Item 12.41
Item 13.44
Item 14.45
PART IV.
Item 15.46
Item 16.47
50
INDEX
INHERENT LIMITATIONS ON EFFECTIVENESS OF CONTROLS
Because of inherent limitations, our disclosure controls or our internal control over financial reporting may not prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

ITEM 9B. OTHER INFORMATION
None.
82

INDEX

PART III

ITEM 10.
ITEM 10.DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
The information required by Item 10Directors
As of Form 10-KJanuary 7, 2022, our current directors are as follows:
Richard S. Hill, 69. Mr. Hill was elected a director of our company in June 2012. Mr. Hill retired as the Chairman and Chief Executive Officer of Novellus Systems, Inc. in June 2012 after serving in these positions since 1996, and since 1993 as CEO upon his joining Novellus. Prior to leading Novellus, Mr. Hill held various senior leadership and management positions with respectTektronix, Inc., General Electric, Inc., Motorola, Inc., and Hughes Aircraft, Inc. Mr. Hill also serves as a director of Arrow Electronics, Inc. and Marvell Technology Group Ltd. He also previously served as a director of Xperi, Inc. until June 2020, and of Symantec, Inc. from January until December 2019, also having served as Interim Chief Executive Officer there from May to identification of directors, the existence ofNovember 2019. He received a separately-designated standing audit committee, identification of members of such committee, and identification of an audit committee financial expert, is incorporated by referenceB.S. in bioengineering from the information containedUniversity of Illinois and a M.B.A. from Syracuse University. Based upon Mr. Hill’s management and director experience and his technical background discussed above, the board has concluded Mr. Hill should serve as a director of our company.
Barbara A. Klein, 67. Ms. Klein was elected a director of our company in April 2008. Ms. Klein also is a director of Ingredion, Inc. She retired in May 2008 as the sections captioned "ElectionSenior Vice President and Chief Financial Officer of Directors"CDW Corporation. Prior to that, Ms. Klein held a variety of senior finance positions including Vice President and "Board StructureChief Financial Officer of Dean Foods Company, Vice President and Compensation"Corporate Controller of Ameritech Corporation, and Vice President and Corporate Controller of Pillsbury Co. Ms. Klein received a B.S. in accounting and finance from Marquette University, and an M.B.A. from Loyola University. Based upon Ms. Klein’s management and director experience and her accounting and finance background discussed above, the board has concluded Ms. Klein should serve as a director of our definitive Proxy Statementcompany.
David H. Li, 49. Mr. Li was elected a director of our company in January 2015, and has served as our President and Chief Executive Officer since then. From June 2008 through December 2014, Mr. Li served as our Vice President of the Asia Pacific Region. Prior to that role, Mr. Li served in various leadership roles throughout our business since joining us in 1998. Mr. Li received a B.S. in chemical engineering from Purdue University and an M.B.A. from Northwestern University. Based upon Mr. Li’s management experience, his knowledge of our company, its operations and customers, his knowledge of the chemical and semiconductor industries, and his Asia-focused, cross-border business experience, the board has concluded Mr. Li should serve as a director of our company.
William P. Noglows, 63. Mr. Noglows has served as our Chairman since 2003, and was our President and Chief Executive Officer from November 2003 through December 2014. Mr. Noglows also is a director of Aspen Aerogels, Inc. and Littelfuse, Inc. From 1984 through 2003, he served in various leadership positions at Cabot Corporation, culminating in serving as an executive vice president and general manager. Mr. Noglows had previously served as a director of our company from December 1999 until April 2002. Mr. Noglows received his B.S. in chemical engineering from the Georgia Institute of Technology. Based upon Mr. Noglows’ management experience, his knowledge of our company and its operations, and his knowledge of the chemical and semiconductor industries, the board has concluded Mr. Noglows should serve as a director of our company.
Paul J. Reilly, 64. Mr. Reilly was elected a director of our company in March 2017. Mr. Reilly served as an executive vice president of Arrow Electronics, Inc. through his retirement in January 2017, and had held various leadership roles there, including serving as the executive vice president, finance and operations, and chief financial officer from 2001 through May 2016, and head of global operations from 2009 through May 2016. Prior to joining Arrow in 1991, Mr. Reilly was a certified public accountant at KPMG Peat Marwick. Mr. Reilly also serves as a director of Assurant, Inc., and previously served as a director of comScore, Inc. from September 2017 until August 2019. He has a B.S. in accounting from St. John’s University. Based upon Mr. Reilly’s management and director experience and his accounting and finance background discussed above, the board has concluded Mr. Reilly should serve as a director of our company.

Dr. Anne K. Roby, 57. Dr. Roby was elected a director of our company in June 2021. She most recently served as an Executive Vice President and Member of the Management Committee of Linde plc, a leader in industrial and specialty materials for the Annual Meetingsemiconductor and other industries, from September 2017, upon Linde’s merger with Praxair, Inc., until her retirement in July 2020. Her tenure at Linde capped a more than 25-year career at Praxair prior to the merger, culminating in her serving as a Senior Vice President and Member of Stockholdersthe Office of the Chairman from 2014 to be2017. Prior to this, she was the President, Praxair Asia and Electronics, based in Shanghai, China, for four years. Dr. Roby is the Vice Chair of the Board of the Nuvance Health Network, and is a Trustee of Villanova University. She received her B.Sc. from Villanova University, and her Ph.D. from the University of Delaware, both in Chemical Engineering, and is a Member of the National Academy of Engineering. Based upon Dr. Roby’s management experience and her technical background discussed above, the board has concluded that Dr. Roby should serve as a director of our company.
Susan M. Whitney, 71. Ms. Whitney was elected a director of our company in April 2015. Ms. Whitney retired from the IBM Corporation in 2007, following a 35-year career in which she held various operational leadership roles throughout the company. Ms. Whitney also serves as a trustee of the College of Mt. St. Vincent, and served as a director of LSI Logic Corporation prior to its acquisition by Avago Technologies, Ltd. in 2014. She received her B.A. in mathematics and economics from the College of Mt. St. Vincent. Based upon Ms. Whitney’s management and director experience and her background in technology companies discussed above, the board has concluded Ms. Whitney should serve as a director of our company.
Geoffrey Wild, 65. Mr. Wild was elected a director of our company in September 2015. Mr. Wild is the Chief Executive Officer of Atotech since March 3, 2020 (the "Proxy Statement"). In addition, for2017. He previously had served successively as the Chief Executive Officer of AZ Electronic Materials, Cascade Microtech, Inc. and Nikon Precision, Inc. Mr. Wild previously served as a director of Materion Corporation until December 2019, and Axcelis Technologies, Inc. He received his B.S. in chemistry from the University of Bath, UK. Based upon Mr. Wild’s management and director experience and his technical background discussed above, the board has concluded Mr. Wild should serve as a director of our company.
Executive Officers
For information with respect to the executive officers of our Company, see "Information“Information about our Executive Officers"Officers” in Part I of this Annual Report onour Original Form 10-K and the section captioned "Section 16(a) Beneficial Ownership Reporting Compliance" in the Proxy Statement. Information required by Item 40510-K.
Code of Regulation S-K is incorporated by reference from the information contained in the section captioned "Section 16(a) Beneficial Ownership Reporting Compliance" in the Proxy Statement.Business Conduct
We have adopted a code of business conduct for all of our employees and directors, including our principal executive officer, other executive officers, principal financial officer and senior financial personnel. A copy of our code of business conduct is available free of charge on our Company website at www.cmcmaterials.com. We intend to post on our website any material changes to, or waivers from, our code of business conduct, if any, within two days of any such event.

Audit Committee Members and Financial Expert
ITEM 11. EXECUTIVE COMPENSATION
The information requiredAudit Committee consists of Messrs. Hill, Reilly and Wild and Ms. Klein, with Mr. Reilly serving as the chair. The Board has determined that each current member of the Audit Committee is financially sophisticated under the listing standards of The Nasdaq Stock Market (the “Nasdaq Rules”). The Board has also determined that Mr. Reilly and Ms. Klein are “audit committee financial experts” as defined in Regulation S-K Item 407(d)(5)(ii) adopted by Item 11the SEC. All current members of Form 10-Kthe Audit Committee are considered independent because they satisfy the independence requirements prescribed by the Nasdaq Rules, including those set forth in Rule 10A-3 under the Securities Exchange Act of 1934, as amended.
ITEM 11.EXECUTIVE COMPENSATION
Compensation Discussion and Analysis
In this section, we discuss and analyze our executive officer compensation program and how we compensated each of our named executive officers identified in the following table in fiscal year 2021. The individuals listed below include our chief executive officer, chief financial officer, and our three other most highly compensated executive officers based on total compensation.

NameTitle
David H. LiPresident and Chief Executive Officer
Scott D. BeamerFormer Vice President and Chief Financial Officer
Daniel D. WoodlandVice President and President, Electronic Materials
Jeffrey M. DysardVice President and President, Performance Materials
H. Carol BernsteinVice President, Secretary and General Counsel
As previously disclosed, on November 15, 2021, Mr. Beamer resigned as Vice President and Chief Financial Officer and Jeanette A. Press, our Principal Accounting Officer and Controller, was appointed to the additional role of Interim Chief Financial Officer. A description of the compensation arrangements with Mr. Beamer and Ms. Press in connection with the transition can be found under the headings, “Transition Arrangement with Mr. Beamer” and “Interim CFO Compensation Arrangement,” following the Summary Compensation Table below.
Fiscal Year 2021 Executive Compensation Summary
Our executive compensation program is incorporatedstructured to align our named executive officers’ interests with those of our stockholders, by referencelinking compensation to business objectives and performance, and to attract and retain talented executives. In general, our executive officers, including David H. Li, our President and Chief Executive Officer, and our other named executive officers, are eligible for, and participate in, our compensation and benefits programs according to the same terms as those available to all our employees. Our executive officer compensation program is administered by the compensation committee of our board of directors, which is composed solely of independent directors. The key elements of our executive compensation program are base salary, annual cash incentives pursuant to our Short-Term Incentive Program (“STIP”), and long-term equity incentives. The compensation committee is responsible for determining the level of compensation awarded to our named executive officers and our other executive officers. The compensation committee targets compensation levels that take into account current market practices and believes that offering market-comparable pay opportunities allows our company to maintain a successful and stable executive team.
In fiscal year 2021, we achieved another year of record revenue, driven by the continued remarkable efforts of our worldwide team of employees who tirelessly and safely delivered on commitments to our customers, with a paramount focus on employee health and workplace safety occasioned by the ongoing challenges of the COVID-19 pandemic (the “Pandemic”). However, inflationary and supply chain challenges arising out of the Pandemic, which have affected many other businesses globally, adversely affected our profitability in fiscal year 2021, and as previously disclosed, we have implemented various cost optimization and productivity enhancement measures to mitigate their effect on our company.   Regardless of these challenges, all our businesses have continued in full operation around the world, as they have since the onset of the Pandemic as essential businesses according to various government requirements. As in fiscal year 2020, in fiscal year 2021, we continued to refine our global business continuity plans to help mitigate the impact of the Pandemic and global supply chain disruptions on our operations. We continue our operations with vigilance as the Pandemic has continued through the end of fiscal year 2021 and through our fiscal year 2022 to date. During these challenging times, we have also made efforts to give back and help the communities in which we operate, and to enhance our focus on sustainability, as demonstrated through our recently published 2021 Corporate Sustainability Report, which includes our Fiscal Year 2022 – Fiscal Year 2026 Sustainability Goals.
For fiscal year 2021, our leadership team, composed of our executive officers, including our named executive officers, achieved record revenue for the sixth consecutive year. Our electronic materials business, which comprises approximately 80 percent of our business and serves the semiconductor industry, contributed to this growth and maintained stability throughout the year as the industry showed resilience and some continued strengthening as the Pandemic drove technology demand through work from home, e-learning, and healthcare-related needs. Fiscal year 2021 also marked our first fiscal year operating as the rebranded CMC Materials, Inc. Our fiscal year 2021 results reflect the efforts of our global workforce, led by Mr. Li and our other executive officers, including our named executive officers.
Overview
General
Our executive compensation program is administered by the compensation committee of our board of directors, which is composed solely of independent directors. The compensation committee is responsible for determining the level of compensation paid to our named executive officers and our other executive officers, including determining awards under and administering the CMC Materials, Inc. 2021 Omnibus Incentive Plan (“2021 OIP”) (which replaced the CMC Materials, Inc. 2012 Omnibus Incentive Plan (“2012 OIP”) effective as of our 2021 annual meeting of stockholders). The compensation committee is also responsible for reviewing and establishing all other executive officer compensation programs and plans that we may adopt from time to time. During, and for, fiscal year 2021, the compensation committee made all decisions pertaining to the compensation of our named executive officers and our other executive officers. The compensation committee also reviewed and approved the methodology used for compensation of our general employee population. Our chief executive officer is neither present for voting or deliberation on, nor votes upon decisions relating to, his compensation. In addition, our chief executive officer does not vote upon decisions related to the compensation of our other executive officers. Our chief executive officer evaluates the performance of our other executive officers, including the named executive officers, discusses the compensation and mix and forms of compensation of the other executive officers with the compensation committee’s independent compensation consultant and with the committee, and makes recommendations to the committee with respect to the compensation of the other executive officers. However, the committee makes all final decisions regarding the executive officers’ compensation. Also, our vice president of human resources and her human resources staff support the compensation committee in its work by providing input and recommendations on the overall mix and forms of executive officer compensation, and discuss such matters with the committee’s independent compensation consultant, as directed by the compensation committee. Our vice president of human resources and her human resources staff do not make decisions regarding the amount of compensation for our named executive officers or other executive officers, and are not present for voting on any such matters.
As part of its responsibilities pursuant to its charter, the compensation committee also authorizes and reviews the non-binding stockholder advisory vote to approve our named executive officer compensation, as described in our proxy statement. At our 2021 annual meeting of stockholders, our stockholders approved the company’s named executive officer compensation, as described in our 2021 proxy statement, with approximately 97% of the votes cast in favor of the matter. Our compensation committee and our board of directors met following the 2021 annual meeting to consider the results of such non-binding stockholder advisory vote and made no changes to the company’s executive compensation program as a result of such vote.
Compensation Policy and Overall Objectives
In determining the amount and composition of executive officer compensation, the committee’s goal is to provide compensation that will enable us to:
link the interests of our executive officers to the interests of our stockholders,
align compensation with business objectives and performance, and
attract and retain talented executives.

In general, executive officers, including our President and Chief Executive Officer and our other named executive officers, are eligible for, and participate in, our compensation and benefits programs according to the same terms as those available to all our employees. For example, the terms and conditions of our annual non-qualified stock option and restricted stock unit awards under the 2021 OIP (and previously, the 2012 OIP) are the same for our executive officers as they are for our other employees. Similarly, the health and welfare benefit programs in the countries in which we operate are generally the same for all our employees, including our named executive officers and other executive officers; our executive officers participate in the same Employee Stock Purchase Plan, tax-qualified savings plan (the “401(k) Plan”) and non-qualified supplemental savings plan (the “Supplemental Plan”), according to the same terms, as our other employees. Aside from the information containedchange-in-control severance protection agreements with our named executive officers and other executive officers, and an employment agreement with Mr. Li, all of which are described in greater detail in the “Executive Compensation” section below, we do not have general post-termination of service agreements with our executive officers. Our executive officers have been eligible to participate in our Executive Officer Deposit Share Program, as described in greater detail below in the section captioned "Executive Compensation"entitled “Executive Compensation.” Since December 2017, the mix of annual equity awards granted to Mr. Li and our other named executive officers has been weighted in favor of performance-based awards, which helps to more closely link long term incentives with company performance and the interests of our stockholders. Such awards are more fully described below.
Competitive Compensation Benchmarking
The compensation committee believes that each element of the compensation program should target compensation levels that take into account current market practices. Offering market-comparable pay opportunities allows us to maintain a successful and stable management team. Since our acquisition of KMG Chemicals, Inc. in fiscal year 2019, we broadened our portfolio of specialty materials and strengthened our position as a premier materials supplier to the semiconductor industry by adding KMG’s electronic chemicals business to our portfolio, and also adding the performance materials businesses of KMG, which serve customers in several industries and generally relate to the broader specialty chemicals sector, and made related changes to our peer group of companies for compensation comparison purposes to include specialty materials companies in addition to semiconductor materials companies, as well as companies that have similar levels of revenue, market capitalization, geographic scope, and employment. The compensation committee considers changes to the composition of our peer group from time to time based on changes in our or others’ business, and last reviewed the group during fiscal year 2021 with analysis from the independent compensation consultant to the compensation committee, who as of April 2017 is Meridian. The compensation committee first used the current group for comparison purposes at the end of fiscal year 2019, and confirmed the use of such group (but for any changes due to prior peers no longer being independent entities due to acquisitions in the Proxy Statement.prior year) in fiscal year 2021 to consider benchmarks for fiscal year 2021 annual cash incentives under our STIP, and to assist in its review and consideration of fiscal year 2022 base salaries, annual cash incentive targets, and long-term equity incentive awards. The peer group is comprised of the following companies:

Advanced Energy IndustriesII-VI, Inc.
Brooks Automation, Inc.Ingevity Corp.
Cognex CorporationInnospec Inc.
Coherent, Inc.Macom Technology Solutions
Element Solutions, Inc.Rogers Corporation
Entegris, Inc.Semtech Corporation
FormFactor, Inc.W.R. Grace & Co.

In evaluating the comparison group for compensation purposes, the compensation committee, in consultation with Meridian exercises its discretion and makes its judgment regarding executive officer compensation matters after considering all relevant factors. In general, the compensation committee targets total compensation for our named executive officers and our other executive officers at approximately the 50th percentile for comparable positions within the comparison group, with performance-based elements such as annual cash incentives under our STIP and long-term equity incentives affording a higher-level opportunity depending on the company’s and individual’s performance. A direct correlation may not always exist between the roles, responsibilities, experience and performance of each of our executive officers and those of the position that appears to best correspond to such individual at companies within the comparison group, and in these situations, the compensation committee also may use a comparison to another index, such as those for similarly-sized technology companies (collectively, “comparison group”). In addition, a direct correlation may not always exist between the relevant time period of evaluation given that the fiscal year end of companies within the comparison group is in most cases different from the company’s fiscal year end of September 30, thereby making direct or any comparison difficult, especially when significant macro-economic (i.e., the Pandemic) or other changes occur that materially affect business performance and therefore, compensation differently and in different reporting periods, for each the company and the companies within the comparison group.


9

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
INDEX
Elements of Compensation
The informationkey elements of our compensation program for our named executive officers and other executive officers, and the reasons we provide them, are set forth in the following table:

ElementDescriptionReason Provided
Base SalaryFixed amount paid in cash biweekly, as for all our employees.
As for all our employees, provides named executive officers with a steady, predictable amount of fixed income with merit increases from time-to-time based on performance and market comparisons (if provided, usually effective on January 1 of the calendar year following such evaluation).

Annual Cash Incentives (Short-Term Incentive Program, currently, pursuant to 2021 OIP and previously, pursuant to 2012 OIP)Cash payment made within 75 days following completion of fiscal year depending on company and individual performance, as for all our employees.
As for all our employees, aligns compensation with business objectives and performance by communicating goals and motivating individuals to achieve these goals, and rewarding performance actually achieved.

Long-Term Equity Incentives (currently, pursuant to 2021 OIP and previously, pursuant to 2012 OIP)Performance Share Units (Annual), Restricted Stock/Restricted Stock Unit Awards (Initial, Annual and Deposit Share Program) and Stock Option Grants (Initial, Annual).
As for all our employees who receive awards pursuant to our equity incentive plan, “at risk” and long-term performance goal-based nature of equity awards links interests with those of our stockholders; provides ongoing retention mechanism over vesting periods.

Change in Control Severance Protection Benefits for Executive Officers and other Key Employees (and Post-Termination Agreement for Chief Executive Officer)
Salary and other benefits paid if terminated within a certain period of time pursuant to a Change in Control of our company (three years’ salary and other benefits for Chief Executive Officer; two years’ for other Executive Officers other than Principal Accounting Officer; one year’s for Key Employees and Principal Accounting Officer).

Assures company of dedicated executive and key employee team, notwithstanding the possibility, threat or occurrence of a change in control; provides for continuity of executive management and key employees in the event of an actual or threatened change in control.
Retirement and Other Benefits 401(k) defined contribution savings plan, Supplemental Plan, statutory benefits, basic life and disability insurance and limited perquisites, as for all our employees.
Represents market practice and competitive factors; the Supplemental Plan is a broad-based program for all U.S. employees who exceed the federal 401(k) compensation limit.

Each of these elements is also addressed separately below. In determining compensation for executive officers, the compensation committee considers all elements of an executive officer’s total compensation package in comparison to current market practices, and ability to participate in savings plans and other benefits. On at least an annual basis, the compensation committee considers the base salary, annual cash incentive opportunity under our STIP, and long-term equity incentive elements, and balance among these elements, of each executive officer’s overall compensation.

The receipt and retention by executive officers of certain elements of compensation, such as annual cash incentive and equity-based compensation, are subject to our company’s Code of Business Conduct, and the terms and conditions of relevant program, plan, and grant and award agreements, all of which include provisions that provide that the company may rescind or recover (“clawback”) from an executive officer, including post-separation of service, annual cash incentives and/or equity-based incentives paid or awarded to such executive officer immediately under certain circumstances, including, but not limited to, actions by the individual constituting Cause, as determined by the company in its discretion and as otherwise enforceable under local law and violation of our Code of Business Conduct, including those provisions related to financial reporting (e.g., in the event of a restatement caused by certain factors) and as may be required by Item 12law. In the event of Form 10-Kany such rescission or right of recovery, the individual must repay the amount in question to the company, and the company shall be entitled to set-off against such amount any amount owed to the individual by the company, including unvested equity awards.
Base Salaries
The compensation committee regularly reviews each executive officer’s base salary. Base salaries for executive officers are initially determined by evaluating each executive officer’s level of responsibility, prior experience, breadth of knowledge, internal equity issues and external compensation practices, with particular reference to the comparison peer group of companies. Increases to base salaries are driven primarily by performance and current market practices and are evaluated by the compensation committee based on sustained levels of contribution to the company in the context of our performance-based management process. In the past several years, this generally has meant base salaries around the 50th percentile of the salary ranges of similarly positioned executive officers in the comparison group. The factors the compensation committee considers in determining base salary levels are not assigned specific weights. Rather, the compensation committee reviews all factors and makes base pay determinations that reflect the compensation committee’s analysis of the aggregate impact of these factors.
Current market practices, as represented by a comparison to executive officer base salaries in the comparison peer group of companies continued to serve as the primary reference for the compensation committee with respect to deciding upon any changes to base salary for both fiscal year 2021 (effective as of the January 1, 2021 pay period) and fiscal year 2022 (effective as of the January 1, 2022 pay period), similar to fiscal year 2020 (effective as of the January 1, 2020 pay period). Over this period, the comparative data reflect the effects of macroeconomic and industry factors, set in the context of individual company performance.  In light of the Pandemic-related inflationary and supply chain challenges to our business described above, the compensation committee determined not to increase the base salaries of any of our named executive officers for 2022.
According to methodology consistent with the above, the resulting base salaries for 2021 and 2022 for each of the named executive officers are:

Name
2021 Base Salary ($)
(Effective as of the
January 1, 2021 Pay Period)
Percentage Increase
Over FY 2020
and Reasoning
2022 Base Salary ($)
(Effective as of the
January 1, 2022 Pay Period)
Percentage Increase
Over FY 2021
and Reasoning
David H. Li735,0005%, in consideration of market comparables and individual and company performance735,000See above
Scott D. Beamer432,6003%, in consideration of market comparables and individual and company performance432,600*N/A
Daniel D. Woodland500,0005.3%, in consideration of market comparables and individual and company performance500,000See above
Jeffrey M. Dysard445,50010%, in consideration of market comparables, his relatively recent promotion to his current position and individual and company performance445,500
See above
 
H. Carol Bernstein425,3005%, in consideration of market comparables and individual and company performance425,300See above
*Mr. Beamer will continue to receive his base salary during the transition period until February 1, 2022 following his resignation as an executive officer on November 15, 2021, as described in greater detail under the heading, “Transition Arrangement with Mr. Beamer,” following the Summary Compensation Table below.

Annual Cash Incentives Under Our Short Term Incentive Program (STIP)
All the company’s employees are eligible to participate in the company’s annual cash incentive program, the STIP. This program is incorporatedadministered pursuant to our 2021 OIP (and previously, pursuant to our 2012 OIP), with executive officer, including named executive officer, payouts, if any, determined by the compensation committee. As with all employees, executive officers’ opportunities to earn annual cash incentives correspond to the degree to which our company achieves the annually-established goals under the STIP. The compensation committee believes that an annual cash incentive program allows us to communicate specific goals that are of primary importance during such year and motivates executive officers to achieve these goals.
Performance-Based Management Program and Company Performance Objectives: At the beginning of each fiscal year, the compensation committee and board of directors establish specific performance goals for the company in accordance with our performance-based management process. These objectives are set to reflect the key elements of our annual plan and budget, and provide a common platform for our initiatives for the year, which are set within the context of our focus on achievement of our longer-term strategic initiatives. Throughout the year, our senior management periodically reviews the company’s progress in achieving these goals with our board of directors and compensation committee. In November 2020, according to our annual practice, the board of directors and compensation committee approved our Fiscal Year 2021 Company Performance Objectives, which also served as our Performance Goals for the purposes of our STIP. The fiscal year 2021 STIP Performance Goals were chosen to encourage a particular and enhanced focus on certain aspects of our company’s performance, business strategy and objectives for our named executive officers and other executive officers, and for which all our executive officers collectively have responsibility for influencing and driving.
The board of directors and compensation committee selected revenue and earnings before interest, income taxes, depreciation and amortization, adjusted for certain items that affect comparability from period to period (“adjusted EBITDA”), as our Fiscal Year 2021 Company Performance Objectives and STIP Performance Goals. These are financial measures that are consistent with those used by the investment community to evaluate the performance of our company, and which the board and committee determined would be appropriate goals by which to incent the ongoing balanced performance of the company and its executive officers, across all its operational units, within the industry environment anticipated in early fiscal year 2021. The Fiscal Year 2021 Company Performance Objectives and STIP Performance Goals with corresponding Weighting, Measures for evaluating attainment of such, and corresponding Performance Targets were as follows:

 FY21 STIP Achievement Against Performance Goals 
Performance Objectives and Weighting Threshold  Target  Stretch  Actual 
Revenue, $M (Weighted 50%) 
$
1,104.1
  
$
1,200.1
  
$
1,296.1
  
$
1,199.8
 
Adjusted EBITDA, as a percentage of Revenue (Weighted 50%)  
31.0
%
  
32.0
%
  
33.0
%
  
29.9
%
Performance Goals, Cash Incentive Pool and Cash Incentive Calculation: As in prior years, in fiscal year 2021, the level of achievement of the noted two Fiscal Year 2021 STIP Performance Goals served as the mechanism by which the company determined the amount of funding for our STIP Pool, which is approved by the compensation committee for our named executive officers and other executive officers.

To determine the funding of the STIP Pool, the performance goals generally are weighted, based on their relative importance to achieving the company’s overall goals. Then, for each performance goal, “threshold”, “target” and “stretch” metrics, or levels, of performance are established. Because each year our performance goals are set to reflect the key objectives of our annual plan and budget, the “threshold”, “target” and “stretch” metrics for each goal are designed to reflect increasing levels of difficulty and motivation in achieving each level; even the “threshold” level requires demonstrated significant achievement against objectives. For fiscal year 2021, the company set challenging Performance Targets for the STIP Performance Goals to encourage focus on continuing to achieve our strategic initiatives, regardless of any difficult industry or macroeconomic conditions (i.e., the Pandemic). As part of our senior management’s periodic review throughout the year of our progress in meeting our Company Performance Objectives and STIP Performance Goals with the compensation committee and board of directors, performance is discussed against a particular goal’s “threshold”, “target” and “stretch” levels.
The “threshold” level of performance for a particular performance goal represents the lowest level of performance for which any cash incentive would be earned on that goal. The “stretch” level of performance represents the level for which the maximum cash incentive would be earned for that particular goal, and the “target” represents the target level of performance. The actual cash incentive earned, if any, attributable to each performance goal is calculated based on the actual performance compared to these “threshold”, “target” and “stretch” performance levels, and these are added together for all the performance goals to determine the funding of the STIP Pool. In turn, the STIP Pool is allocated for payment of annual cash incentives to executive officers, including our named executive officers. For fiscal year 2021, the cash incentive payout for a particular executive officer was calculated by taking the applicable target annual cash incentive opportunity (percentage of base pay), multiplied by the weighting factor (for executive officers, 100% based solely on company achievement of performance goals), and multiplied by the performance factor (actual achievement of performance goals, ranging from 0% to 200%).
In addition, in certain years, in assessing the company’s overall performance and calculating the funding of the STIP Pool for our named executive officers and other executive officers, the compensation committee also may consider certain additional factors, such as, for example, acquisition activity or the impact of global or other events beyond the company’s control (i.e., the Pandemic), that may have affected our company’s achievement of certain of the Performance Goals that the committee considered important in evaluating the company’s performance for the particular fiscal year, but that were not able to be known to the company at the time the year’s STIP Performance Goals and related metrics were established. Examples of additional factors that the compensation committee considered in fiscal year 2021 were acquisition-related costs, acquisition-related amortization costs, restructuring and impairment charges related to the company’s wood treatment and pipeline and industrial materials businesses, superfund remedial action phase accruals, and certain operational costs (net of grants) related to the Pandemic.
For employees other than our named executive officers and other executive officers, the fiscal year 2021 STIP performance goals and measures were tied to a combination of the performance of the overall company and business segments to which such employees provided services in fiscal year 2021, and also included consideration of employees’ performance against their individual performance goals.
Individual Executive Officer STIP Target Levels and Cash Incentives Earned Under Our STIP: The compensation committee, in consultation with Meridian, its independent compensation consultant, has established an STIP award target for each executive officer, including each named executive officer, by evaluating factors such as external pay practices, with particular reference to the comparison group of companies (as described above, STIP award targets are established for each of our executive officers based on an individual’s role). In this regard, for fiscal year 2021, the compensation committee retained the STIP award targets for Mr. Li at 105% and for Mr. Beamer, Dr. Woodland, Dr. Dysard and Ms. Bernstein at 65%. As described above, actual payouts for cash incentive awards to executive officers are determined by the level of performance of our company, which as described above, consisted of performance for fiscal year 2021 exceeding the threshold level for revenue and falling just short of the threshold level for adjusted EBITDA. The compensation committee determined that overall performance against the fiscal year 2021 STIP Performance Goals was achieved at 49.9% of target. Thus, for fiscal year 2021, the actual payouts for cash incentive awards for all executive officers, including the named executive officers, as well as for the corporate component of performance for all employees, were reflected at the 49.9% level. The STIP award targets and actual amounts earned for our named executive officers for fiscal year 2021 were as follows:

 Name
Fiscal Year 2021
STIP Target (as %
of Base Salary)
Fiscal Year 2021
STIP Target* ($)
Fiscal Year 2021
Actual Cash
Incentive Earned** ($)
 David H. Li  
105
  
771,750
  
380,481
 
 Scott D. Beamer  
65
  
281,200
  
139,300
 
 Daniel D. Woodland  
65
  
325,000
  
160,100
 
 Jeffrey M. Dysard  
65
  
289,600
  
141,200
 
 H. Carol Bernstein  
65
  
276,400
  
136,300
 

*
The STIP award target is calculated by reference to the actual base salary earned with respect to the fiscal year.
**
In assessing our company’s and executive officers’ achievement of the noted Performance Goals for purposes of the multiplier described above, the compensation committee concluded that a performance factor of 49.9% had been achieved and the STIP pool was funded accordingly, with allocation to the executive officers according to this percentage achievement. In assessing each named executive officer’s individual performance for fiscal year 2021, and for purposes of the multiplier described above, the compensation committee pursuant to its ability to exercise negative discretion, ultimately decided upon a factor of 1.0 for each named executive officer that recognized the collective contributions of the executive officers to the company’s success for the year.
As discussed above, cash incentives awarded to our executive officers are subject to rescission and recovery (“clawback”) by the company in certain circumstances.
Fiscal Year 2022 STIP, Performance Goals and STIP Targets: In November 2021, according to our annual practice, the compensation committee set our fiscal year 2022 STIP Performance Goals, generally using the process described above. The Performance Goals approved for fiscal year 2022 for all executive officers and certain other senior management of the company are financial goals that include revenue and adjusted EBITDA. In addition, the compensation committee approved and set the individual performance factor multiplier for each participant at the maximum level of 200%, and the compensation committee retained discretion to reduce this amount. The fiscal year 2022 STIP targets for all the named executive officers, including Mr. Li, remained unchanged from the information containedfiscal year 2021 STIP targets. All our named executive officers and other executive officers are eligible to participate in the sections captioned "Stock Ownership"STIP based on the achievement of these overall company objectives. All our employees, other than our named executive officers and “Equity Compensation Plan Informationother executive officers, are eligible to participate in the fiscal year 2022 STIP subject to achievement of a combination of overall company and specific business segment goals, as well as achievement of certain individual performance objectives.
Long-Term Equity Incentives
Long-term equity incentives are provided to our named executive officers and other executive officers pursuant to the 2021 OIP (and before the 2021 OIP was adopted in March 2021, the 2012 OIP). All the company’s employees are eligible to participate in the 2021 OIP (and previously, the 2012 OIP), with the compensation committee determining all awards to executive officers, including named executive officers. The compensation committee believes that equity-based compensation is essential to our overall compensation program because it involves at-risk components of compensation that directly link our executive officers’ interests with those of our stockholders. The compensation committee, in consultation with its independent compensation consultant, evaluates the balance of equity-based compensation with cash compensation by considering factors such as the desired balance between the two elements, external compensation practices (particularly those practices of the comparison group of companies), and the financial impact of providing various kinds and amounts of equity-based compensation to our employees, including our executive officers.
Timing of Grants: Initial or “new-hire” equity grants may be awarded when employees, including our executive officers, join the company. Thereafter, equity grants may be awarded to employees, including each executive officer, annually or from time to time based on performance or certain other factors, such as promotion or retention awards. To enhance retention, equity grants awarded to all employees, including our executive officers, are subject to vesting restrictions that generally lapse over a four-year period, and performance-based awards are generally subject to three-year performance requirements.  For the annual equity award cycle, whether for executive officers, including our named executive officers, or other employees participating in our equity incentive program, our compensation committee has, for more than a decade, made decisions in November, following the close of our fiscal year, for annual awards to be made the first week in December.   Our practice with respect to stock options consistently has been to grant them, as approved by the compensation committee, with an exercise price that is the fair market value, as represented by the closing price on NASDAQ, of our stock on the applicable grant date. It is not our practice to set a stock option’s grant date as a date prior to the date of approval by the compensation committee (i.e., “backdating”), and we never have done so. In addition, we follow our annual award cycle, new hire award, and certain retention award processes, rather than making ad hoc stock option grants or other equity awards.

Allocation Among Award Types: As permitted by the 2021 OIP (and previously, the 2012 OIP), our compensation committee awards non-qualified stock options, restricted stock units and performance share units to certain employees selected to receive awards, including the named executive officers and other executive officers. The performance share units vest based on the company’s achievement of certain performance metrics (average annual revenue growth and cumulative earnings per share), with potential adjustment based on the total shareholder return (“TSR”) achieved by our company relative to the TSR of the S&P MidCap 400 Index over the respective three-year performance period (e.g., ending September 30, 2024, 2023, and 2022, respectively, for each of the fiscal year 2022, fiscal year 2021, and fiscal year 2020 awards), generally subject to continued employment through the end of the performance period. We believe that these performance share unit awards help us to even more directly align our executive officers’ interests with those of our stockholders and further enhance the link between pay and performance. In fiscal year 2021, the compensation committee also approved non-qualified stock option and time-based restricted stock unit awards to the company’s named executive officers and other executive officers with terms and conditions that are generally consistent with the awards granted in prior years. All equity awards granted in fiscal year 2021 provide for accelerated vesting, either in full or on a prorated basis, upon the recipient’s “retirement,” defined as the termination of the recipient’s employment following the attainment of a combination of age and years of service of at least 70, with a minimum of 55 years of age, or upon an involuntary termination of employment due to a position elimination or reorganization of the company. In addition, these awards will vest in full in the event of a change in control (see “Treatment of Equity Awards” following the Potential Payments Upon Termination or Change in Control table below for more information). For additional information regarding the fiscal year 2021 performance share unit awards, please see footnote 5 to the Grants of Plan-Based Awards table in the “Executive Compensation” section below.
In determining the allocation among award types for a particular fiscal year, our compensation committee considers a number of factors, including the overall number of units to be awarded pursuant to our annual equity incentive award program to all employees. The allocation of value for the fiscal year 2021 long-term equity incentive awards made to our named executive officers (other than Mr. Li) was 40% in the form of performance share units, 30% in the form of non-qualified stock options and 30% in the form of time-based restricted stock units, to reflect current market practices. As previously disclosed, upon the advice of the independent compensation consultant to the compensation committee, the compensation committee decided to award Mr. Li (as chief executive officer of our company) fiscal year 2021 long-term equity incentive awards with a value of 50% in the form of performance share units, 25% in the form of non-qualified stock options and 25% in the form of time-based restricted stock units.
Our compensation committee believes that this mix of awards competitively balances the types of equity incentives being awarded to our employees, and also appropriately addresses the financial impact of the expensing of equity-based compensation required pursuant to an accounting standard issued by the Financial Accounting Standards Board (ASC 718).
The breakdown of the allocation of value for the fiscal year 2022 long-term equity incentive awards is the same as set forth above for fiscal year 2021 for Mr. Li and for our other named executive officers.
Size of Awards: When determining awards for individual executive officers under the 2021 OIP (and previously, the 2012 OIP), the compensation committee primarily considers compensation practices and equity values awarded by the comparison group of companies, as well as the executive officer’s level of current and potential future responsibility, and also considers performance in the prior year and the underlying economic value associated with equity incentive awards. In determining award sizes, the compensation committee does not assign specific weights to these factors. Rather, the factors are evaluated on an aggregate basis. In November 2020, according to our annual practice, the compensation committee, upon the advice of its independent compensation consultant, considered all these factors in deciding our fiscal year 2021 annual equity incentive awards to be made on December 3, 2020, under the 2012 OIP, which for our named executive officers are shown in the following table:

 Name 
Fiscal Year 2021
Non-Qualified Stock
Option Grant (#)
  
Fiscal Year 2021
Restricted Stock Unit Award (#)
  
Target Performance Share Unit
Award (#) for the Fiscal Year
2021 through Fiscal Year 2023
Performance Period
 
 David H. Li 
23,196
  
6,680
  
13,360
 
 Scott D. Beamer 
6,610
  
1,903
  
2,538
 
 Daniel D. Woodland 
6,958
  
2,004
  
2,672
 
 Jeffrey M. Dysard 
5,915
  
1,703
  
2,271
 
 H. Carol Bernstein 
5,362
  
1,603
  
2,137
 

In November 2021, according to our annual practice, the compensation committee considered the same factors described above in deciding our fiscal year 2022 annual equity incentive awards to be made on December 6, 2021, under the 2021 OIP, which for our named executive officers are shown in the following table:

 Name 
Fiscal Year 2022
Non-Qualified Stock
Option Grant (#)
  
Fiscal Year 2022
Restricted Stock Unit Award (#)
  
Target Performance Share Unit
Award (#) for the Fiscal Year
2022 through Fiscal Year 2024
Performance Period
 
 David H. Li 
21,105
  
7,580
  
15,160
 
 Scott D. Beamer* 
  
  
 
 Daniel D. Woodland 
5,803
  
2,274
  
3,032
 
 Jeffrey M. Dysard 
5,381
  
1,932
  
2,577
 
 H. Carol Bernstein 
4,642
  
1,819
  
2,425
 
*As previously disclosed, Mr. Beamer resigned as Vice President and Chief Financial Officer on November 15, 2021 and as such, he did not receive any equity incentive awards with respect to fiscal year 2022.
In general, the compensation committee has not considered any actual amounts that may have been realized from prior equity-based compensation awards in awarding subsequent equity-based compensation, or other elements of compensation. However, in considering awards under the 2021 OIP (and previously, the 2012 OIP) to our employees, including executive officers, the compensation committee does consider whether equity-based awards that previously may have been made to them continue to fulfill the purposes of motivation and retention.
All our executive officers have meaningful equity ownership in our company through participation in various equity-based programs such as the Employee Stock Purchase Plan, Executive Officer Deposit Share Program, and our annual equity incentive award program, but we do not currently have equity-ownership requirements or guidelines for our executive officers.
Vesting of Fiscal Year 2019 through Fiscal Year 2021 Performance Share Unit Awards: In January 2019, each of our named executive officers received grants of performance share units for the performance period beginning on October 1, 2018 and ending on September 30, 2021. The performance share units were subject to vesting conditions based on the company’s achievement of average annual revenue growth and cumulative earnings per share metrics during the performance period. If threshold, target or maximum were attained for these measures during the performance period, 50%, 100% or 200% of the target performance share units for each named executive officer, respectively, would be earned, subject to potential upward (+20%) or downward (-20%) adjustment based on the TSR achieved by our company relative to the TSR of the S&P MidCap 400 Index over the three-year performance period.
The Company Performance Objectives applicable to the performance share units and Performance Goals with corresponding Weighting, Measures for evaluating attainment of such, and corresponding Performance Targets were as follows:

 FY19-21 PSU Award Achievement Against Performance Goals 
Performance Objectives and Weighting 
Threshold
(50%)
  
Target
(100%)
  
Stretch
(200%)
  Actual 
Revenue Growth (Weighted 50%)  
4%

  
7%

  
10%

  
4.1%

Cumulative Earnings per Share (Weighted 50%) 
$
15.75
  
$
21.00
  
$
24.50
  
$
20.70
 
Our relative TSR ranking within the S&P MidCap 400 Index over the three-year performance period was in the 55th percentile, resulting in no adjustment to the award payout based on relative TSR.

The target number of performance share units granted to each named executive officer for the fiscal year 2019 through fiscal year 2021 performance share unit award, our overall actual performance, and the resulting share amounts earned, are set forth in the table below:

 Name 
Target Performance
Share Unit Award (#)
for the Fiscal Year
2019 through Fiscal
Year 2021
Performance Period
 
Revenue Growth
and
Cumulative EPS
Actual Performance
  Relative TSR Multiplier  
Overall Actual
Performance
  
Actual Shares
Earned (#)
 
 David H. Li  
13,728
  
74.7
%
  
1.0
x
  
74.7
%
  
10,255
 
 Scott D. Beamer  
3,295
  
74.7
%
  
1.0
x
  
74.7
%
  
2,461
 
 Daniel D. Woodland  
3,494
  
74.7
%
  
1.0
x
  
74.7
%
  
2,610
 
 Jeffrey M. Dysard  
1,997
  
74.7
%
  
1.0
x
  
74.7
%
  
1,492
 
 H. Carol Bernstein  
2,895
  
74.7
%
  
1.0
x
  
74.7
%
  
2,163
 
Clawback Policy; Anti-Hedging or Anti-Pledging Policy: As discussed above, equity-based compensation awarded to our executive officers is subject to rescission and recovery (“clawback”) by the company in certain circumstances. In addition, all equity-based compensation is subject to all the terms of our 2021 OIP (or the 2012 OIP, as applicable), the respective grant and award agreements for particular grants and awards, our Code of Business Conduct, our Insider Trading and Non-Disclosure Policy, including Trading Guidelines for Directors, Executive Officers and Other Key Employees, and our Reporting Requirements and Trading Guidelines for Directors and Executive Officers Under Section 16 of the Exchange Act and Rule 144 Under the Securities Act of 1933; as applicable, noted policies and procedures apply to any and all equity in our company held by our executive officers. For example, our executive officers, as well as our directors and designated other key employees, observe various requirements, such as those related to quarterly trading and other “blackout” periods, and affirmative pre-clearance of any transactions in our company’s securities. Our executive officers and directors are prohibited from and do not hedge or pledge equity in our company.
Change in Control Severance Protection Benefits.
The terms and conditions of the change in control severance protection agreements with our named executive officers and the employment letter with Mr. Li are described in more detail in the section entitled “Executive Compensation,” below. The board of directors and compensation committee originally determined the terms and conditions of the change in control severance protection agreements, including the severance benefit payable, and the triggering events for the payment of such severance benefit, pursuant to such agreement, in consultation with their independent compensation consultant and our financial and other advisors, and considered external practices at similarly situated companies regarding change in control arrangements. The board of directors and compensation committee also review the costs and benefits of the change in control severance protection agreements periodically. As a result of the most recent review, the board of directors and compensation committee, with advice from an independent outside compensation consultant regarding market practices, determined that the design of such agreements remains competitive and reasonable. The agreements are described in more detail in the section entitled “Executive Compensation,” below.
Retirement and Other Benefits.
We have adopted various employee benefit plans and arrangements for the purpose of providing employee benefits to our employees, including our executive officers. In general, the same terms apply to all our employees, including our executive officers. These plans and arrangements include our Employee Stock Purchase Plan, the 401(k) Plan, the Supplemental Plan, and the CMC Materials Health and Welfare Benefit Plan.
CEO Compensation
When Mr. Li became our President and Chief Executive Officer effective January 1, 2015, the compensation committee, in consultation with the committee’s independent compensation consultant at the time, considered the executive compensation practices described above to determine the terms of Mr. Li’s initial compensation, comprised of base salary, annual cash incentive under our STIP, and equity-based compensation elements, along with other terms, which are part of Mr. Li’s employment letter agreement with our company.

Upon completion of fiscal year 2021, the compensation committee, in consultation with the compensation committee’s independent compensation consultant, Meridian, considered the executive compensation practices described above, including the performance goals established by the committee, to determine Mr. Li’s total compensation, composed of an annual base salary, an annual cash incentive payment under our STIP for fiscal year 2021, and for fiscal year 2022 according to the annual equity incentive award cycle for which all employees were eligible, a non-qualified stock option grant, performance-share unit award, and restricted stock unit award. In addition, in setting both the cash-based and equity-based elements of Mr. Li’s compensation, the compensation committee made an overall assessment of Mr. Li’s leadership in achieving the company’s long-term and short-term strategic, operational and business goals. The compensation committee noted Mr. Li’s leadership throughout fiscal year 2021, which continued to be especially challenging due to the Pandemic. As noted above regarding the company’s performance overall in fiscal year 2021, the compensation committee observed that throughout the ongoing Pandemic, the company had continued to operate safely all manufacturing facilities, and also had secured its supply chain and had continued to supply customers on an ongoing basis despite Pandemic-related operational and logistics constraints, including inflationary and supply chain pressures. In addition, during the fiscal year and ongoing Pandemic, Mr. Li had continued to maintain and emphasize the Company’s culture and values. Further, he led the company to achieve another year of record revenue. Fiscal year 2021, in which the company recorded record revenue and other strong financial results, especially with respect to the company’s electronic materials business segment, followed consecutive successful years in fiscal years 2020 and 2019. Related to the company’s long-term strategic initiatives, the compensation committee noted Mr. Li’s leadership with respect to ongoing plans to continue to grow the company profitably and faster than the industries that it serves, while implementing cost and productivity improvement measures. The compensation committee, using its discretion, also considered Mr. Li’s compensation with respect to chief executive officers among the comparison group of companies, as well as equitable and consistent treatment compared to our other executive officers. In addition to these factors, as described in greater detail above, Mr. Li’s cash incentive award for fiscal year 2021, which was paid under our STIP, reflected the company’s overall performance against the pre-established goals for fiscal year 2021.
Based upon all this, the compensation committee awarded Mr. Li $380,481 as a cash incentive for fiscal year 2021. Mr. Li’s fiscal year 2021 cash incentive under our STIP of $380,481, together with his $726,250 base salary paid during fiscal year 2021, resulted in total cash compensation to Mr. Li for fiscal year 2021 of $1,106,731, which was a decrease of $418,269 from Mr. Li’s total cash compensation for fiscal year 2020 of $1,525,000, comprised of base salary paid in fiscal year 2020 of $700,000 and cash incentive under our STIP for fiscal year 2020 of $825,000.
In addition, as noted above and as reported in footnotes 2 and 3 to the 2021 Grants of Plan-Based Awards table that follows, in November 2021, according to our annual practice, the compensation committee awarded Mr. Li equity-based compensation to be made on the annual equity award date of December 6, 2021, in the form of 21,105 non-qualified stock options, 7,580 restricted stock units, and 15,160 performance share units (at target). Aside from the number of non-qualified stock options, restricted stock units and performance share units awarded, the terms and conditions of these grants and awards are the same as those for grants and awards made to our other employees and executive officers, including provisions that unvested awards will be forfeited at the time of certain terminations of employment. Because these equity awards were made after the completion of fiscal year 2021, they are reported in the referenced footnote and not specifically reported in the compensation tables that follow.
As noted above, the compensation committee and the board of directors review on a periodic basis the hypothetical costs to the company of Mr. Li’s change-in-control severance protection agreement, and those of the company’s other executive officers and key employees who have such agreements.

Regulatory and Other Factors
Internal Revenue Code Section 162(m). In its review of compensation matters, one of the factors the compensation committee considers is the anticipated tax treatment to our company and to our executive officers of various payments and benefits. Section 162(m) of the Internal Revenue Code (“Section 162(m)”) generally places a $1 million limit on the amount of compensation payable to certain covered executive officers that a company may deduct in any one year. While the compensation committee generally considers this limit when determining executive officer compensation, there are instances in which the compensation committee has concluded, and reserves the discretion to conclude in the future, that it is appropriate to exceed the limitation on deductibility under Section 162(m) such that executive officers are compensated in a manner that it believes to be consistent with the company’s best interests and those of its stockholders. Furthermore, interpretations of and changes in the tax laws, and other factors beyond the compensation committee’s control, may also affect the deductibility of compensation.
It is no longer necessary to include specific Section 162(m)-related limitations or provisions in our compensation plans and programs or to request stockholder approval for the purpose of a performance-based compensation exception to the $1 million limit referenced above. The company will continue to seek stockholder approval of certain compensation plans as may be required by applicable laws, regulations, or the rules of the applicable exchange on which the company’s shares are listed.
Other Factors. As described above, our compensation committee uses awards of performance share units, restricted stock and restricted stock units in addition to grants of non-qualified stock options to, among other reasons, address the financial impact of the expensing of equity-based compensation required under FASB ASC Topic 718. In addition, the company has intended for its non-qualified deferred compensation plans and other plans, programs and agreements subject to the requirements of Internal Revenue Code Section 409A to be in compliance with such requirements.
Executive Compensation
The following tables set forth certain compensation information for our Chief Executive Officer, Chief Financial Officer, and three other most highly compensated executive officers of the company (collectively, the “named executive officers”) for the fiscal year ended September 30, 2020”2021. Information for the fiscal years ended September 30, 2020 and September 30, 2019 is also presented for executive officers who were named executive officers during those years.
Summary Compensation Table
Name and Principal
Position
Year 
Salary
($)
  
Stock Awards
($)1
  
Option Awards
($)1
  
Non-Equity
Incentive
Plan
Compensation
($)2
  
All Other
Compen-
sation
($)3
  
Total Compen-
sation
($)
 
David H. Li
2021
   
726,250
  
3,004,303
   
1,186,107
   
380,481
   
298,319
   
5,595,460
 
President and Chief
Executive Officer
2020
   
700,000
  
2,423,521
   
938,799
   
825,000
   
264,081
   
5,151,401
 
2019
   
687,500
  
2,120,064
   
707,868
   
742,000
   
451,304
   
4,708,736
 
Scott D. Beamer
2021
   
429,450
  
668,283
   
337,996
   
139,300
   
28,709
   
1,603,738
 
Former Vice President and
Chief Financial Officer4
2020
   
418,000
  
531,294
   
260,822
   
304,800
   
46,896
   
1,561,812
 
2019
   
409,000
  
583,744
   
254,815
   
283,900
   
46,919
   
1,578,378
 
Daniel D. Woodland
2021
   
493,750
  
693,130
   
355,791
   
160,100
   
47,979
   
1,750,750
 
Vice President and President, Electronic Materials
2020
   
462,650
  
554,086
   
276,407
   
337,400
   
44,224
   
1,674,767
 
2019
   
414,200
  
619,274
   
270,295
   
293,200
   
51,064
   
1,648,033
 
Jeffrey M. Dysard
2021
   
435,375
  
639,001
   
302,458
   
141,200
   
43,367
   
1,561,401
 
    Vice President and
2020
   
391,250
  
429,190
   
189,732
   
285,300
   
36,404
   
1,331,876
 
President, Performance Materials
2019
   
337,278
  
353,972
   
154,470
   
221,200
   
127,462
   
1,194,383
 
H. Carol Bernstein
2021
   
420,225
  
554,385
   
300,985
   
136,300
   
43,490
   
1,455,385
 
Vice President, Secretary and General Counsel
2020
   
400,000
  
459,137
   
233,483
   
291,700
   
48,678
   
1,432,998
 
2019
   
380,075
  
512,889
   
227,023
   
265,300
   
54,950
   
1,440,237
 


1
The amounts in the column headed “Stock Awards” represent the aggregate grant date fair value of grants in fiscal years 2021, 2020 and 2019 computed in accordance with ASC 718. The actual value realized by a named executive officer related to stock or stock unit awards will depend on the market value of our common stock on the date the stock is sold. For restricted stock unit awards, the fair value is equal to the underlying value of the stock and is calculated using the closing price of our common stock on the award date. For performance share unit awards, the fair value is equal to the grant date fair value computed in accordance with ASC 718. The maximum potential value of the fiscal year 2021 performance share unit awards is shown below:

Name
Performance
Share
Units at
Maximum
Value ($)
Mr. Li
4,013,878
Mr. Beamer762,516
Dr. Woodland802,776
Dr. Dysard682,300
Ms. Bernstein642,040
The amounts in the Proxy Statement.column headed “Option Awards” represent the aggregate grant date fair value of grants in fiscal years 2021, 2020 and 2019 computed in accordance with ASC 718 (see Note 16 of Notes to Consolidated Financial Statements included in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021 for a description of the assumptions used in that computation). The actual value realized by a named executive officer related to option awards will depend on the difference between the market value of our common stock on the date the option is exercised and the exercise price of the option.

During fiscal years 2021, 2020 and 2019, no stock awards held by any of our named executive officers were modified or cancelled (forfeited).
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
2
The amounts in the column headed “Non-Equity Incentive Plan Compensation” represent the amounts earned under the STIP for fiscal years 2021, 2020 and 2019.

3
The information in the column headed “All Other Compensation” predominantly reflects amounts that by nature generally recur each year, such as benefit costs we contribute on behalf of our named executive officers in the same manner in which we contribute such costs for all our employees. For example, the information in the column includes contributions (both “nonelective” employer contributions and “matching” contributions) made by us to our tax-qualified savings plan (the “401(k) Plan”) and accruals under our non-qualified supplemental savings plan (the “Supplemental Plan”) according to the standard terms of each of these plans as applied to all our employees, including our named executive officers and other executive officers. Under the 401(k) Plan, we make a nonelective employer contribution on each employee’s behalf of 3% of the employee’s eligible compensation (up to the I.R.S. eligible compensation limit), regardless of whether the employee makes a contribution to the 401(k) Plan, and a safe harbor matching contribution on each employee’s behalf of 100% of the first 6% of the employee’s eligible compensation (up to the I.R.S. eligible compensation limit), that the employee contributes to the 401(k) Plan. With respect to the Supplemental Plan, which applies to all employees, including our named executive officers and other executive officers, at such time as they reach the I.R.S. eligible compensation limit under the 401(k) Plan, we continue to make an employer contribution of the equivalent of 4% of each employee’s eligible compensation (over the I.R.S. eligible compensation limit) to the Supplemental Plan on the employee’s behalf. Through December 31, 2021, employees have not been able to make contributions to the Supplemental Plan.
For fiscal year 2021, contributions as such to the 401(k) Plan and the Supplemental Plan on behalf of the named executive officers were made in the following amounts:
 Name 401(k) Plan ($)  Supplemental Plan ($) 
 Mr. Li  
14,644
   50,423 
 Mr. Beamer  10,697   17,760 

Dr. Woodland
  26,100   21,627 
 Dr. Dysard  25,919   17,196 
 Ms. Bernstein  13,607   16,861 
Similarly, the amounts in the column headed “All Other Compensation” include amounts we provided on behalf of each of our named executive officers for basic life insurance and accidental death and dismemberment insurance coverage in fiscal year 2021, which was provided on the same basis to all our employees. There is no cash surrender value associated with this insurance coverage. The value paid for this coverage in fiscal year 2021 attributable to each named executive officer is $252 for each of Mr. Li, Mr. Beamer, Dr. Woodland, Dr. Dysard, and Ms. Bernstein.
In addition, the figures in the column headed “All Other Compensation” for fiscal year 2021 reflect, for Ms. Bernstein, a transportation allowance for fiscal year 2021 in the amount of $8,000 and an executive physical of $4,770.
The amounts in the column headed “All Other Compensation” for fiscal years 2021, 2020 and 2019 for Mr. Li include certain amounts covered by his employment letter dated December 12, 2014. For fiscal year 2021, the amounts included housing-related expenses of $100,000, transportation expenses of $126,125 (paid in Singapore dollars and converted to U.S. dollars), tax preparation fees of $1,250, and an executive physical of $5,625.
4
Mr. Beamer resigned as Vice President and Chief Financial Officer on November 15, 2021.
Employment Letter with Mr. Li
As described in the Compensation Discussion and Analysis and as previously disclosed, on December 12, 2014, we entered into an employment letter with Mr. Li in connection with his appointment as our President and Chief Executive Officer effective as of January 1, 2015, which set forth his initial base salary and target bonus. Mr. Li also received an initial non-qualified stock option grant and an award of restricted shares of our common stock, each of which have vested in full.

Other than in a situation involving a change of control of our company, which would be addressed by Mr. Li’s Change in Control Severance Protection Agreement that had been previously entered into in 2008, in the event that Mr. Li’s employment is terminated by us without cause or by Mr. Li due to a material breach by us of the employment letter, (1) Mr. Li would be entitled to vesting of stock options and restricted shares held by him, including those described above, to the extent that such awards would have otherwise vested in accordance with their terms during the twelve-month period following the date of termination, and (2) Mr. Li would continue to receive his base salary for twelve months. Receipt of severance and the accelerated vesting described above is subject to Mr. Li’s execution and non-revocation of a release of claims against us.
In the event of a termination of Mr. Li’s employment in connection with a change of control of our company, Mr. Li’s rights are set forth in his existing change in control agreement. As of January 1, 2015, the severance amount multiple pursuant thereto is three times, and the benefits continuation period is 36 months.
Mr. Li is eligible to participate in all employee benefit plans, programs and arrangements applicable to our employees and executive officers. Due to the significant amount of time Mr. Li is expected to spend in Asia (Singapore since March 2019, and China prior to that time) and the United States, Mr. Li is also entitled to the continued provision of a car and driver in Singapore (China until March 2019) on the same basis as applied prior to January 1, 2015, a housing allowance of up to $100,000 per year to be used for housing expenses in Singapore (China until March 2019) and Aurora, Illinois, and a tax equalization benefit, on the same basis as applied prior to January  1, 2015. He also is able to utilize first class travel while he is employed by us.
Transition Arrangement with Mr. Beamer
As previously disclosed, effective as of November 15, 2021 (“Effective Date”), Mr. Beamer resigned as Vice President and Chief Financial Officer of the company. On December 6, 2021, we entered into a letter of understanding (the “Letter”) with Mr. Beamer, regarding the transition of his duties of employment on behalf of the company. Pursuant to the Letter, from the Effective Date through February 1, 2022 (the “Separation Date,” and such period, the “Transition Period”), Mr. Beamer is providing certain transition services in the role of Senior Advisor to the company’s Chief Executive Officer. Following the Separation Date, in consideration of a release of claims from Mr. Beamer and his agreement to abide by certain non-competition, non-solicitation, non-disparagement and confidentiality covenants, Mr. Beamer will receive a cash payment equal to one year of his current base salary ($432,600). The Letter also provides that the company will pay up to $10,000 in professional fees incurred by Mr. Beamer in the process of negotiating and preparing the Letter.
In addition, Mr. Beamer’s non-qualified stock option, restricted stock unit and performance share unit grants and awards under our 2012 OIP will remain outstanding and continue to vest in accordance with their terms during the Transition Period. Mr. Beamer will forfeit any non-qualified stock options and restricted stock units that remain unvested in accordance with their terms as of the Separation Date. In addition, Mr. Beamer will be eligible to vest in (i) his performance share unit award with respect to the 2020 fiscal year through 2022 fiscal year performance period, without proration, based on actual performance results, and (ii) a portion of his performance share unit award with respect to the 2021 fiscal year through 2023 fiscal year performance period, based on actual performance results and prorated for the time that Mr. Beamer was employed by us during such performance period through the Separation Date. Mr. Beamer also will be eligible for certain benefits of his Change in Control Severance Protection Agreement to the extent that a Change in Control, as defined thereunder, occurs within one year of the Separation Date, but any such benefits will be netted against the cash payment received pursuant to the Letter. Mr. Beamer will be reimbursed for up to $15,000 in costs associated with outplacement services. Mr. Beamer will not receive any short-term or long-term incentive awards with respect to the 2022 fiscal year or any future years.

Interim CFO Compensation Arrangement
As previously disclosed, on November 15, 2021, in conjunction with Mr. Beamer’s resignation as Vice President and Chief Financial Officer, the board of directors appointed Jeanette A. Press to the role of Interim Chief Financial Officer, in addition to the roles she already held as Principal Accounting Officer and Controller of the company. For the role of Interim Chief Financial Officer, Ms. Press will receive an incentive cash award of $150,000, to be paid the earlier of three months following the commencement of employment of a permanent chief financial officer, or November 15, 2022, subject to her continued employment through the payment date and certain other terms. In addition, on her appointment date, Ms. Press received an award of 1,162 restricted stock units pursuant to the 2021 OIP, with a grant date value equal to $150,000, which will vest in full on November 15, 2022. While serving as Interim Chief Financial Officer, Ms. Press will continue to receive her base salary, STIP target, and annual long-term equity incentive award target, as well as standard employee benefits, in effect immediately prior to her appointment.
Standard Employee Benefits
We have adopted various employee benefit plans and arrangements for the purpose of providing employee benefits to our employees, including our named executive officers and our other executive officers. In general, the same terms apply to all our employees, including our named executive officers and our other executive officers. These plans and arrangements include the Employee Stock Purchase Plan, the 401(k) Plan, the Supplemental Plan, and the CMC Health and Welfare Benefit Plan.
2021 Grants of Plan-Based Awards
The following table shows all awards granted to the named executive officers during the fiscal year ended September 30, 2021 pursuant to the 2012 OIP and the STIP.
 
Type of
Award
  
Grant
Date
  
Estimated Possible Payouts
Under Non-Equity Incentive
Plan Awards ($) (1)
  



Estimated Possible
Payouts Under Equity
Incentive Plan Awards (#)(2)
  
All Other
Stock
Awards:
Number
of Shares
of Stock
or
Units (#)(2)
  
All Other
Option
Awards:
Number of
Securities
Underlying
Options (#)(3)
   
Exercise
or Base
Price of
Option
Awards
($/Sh)(4)
   
Grant Date
Fair Value
of Stock
and Option
Awards
($)(4)
 
Name    Threshold  Target  Maximum  Threshold  Target  Maximum         
David H. Li 
PSU(5)
  
12/3/20
            
6,680
   
13,360
   
32,064
            
2,006,939
 

 
RSU(6)
  
12/3/20
                     
6,680
         
972,474
 

 
Option(6)
  
12/3/20
                        
23,196
   
145.58
   
1,186,107
 
  STIP   
   
0
   
771,750
   
1,543,500
                      
Scott D. Beamer 
PSU(5)
  
12/3/20
            
1,269
   
2,538
   
6,091
            
381,258
 

 
RSU(6)
  
12/3/20
                     
1,903
         
277,039
 

  
Option(6)
  
12/3/20
                        
6,610
   
145.58
   
337,996
 
  STIP   
   0   
281,200
   
562,400
                      
Daniel D. Woodland 
PSU(5)
  
12/3/20
            
1,336
   
2,672
   
6,413
            
401,388
 

 
RSU(6)
  
12/3/20
                     
2,004
         
291,742
 

 
Option(6)
  
12/3/20
                        
6,958
   
145.58
   
355,791
 

 
STIP
   
   0   
325,000
   
650,000
                      
Jeffrey M. Dysard 
PSU(5)
  
12/3/20
            
1,136
   
2,271
   
5,450
            
341,150
 

 
RSU(6)
  
12/3/20
                     
1,703
         
247,923
 

 
Option(6)
  
12/3/20
                        
5,915
   
145.58
   
302,458
 

 
STIP
   
   0   
289,600
   
597,200
                      
H. Carol Bernstein 
PSU(5)
  
12/3/20
            
1,069
   
2,137
   
5,129
            
321,020
 

 
RSU(6)
  
12/3/20
                     
1,603
         
233,365
 

 
Option(6)
  
12/3/20
                        
5,362
   
145.58
   
300,985
 

 
STIP
��  
   0   
276,400
   
552,800
                      

1
The amounts in these columns reflect the threshold (0%), target (100%) and maximum (200%) amounts that could be earned by each named executive officer pursuant to the STIP for fiscal year 2021. The target STIP opportunity for each named executive officer was based on a percentage of base salary, which was 105% for Mr. Li, and 65% for each of Mr. Beamer, Dr. Woodland, Dr. Dysard, and Ms. Bernstein.
2
The amounts in these columns do not include restricted stock units and performance share units awarded to our named executive officers after the end of fiscal year 2021. On December 6, 2021, as part of our annual equity incentive award program, we awarded restricted stock units to our named executive officers (other than Mr. Beamer) with a fair market value based on the closing price of our stock on the award date of $141.18 per share that lapse in equal increments upon each anniversary over four years, and performance share units to our named executive officers for the performance period of fiscal year 2022 through fiscal year 2024, in the amounts set forth in the table below:

 Name 
Restricted Stock
Unit Award (#)
  
Performance
Share
Unit Award
(#)
(Target)
 
 Mr. Li  
7,580
   
15,160
 
 Mr. Beamer      
 Dr. Woodland  
2,274
   
3,032
 
 Dr. Dysard  1,932   2,577 
 Ms. Bernstein  1,819   2,425 

3
As with all other grants of stock options and stock awards to our named executive officers and other executive officers, other than the number of options or restricted stock or restricted stock units awarded, the terms and conditions of the stock option grants in this column are the same as those made to all other employees.
These amounts do not include options granted to our named executive officers after the end of fiscal year 2021. On December 6, 2021, as part of our annual equity incentive award program, we granted options to our named executive officers (other than Mr. Beamer) that have an exercise price of $141.18, which as with all our grants and awards to date was the fair market value based on the closing price of our common stock on the date of grant, vest in equal increments upon each anniversary over four years and expire on December 6, 2031, in the amounts set forth in the table below:
NameSecurities Underlying Options (#)
Mr. Li
21,105
Mr. Beamer
Dr. Woodland
5,803
Dr. Dysard
5,381
Ms. Bernstein
4,642

4
As with all our grants and stock awards to date, the exercise price was the fair market value based on the closing price of our stock on the date of grant.
The grant date fair value was estimated using the Black-Scholes option pricing formula on the basis of the following assumptions: expected volatility: 39.54%; risk free rate of return: 0.65%; annualized dividend yield: 1.21%; and expected time until exercise: 8.58 years for people who were retirement eligible at the date of grant or those who will become retirement eligible during the four-year vesting period, and 6.75 years for people who were not retirement eligible at the date of grant and who will not become retirement eligible during the four-year vesting period. The differing assumptions reflect the differing statistical likelihoods of the named executive officers satisfying the “Rule of 70” for retirement vesting, which is applicable to all option grants made in fiscal year 2021. The “Rule of 70” means that the employee or executive officer has achieved a combination of age and years of service of at least seventy (70), with a minimum of fifty-five (55) years of age. On the December 3, 2020 grant date, Ms. Bernstein was retirement eligible at the date of grant, and Mr. Li, Dr. Woodland, Mr. Beamer, and Dr. Dysard were not retirement eligible at the date of grant and will not become retirement eligible during the four-year vesting period.
During fiscal year 2021, no stock awards held by our named executive officers were modified or cancelled (forfeited).
5
Payment of each performance share unit award is contingent on the company attaining certain levels of average annual revenue growth and cumulative earnings per share in the fiscal year 2021 through fiscal year 2023 performance period (weighted 50% each). If threshold, target, or stretch (maximum) performance goals are attained in the performance period, 50%, 100%, or 200% of the target amount, respectively, may be earned. If actual performance falls between the threshold and target goals or the target and stretch goals, the payout would be determined using linear interpolation. The shares initially earned based on performance against the performance metrics are subject to potential upward (+20%) or downward (-20%) adjustment based on the company’s relative TSR against a peer group during the performance period, resulting in a maximum payout of up to 240% of target.
6
Each restricted stock unit award and stock option grant vests in 25% increments on each of the first four anniversaries of the grant date.
Executive Officer Deposit Share Program
Our executive officers have been eligible to participate in the Executive Officer Deposit Share Program that our board of directors adopted in March 2000. Under this program, our executive officers have been entitled to use all or a portion of their after-tax annual cash incentive compensation to purchase at fair market value shares of restricted stock awarded under the 2021 OIP (previously, under the 2012 OIP). These shares are retained on deposit with us until the third anniversary of the date of deposit (“deposit shares”), and our company matches the deposit with a restricted stock award equal to 50% of the shares deposited by the participant (“award shares”). If the participant is employed by us on the third anniversary of the deposit date and the deposit shares have remained on deposit with us through such date, the restrictions on the award shares will lapse. As of January 7, 2022, Mr. Li, Mr. Beamer, and Dr. Dysard participate in the Executive Officer Deposit Share Program, as summarized in the table below:

 Name Shares on Deposit (#)  Corresponding Award Shares (#) 
 Mr. Li 335  167 
 Mr. Beamer 279  139 
 Dr. Dysard 1,398  699 
Mr. Beamer will forfeit the award shares set forth in the table above as of February 1, 2022, commensurate with the termination of his employment with our company.

Outstanding Equity Awards at 2021 Fiscal Year-End
The following table shows outstanding equity awards as of September 30, 2021 for each named executive officer.

  Option AwardsStock Awards
 Name 
Number of
Securities
Underlying
Unexercised
Options
(#)
Exercisable(1)
  
Number of
Securities
Underlying
Unexercised
Options
(#)
Unexercisable(1)
  
Option
Exercise Price
($)
  
Option
Expiration
Date
  
Number of
Shares or Units
of Stock That
Have Not
Vested
(#)(2)
  
Market Value
of Shares or
Units of Stock
That Have Not
Vested
($)(2)
  
Equity
Incentive
Plan
Awards:
Number
of
Unearned
Shares,
Units, or
Other
Rights
That
Have Not
Vested
(#)(3)
  
Equity
Incentive
Plan
Awards:
Market or
Payout
Value of
Unearned
Shares,
Units, or
Other
Rights
That Have
Not Vested
($)(3)
 
 David H. Li  
31,100
      
60.27
  12/5/2026             
    
16,540
   5,514   
92.57
  12/5/2027             
    
12,712
   
12,712
   
101.73
  12/6/2028             
    5,903   
17,709
   
127.48
  12/5/2029             
       
23,196
   
145.58
  12/3/2030   
16,987
   
2,093,308
   
25,780
   
3,176,869
 
 Scott D. Beamer  5,847   1,949   
97.89
  1/16/2028                 
    4,576   4,576   
101.73
  12/6/2028                 
    1,640   4,920   
127.48
  12/5/2029                 
       6,610   
145.58
  12/3/2030   8,376   
1,032,174
   
4,838
   
596,187
 
 Daniel D. Woodland  1,055      
46.45
  12/3/2024                 
    7,850      
42.37
  12/3/2025                 
    
15,800
      
60.27
  12/5/2026                 
    7,200   2,400   
92.57
  12/5/2027                 
    4,854   4,854   
101.73
  12/6/2028                 
    1,738   5,214   
127.48
  12/5/2029                 
       6,958   
145.58
  12/3/2030   5,415   
667,290
   
5,112
   
629,952
 
 Jeffrey M. Dysard  1,293      
60.27
  12/5/2026                 
    1,564   1,564   
92.57
  12/5/2027                 
    1,387   2,774   
101.73
  12/6/2028                 
    1,193   3,579   
127.48
  12/5/2029                 
       5,915   
145.58
  12/3/2030   4,560   
561,929
   
3,943
   
485,896
 
  H. Carol Bernstein  5,850   1,950   
92.57
  12/5/2027                 
    4,022   4,022   
101.73
  12/6/2028                 
    1,418   4,254   
127.48
  12/5/2029                 
       5,362   
145.58
  12/3/2030   4,404   
542,705
   
4,157
   
512,267
 
  

1
These columns show the outstanding stock option awards that are classified as exercisable or unexercisable that were held by each named executive officer as of September 30, 2021. The option awards vest or vested over four years in equal increments upon each anniversary of the grant date, with a term expiring on the tenth anniversary of the grant date. Outstanding options that vested after September 30, 2021 are shown in the section entitled “Security Ownership of Certain Beneficial Ownership and Management” above.
2
The restricted stock unit awards made to Mr. Li have the following vesting schedules: 6,680 units vest over four years in equal increments upon each anniversary of the December 3, 2020 award date, 4,659 units vest over three years in equal increments upon each anniversary of the December 5, 2019 award date, 3,432 units vest over two years in equal increments upon each anniversary of the December 6, 2018 award date, and 1,654 units vested on December 5, 2021 upon the anniversary of the December 5, 2017 award date. The restricted stock awards made to Mr. Li under the Deposit Share Program have the following vesting schedules: 395 shares vested on December 12, 2021 upon the third anniversary of the December 12, 2018 award date and 167 shares vest on December 15, 2023 upon the third anniversary of the December 15, 2020 award date.
The restricted stock unit awards made to Mr. Beamer have the following vesting schedules: 1,903 units vest over four years in equal increments upon each anniversary of the December 3, 2020 award date, 1,290 units vest over three years in equal increments upon each anniversary of the December 5, 2019 award date, 1,236 units vest over two years in equal increments upon each anniversary of the December 6, 2018 award date, and 3,808 units vested on January 16, 2022 upon the anniversary of the January 16, 2018 award date. The restricted stock awards made to Mr. Beamer under the Deposit Share Program have the following vesting schedules: 72 shares would vest on December 16, 2022 upon the third anniversary of the December 16, 2019 award date and 67 shares would vest on December 15, 2023 upon the third anniversary of the December 15, 2020 award date. See “Transition Arrangement with Mr. Beamer” above for a description of the treatment of Mr. Beamer’s outstanding equity awards in connection with the termination of his employment with our company.
The restricted stock unit awards made to Dr. Woodland have the following vesting schedules: 2,004 units vest over four years in equal increments upon each anniversary of the December 3, 2020 award date, 1,374 units vest over three years in equal increments upon each anniversary of the December 5, 2019 award date, 1,312 units vest over two years in equal increments upon each anniversary of the December 6, 2018 award date, and 725 units vested on December 5, 2021 upon the anniversary of the December 5, 2017 award date.
The restricted stock unit awards made to Dr. Dysard have the following vesting schedules: 1,703 units vest over four years in equal increments upon each anniversary of the December 3, 2020 award date, 939 units vest over three years in equal increments upon each anniversary of the December 5, 2019 award date, 750 units vest over two years in equal increments upon each anniversary of the December 6, 2018 award date, and 469 units vested on December 5, 2021 upon the anniversary of the December 5, 2017 award date. The restricted stock awards made to Dr. Dysard under the Deposit Share Program have the following vesting schedules: 364 shares vest on December 16, 2022 upon the third anniversary of the December 16, 2019 award date and 335 shares vest on December 15, 2023 upon the third anniversary of the December 15, 2020 award date.
The restricted stock unit awards made to Ms. Bernstein have the following vesting schedules: 1,603 units vest over four years in equal increments upon each anniversary of the December 3, 2020 award date,1,140 units vest over three years in equal increments upon each anniversary of the December 5, 2019 award date, 1,086 units vest over two years in equal increments upon each anniversary of the December 6, 2018 award date, and 575 units vested on December 5, 2021 upon the anniversary of the December 5, 2017 award date.
The value reported with respect to the stock awards held by each named executive officer equals the total number of unvested and unearned stock awards multiplied by $123.23, the closing market price of the company’s stock on the last business day of our fiscal year ending September 30, 2021, plus the following accrued dividend equivalents (which are not paid unless the underlying restricted stock units vest):
Name
Accrued Dividend Equivalents on
Outstanding Restricted Stock Unit
Awards ($)
Mr. Li
57,608
Mr. Beamer
38,955
Dr. Woodland
20,187
Dr. Dysard
13,462
Ms. Bernstein
16,451

3
The total amounts and values in these columns equal the total number of performance share units, at the target level for the fiscal year 2020-2022 performance period and at the maximum level for the fiscal year 2021-2023 performance period, held by each named executive officer and multiplied by the market price of company common stock at the close of the last trading day in fiscal year 2021, which was $123.23 per share. These amounts exclude the performance share units for the fiscal year 2019-2021 performance period that vested based on performance through September 30, 2021, and are reported in the “2021 Option Exercises and Stock Vested” table. In calculating the number of performance share units and their value, we are required by SEC rules to compare our performance through the end of fiscal year 2021 under the performance share unit grants against the threshold, target and maximum performance levels for the grant and report in these columns the applicable potential share number and payout amount. If the performance is between levels, we are required to report the potential payout at the next highest level. For example, if performance through the previous year exceeded target, even by only a modest amount, and even if it is unlikely that we will achieve the results that would dictate the payment of the maximum amount, we are required by SEC rules to report the maximum potential payouts. For the second year of the fiscal year 2020 through fiscal year 2022 performance period, we exceeded threshold levels of average annual revenue growth and cumulative earnings per share and have accordingly reported the performance share units at the target award level for this performance period (i.e., 100% of target). For the first year of the fiscal year 2021 through fiscal year 2023 performance period, we exceeded target levels of average annual revenue growth and cumulative earnings per share and have accordingly reported the performance share units at the maximum award level for this performance period (i.e., 200% of target). Such numbers are further subject to potential upward (+20%) or downward (-20%) adjustment based on the application of the company’s relative TSR multiplier, which will be applied following the completion of each performance period. The total value reported with respect to the performance share units held by each named executive officer includes the following accrued dividend equivalents with respect to each performance period, at the target and maximum levels, respectively (which are not paid unless the performance goals are met with respect to the underlying performance share units):
 Name 
Number of Fiscal
Year 2020 through
Fiscal Year 2022
Performance Shares
(Target)
  
Number of Fiscal
Year 2021 through
Fiscal Year 2023
Performance Shares
(Maximum)
  
Fiscal Year 2020 through
Fiscal Year
2022 Performance
Share Unit
Accrued Dividend
Equivalents ($)
  
Fiscal Year 2021 through
Fiscal Year
2023 Performance
Share Unit
Accrued Dividend
Equivalents ($)
 
 Mr. Li  12,420   26,720   
44,215
   48,630 
 Mr. Beamer  2,300   5,076   
8,188
   9,238 
 Dr. Woodland  2,440   5,344   
8,686
   9,726 
 Dr. Dysard  1,672   4,542   
5,952
   6,086 
 Ms. Bernstein  2,020   4,274   
7,191
   7,779 

2021 Option Exercises and Stock Vested
The following table sets forth certain information regarding stock options exercised during fiscal year 2021 and stock awards vested during fiscal year 2021 for the named executive officers.

  Option Awards  Stock Awards 
 Name 
Number
of Shares
Acquired
on
Exercise
(#)
  
Value
Realized
on
Exercise
($)1
  
Number
of Shares
Acquired
on
Vesting
(#)
  
Value
Realized
on
Vesting
($)2
 
 David H. Li  
38,000
   
3,967,199
   
20,469
   
3,153,159
 
 Scott D. Beamer        7,317   
1,195,571
 
 Daniel D. Woodland        6,674   
1,040,859
 
 Jeffrey M. Dysard        3,374   
524,496
 
 H. Carol Bernstein  3,950   
418,374
   5,886   
919,267
 
   

1
For option awards, the value realized on exercise is equal to the aggregate difference between the exercise price of the options and the fair market value of the shares on the date of exercise.
2
For stock awards (restricted stock units, performance share units, and deposit share program award shares), the value realized is the number of shares vested multiplied by the fair market value of the shares at the time of vesting plus payout of any accrued dividend equivalents.
Pension Benefits
The company does not maintain a defined benefit pension program.
2021 Nonqualified Deferred Compensation
The company maintains the CMC Materials, Inc. Supplemental Employee Retirement Plan, which is a nonqualified supplemental savings plan (the “Supplemental Plan”). The following table discloses the earnings and balances of our named executive officers under the company’s Supplemental Plan that provides for compensation deferral on a non-tax-qualified basis.

 Name 
Registrant
contributions
in last FY ($)1
  
Aggregate
earnings
in last FY ($)
  
Aggregate
balance at
last FYE ($)
 
 David H. Li  50,423   61,328   410,215 
 Scott D. Beamer  17,760   13,240   74,358 
 Daniel D. Woodland  21,627   31,375   145,592 
 Jeffrey M. Dysard  17,196   
7,664
   
60,059
 
 H. Carol Bernstein  16,861   107,874   555,375 
          

1
These amounts are included in the “All Other Compensation” column of the Summary Compensation Table.
Effective May 1, 2000, the company adopted the Supplemental Plan covering all eligible employees as defined by the Supplemental Plan. Through December 31, 2021, participants in the Supplemental Plan, including our named executive officers, do not make any contributions to the Supplemental Plan. The purpose of the Supplemental Plan is to provide for the deferral of the company contributions to certain highly compensated employees as defined under the provision of the Employee Retirement Income Security Act of 1974, as amended. Under the Supplemental Plan, the company contributes up to 4% of the named executive officers’ eligible compensation in excess of the I.R.S. eligible compensation limit. All amounts contributed by the company and earnings on these contributions are fully vested at all times. The same menu of investment funds under the 401(k) Plan is available under the Supplemental Plan. Like the 401(k) Plan, all investment decisions are made by the participants. Participants in the Supplemental Plan are not permitted to make hardship withdrawals prior to termination and distributions under the Supplemental Plan are paid in a lump sum.

Potential Payments Upon Termination or Change in Control
The following table and the accompanying narrative show potential benefits payable to our named executive officers upon the occurrence of the events specified herein, assuming such events occurred on September 30, 2021 and excluding certain benefits generally available to all salaried employees. Footnotes describing the assumptions in calculations are included following the last table in this section, as is a description of the employment terms and plans providing benefits specified in the table below. Except as noted, the amounts disclosed below reflect the aggregate potential payments under each scenario and category. The table does not include amounts to the extent that the form and amount of any payment or benefit are fully disclosed in an earlier table.

 
Named Executive
Officer
and Triggering
Event
 
Cash
Severance
($)1
  
Cash
Incentive
Through
Termination
Date($) 2
  
Cash Incentive
Continuation($)2
  
Retirement
Plan
Contributions($)
  
Accelerated
Vesting of
Equity
Awards($)3
  
Post-
Termination
Healthcare($)4
  
Outplacement
Services($)
  
280G
Tax
Gross
Up($)5
  Total($) 
 David H. Li                           
 
•   Involuntary (Not for Cause or
Good Reason – No Change in
Control)
  735,000            1,166,844            1,901,844 
 •   Involuntary (Not for Cause or Good Reason – With Change in Control)  2,205,000   1,300,000   3,900,000   195,201   
5,712,544
   60,000   110,250   
   13,482,995 
 
•   Position Elimination Termination(6)
                           
 
•   Retirement (Rule of 70)(7)
                           
 •   Death              5,712,544            5,712,544 
 •   Disability              4,395,969            4,395,969 
 Scott D. Beamer 
 •   Involuntary (Not for Cause or Good Reason – No Change in Control)                           
 •   Involuntary (Not for Cause or Good Reason – With Change in Control)  865,200   390,000   780,000   56,914   1,776,133   40,000   64,890      3,973,137 
 •   Position Elimination Termination              1,132,211            1,132,211 
 
•   Retirement (Rule of 70)(7)
                           
 •   Death              1,776,133            1,776,133 
 •   Disability              1,526,633            1,526,633 

 
 
Named Executive
Officer
and Triggering
Event
 
Cash
Severance
($)1
  
Cash
Incentive
Through
Termination
Date($) 2
  
Cash Incentive
Continuation($)2
  
Retirement
Plan
Contributions($)
  
Accelerated
Vesting of
Equity
Awards($)3
  
Post-
Termination
Healthcare($)4
  
Outplacement
Services($)
  
280G
Tax
Gross
Up($)5
  Total($)
 
 Daniel D. Woodland    
 
•   Involuntary (Not for Cause or
Good Reason – No Change in
Control)
                           
 •   Involuntary (Not for Cause or Good Reason – With Change in Control)  1,000,000   494,000   988,000   95,454   1,475,187   40,000   75,000      4,167,641 
 •   Position Elimination Termination              840,722            840,722 
 
•   Retirement (Rule of 70)(7)
                           
 •   Death              1,475,187            1,475,187 
 •   Disability              1,212,323            1,212,323 
 Jeffrey M. Dysard     
 •   Involuntary (Not for Cause or Good Reason – No Change in Control)                           
 •   Involuntary (Not for Cause or Good Reason – With Change in Control)  891,000   289,575   579,150   86,230   1,155,418   40,000   66,825      3,108,198 
 •   Position Elimination Termination              572,417            572,417 
 
•   Retirement (Rule of 70)(7)
                           
 •   Death              1,155,418            1,155,418 
 •   Disability              936,130            936,130 
 H. Carol Bernstein     
 
•   Involuntary (Not for Cause or Good Reason – No Change in Control)(7)
                           
 •   Involuntary (Not for Cause or Good Reason – With Change in Control)  850,600   438,400   876,800   60,937   1,201,232   40,000   63,795      3,531,764 
 
•   Position Elimination Termination(7)
                           
 
•   Retirement (Rule of 70)(7)
              990,297            990,297 
 •   Death              1,201,232            1,201,232 
 •   Disability              990,297            990,297 

1
This figure reflects (i) for Mr. Li only, in the event of a termination not for cause or for good reason not in connection with a Change in Control, the lump sum value of twelve months of salary continuation, or (ii) in the event of a termination not for cause or for good reason in connection with a Change in Control, the lump sum value of three times (in the case of Mr. Li) or two times (in the case of the other named executive officers) the executive’s annual base salary.
2
In accordance with the terms of the change in control agreements described below, for purposes of calculating the annual cash incentive through the termination date, the annual cash incentive amount for each named executive officer is equal to the greatest of: (i) the target annual cash incentive amount for the fiscal year in which the Change in Control occurs, (ii) the target annual cash incentive amount for the fiscal year in which the termination date occurs, and (iii) the highest annual cash incentive amount paid or payable to the named executive officer in respect of any of the three fiscal years preceding the fiscal year in which the Change in Control occurs. Assuming a Change in Control and termination date as of September 30, 2021, the bonus amounts for each named executive officer represent the highest annual cash incentive amounts paid to them in respect of one of the three fiscal years preceding fiscal year 2021. The amounts disclosed as cash incentive continuation for Mr. Li represents three times his annual cash incentive amount and the amounts disclosed as bonus continuation for Mr. Beamer, Dr. Woodland, Dr. Dysard, and Ms. Bernstein represent two times their annual cash incentive amounts, each in accordance with the terms of the change in control agreements described below.
3
This figure represents the aggregate value of stock options, restricted stock units, restricted stock, and performance share units whose vesting either accelerates or continues following the specified termination of service, based on the fair market value of a share of our common stock on September 30, 2021 ($123.23). For the stock options, the aggregate value is equal to the difference between the exercise price of the accelerated options and the fair market value of a share of our common stock multiplied by the number of options on September 30, 2021, not including the value of vested but unexercised options multiplied by the number of stock options. For restricted stock units, restricted stock and performance share units, the aggregate value is equal to the number of shares and units vested (for performance share units, assuming achievement at target) multiplied by the fair market value of a share of common stock on September 30, 2021, not including the value of restricted stock that has already vested (including shares on deposit under our Executive Officer Deposit Share Program). The table below sets forth the value of accelerated options, the total value of all options (including the value of accelerated options and the vested but unexercised options), the value of accelerated restricted stock units and restricted stock and the value of accelerated performance share units as of September 30, 2021:
 Value of Accelerated Equity Awards 
Named
Executive
Officer
 
Options
(Non-Change
in Control)
  
Options
(Change
in
Control)
  
Options
(Position
Elimination)
  
Total Value
of Options
  
RSUs and
Restricted
Stock
(Non-
Change
in Control)
  
RSUs and
Restricted
Stock
(Change
in Control)
  
RSUs
(Position
Elimination)
  
PSUs
(Non-
Change
in
Control)
  
PSUs
(Change
in
Control)
  
PSUs
(Position
Elimination)
 
Mr. Li  
305,713
   
442,367
      
3,180,848
   
861,131
   
2,093,308
         
3,176,869
    
Mr. Beamer     
147,772
   
115,990
   
394,319
      
1,032,174
   
669,534
      
596,187
   
346,687
 
Dr. Woodland     
177,945
   
144,440
   
2,213,580
      
667,290
   
329,194
      
629,952
   
367,088
 
Dr. Dysard     
107,593
   
88,200
   
266,773
      
561,929
   
217,609
      
485,896
   
266,608
 
Ms. Bernstein     
146,260
      
412,094
      
542,705
         
512,267
    
In the event of a termination of service, unvested options, restricted stock, restricted stock unit, and performance share unit awards will be treated as described under “Treatment of Equity Awards” below.
4
This amount assumes comparable health care coverage to that which is currently provided under our existing plan. Our company is self-insured, therefore there is no direct employer contribution amount. We have estimated the cost of post-termination health care to be $20,000 per person per year. This amount could vary depending on the details of any new or replacement plan that may be in place in the event of a change in control, or any changes to our plan that are made for regulatory or other reasons.
5
More detail is provided in the section entitled “Change in Control Severance Protection Agreements,” below.
6
In the event that Mr. Li’s employment was terminated involuntarily due to a position elimination termination, such termination would be treated as a termination without cause, and thus Mr. Li would receive the benefits summarized in this table for a termination without cause.
7
As of September 30, 2021, Ms. Bernstein is retirement-eligible pursuant to the Rule of 70 and therefore, qualifies for accelerated vesting of certain equity awards upon Retirement (as discussed in more detail below under “Treatment of Equity Awards”). As such, in the event that Ms. Bernstein’s employment was terminated involuntarily due to a position elimination termination or for any reason other than for cause, such termination would be treated as a retirement. No other named executive officer was retirement-eligible under the Rule of 70 at the end of fiscal year 2021.
Pursuant to the terms of the company’s 2012 OIP and 2021 OIP, and the awards granted thereunder, the named executive officers receive the accelerated vesting of certain equity awards in the event of a Change in Control without termination of employment. The value of the accelerated vesting for each named executive officer, assuming a change in control, is the same value as disclosed in the “In Connection with a Change in Control” rows above.
Employment Letter with Mr. Li
As described in the narrative to the Summary Compensation Table above, pursuant to the employment letter we entered into with Mr. Li in connection with his appointment as our President and Chief Executive Officer, as of January 1, 2015, the severance amount multiple pursuant to Mr. Li’s Change in Control Severance Protection Agreement was increased to three times, and the benefits continuation period was increased to 36 months.
Change in Control Severance Protection Agreements
We have entered into Change in Control Severance Protection Agreements (“change in control agreements”), the specific form of which is available as Exhibit 10.23 to our Form 10-K filed on November 25, 2008, with each of the named executive officers, our other executive officers, and certain key employees of our company, because we believe such agreements are valuable aspects in enabling a smooth transition and providing continuity of management in the event of a change in control of our company; all the change in control agreements remain unamended and according to such filed exhibit. Under the change in control agreements, which are “double trigger” agreements and which we believe are in compliance with the American Jobs Creation Act, each executive officer, including the named executive officers, whose employment with us terminates (including an executive’s voluntary termination of employment for either “good reason”, as defined in the agreement, or during the thirty-day period commencing on the first anniversary of a “change in control”), other than for cause, disability, death, or certain other specified reasons, within thirteen months after a “change in control” of our company (as such term is defined in the agreements), is entitled to a severance benefit. The severance benefit includes:
accrued and unpaid compensation including: base salary, reimbursement for reasonable and necessary expenses incurred by the executive on our behalf through the date of termination, vacation pay and earned and unpaid bonuses and incentive compensation with respect to the period prior to the termination date;
the Bonus Amount (which is the greatest of (i) the executive’s target cash incentive amount for the fiscal year in which the change in control occurs, (ii) the executive’s target cash incentive amount for the fiscal year in which the termination date occurs, and (iii) the highest annual cash incentive paid or payable to the executive in respect of any of the three fiscal years preceding the fiscal year in which change in control occurs), pro-rated for the number of days that have elapsed in the fiscal year through the termination date;
two times (in the case of Mr. Beamer, Dr. Woodland, Dr. Dysard, and Ms. Bernstein) or three times (in the case of Mr. Li) the executive’s annual base salary plus the Bonus Amount plus an amount equal to the contributions made or credited by us under all qualified and non-qualified retirement plans for the benefit of the executive for the most recently completed plan year of each such plan (e.g., the 401(k) Plan and Supplemental Plan), payable in a lump sum;
health and welfare benefits (consistent with health and welfare benefits available to all employees for which they had been eligible prior to their termination) for 24 months (in the case of Mr. Beamer, Dr. Woodland, Dr. Dysard, and Ms. Bernstein) or 36 months (in the case of Mr. Li) following the executive officer’s termination date;
payment or reimbursement for the costs, fees and expense of outplacement assistance services, up to a maximum of 15% of the executive officer’s annual base salary; and
only for change in control severance protection agreements for executive officers entered into as of 2008, a full “gross-up payment” of any and all excise (but not income) taxes assessed on amounts received under the change in control agreements, as well as all other taxes, other than income taxes, that may become due as a result of the gross-up payment. Mr. Li’s and Ms. Bernstein’s change in control severance protection agreements were entered into as of 2008, and thus the terms of their agreements provide for such treatment. For Mr. Li, the hypothetical amount of the excise tax (“280G”) gross-up reported as payable in the table above for him is based only on circumstances in place as of September 30, 2021, including his average W-2 income level (or “base amount”) used to calculate the potential excise tax amount. Actual excise tax amounts, if any, would be determined based on the circumstances existing at the time of an actual change in control transaction, considering any relevant factors, including but not limited to the value of services to be provided in the event of a change in control, and/or an agreement to refrain from performing services pursuant to a covenant not to compete or similar covenant in existence prior to, at the time of, or after a change in control of the company. Any change in control severance protection agreement entered into subsequent to 2008 for a new executive officer does not include this provision. Mr. Beamer’s, Dr. Woodland’s, and Dr. Dysard’s change in control severance protection agreements, which were entered into subsequent to 2008, thus do not include this provision. Instead, their agreements provide that in the event that amounts or benefits they would receive under such agreements or otherwise would subject them to excise taxes, we would reduce such amounts and benefits to an amount such that they would not be subject to excise taxes, provided that such reduction results in greater after-tax benefits to them. Actual excise tax amounts and related reductions, if any, would be determined based on the circumstances existing at the time of an actual change in control transaction, considering any relevant factors, including but not limited to the value of services to be provided in the event of a change in control, and/or an agreement to refrain from performing services pursuant to a covenant not to compete or similar covenant in existence prior to, at the time of, or after a change in control of the company.
“Cause” as defined in the agreements means (i) the willful and continued failure to perform substantially the duties reasonably assigned to the executive and (ii) the willful engaging in conduct that is demonstrably and materially injurious to the company, monetarily or otherwise.
The agreements define “Good Reason” as the taking of actions by the company that result in a material negative change in the executive’s employment relationship, including (i) a change in the executive’s status, title, position or responsibilities (including reporting responsibilities) that represents a material adverse change from those in effect immediately prior to the Change in Control, (ii) an assignment of the executive’s duties or responsibilities that are materially inconsistent with his or her status, title, position or responsibilities as of immediately prior to the Change in Control, (iii) a material decrease in the executive’s annual base salary below the rate in effect as of the Change in Control or as of any date following the Change in Control, whichever is greater (iv) relocation of the offices of the company or operating unit at which the executive is principally employed that increases the executive’s one-way commute by more than thirty-five (35) miles from the location of the offices occupied immediately prior to such relocation, or (v) any other action or inaction that constitutes a material breach by the company of the agreement.
A “Change in Control” means (i) any person, together with all affiliates and associates (within the meaning of Rule 12b-2 promulgated under the Exchange Act), acquires beneficial ownership, directly or indirectly, or securities of the company representing at least 30% of the combined voting power of the company’s then outstanding voting securities, (ii) during any period of twenty-four (24) consecutive months beginning on or after the date of the agreement, individuals who, at the beginning of that 24-month period, constitute the Board (the “Incumbent Directors”), cease for any reason to constitute at least a majority of the Board; provided, however, that a new director of the company whose election or nomination for election as a director of the company was approved by a vote of at least two-thirds of the Incumbent Directors will be deemed to be an Incumbent Director, (iii) one of the following events occur at a special or annual meeting of the company’s stockholders: (a) two or more nominees who are both (A) nominees of and endorsed by the company and (B) not employees of the company or any Affiliate at the time of the election are not elected to serve as directors; and (b) any person not a nominee of, and endorsed by, the company is elected to serve as a director of the company, (iv) the consummation of: (a) a merger, consolidation or reorganization involving the company, unless the merger, consolidation or reorganization is a “Non-Control Transaction”; or (b) an agreement for the sale or other disposition of all or substantially all of the assets of the company to any Person (other than a transfer to a Change in Control Subsidiary), or (v) the stockholders of the company approve a complete liquidation or dissolution of the company. Notwithstanding the foregoing, a Change in Control will not be deemed to occur solely because a person acquires beneficial ownership of more than the permitted amount of the then outstanding voting securities as a result of the acquisition of voting securities by the company which, by reducing the number of voting securities then outstanding, increases the percentage of shares beneficially owned by the person. Notwithstanding the foregoing, if a Change in Control would occur but for the operation of the preceding sentence as a result of the acquisition of voting securities by the company, and after that acquisition by the company, the person described in the preceding sentence increases the percentage of then outstanding voting securities he or she owns, a Change in Control will occur.
We also have similar change in control severance protection agreements providing for two times severance benefits in place with our other executive officers. Under the change in control agreements, all amounts accrued or awarded to the executive officers under any incentive compensation or benefit plan, including options and restricted stock awarded under the 2021 OIP and 2012 OIP, will immediately vest on each executive’s respective termination date if the executive is entitled to severance benefits.
Our board of directors and compensation committee determined the terms and conditions of the change in control severance protection agreements, including the severance benefit payable, and the triggering events for the payment of such severance benefit, pursuant to such agreement, in consultation with their independent compensation consultant and our financial and other advisors, and considered external practices at similarly situated companies regarding change in control arrangements.
Treatment of Equity Awards
The 2021 OIP and 2012 OIP provide that an award shall immediately terminate on the date a participant’s service terminates, unless otherwise set forth in an award agreement. Similarly, in the event of a Change in Control, the compensation committee has the discretion to provide for accelerated vesting in an award agreement. However, under the 2021 OIP, in the event of a Change in Control, the compensation committee may provide that (i) any or all outstanding awards will be assumed and continued or an equivalent award substituted by our successor (or affiliate thereof) in connection with such Change in Control transaction; provided, however, that if within two years following such Change in Control, a participant’s employment is terminated by us or our successor without Cause or the participant resigns for “Good Reason,” to the extent that the participant is subject to written agreement that contains a “Good Reason” definition, any awards not previously vested will immediately become vested and/or exercisable (and any applicable performance goals will be deemed achieved at the greater of (x) target or (y) actual performance through the date of such termination); and (ii) with respect to outstanding awards that are not assumed and continued or where an equivalent award is not substituted by our successor (or an affiliate thereof) in connection with such Change in Control transaction, then any such awards that have not previously vested will immediately become vested and/or exercisable (and any applicable performance goals will be deemed achieved at the greater of (x) target or (y) actual performance through the date of such Change in Control)

In the event of a Change in Control that is a merger or consolidation in which the company is not the surviving corporation or that results in the acquisition of substantially all the company’s outstanding stock or in the event of a sale or transfer of all or substantially all of the company’s assets (a “Covered Transaction”), the compensation committee has the discretion to provide for the termination of all outstanding options as of the effective date of the Covered Transaction; provided, that, if the Covered Transaction follows a Change in Control or would give rise to a Change in Control, no option will be terminated prior to the expiration of twenty days following the later of: (i) the date on which the award became fully exercisable and (ii) the date on which the participant receive written notice of the Covered Transaction.
Under both the 2021 OIP and  2012 OIP, “Change in Control” generally means: (a) any “person” as such term is used in Sections 13(d) and 14(d) of the 1934 Act (other than (i) the company, (ii) any subsidiary of the company, (iii) any trustee or other fiduciary holding securities under an employee benefit plan of the company or of any subsidiary of the company, or (iv) any company owned, directly or indirectly, by the stockholders of the company in substantially the same proportions as their ownership of stock of the company), is or becomes the “beneficial owner” (as defined in Section 13(d) of the 1934 Act), together with all Affiliates and Associates (as such terms are used in Rule 12b-2 of the General Rules and Regulations under the 1934 Act) of such person, directly or indirectly, of securities of the company representing 30% or more of the combined voting power of the company’s then outstanding securities; (b) the consummation of a merger or consolidation of the company with any other company, other than (i) a merger or consolidation which would result in the voting securities of the company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity), in combination with the ownership of any trustee or other fiduciary holding securities under an employee benefit plan of the company or any subsidiary of the company, at least 60% of the combined voting power of the voting securities of the company or such surviving entity outstanding immediately after such merger or consolidation or (ii) a merger or consolidation effected to implement a recapitalization of the company (or similar transaction) after which no “person” (with the method of determining “beneficial ownership” used in clause (a) of this definition) owns more than 30% of the combined voting power of the securities of the company or the surviving entity of such merger or consolidation; or (c) during any period of two consecutive years (not including any period prior to the execution of the 2021 OIP or 2012 OIP, as applicable), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has conducted or threatened a proxy contest, or has entered into an agreement with the company to effect a transaction described in clause (a), (b) or (d) of this definition) whose election by the Board or nomination for election by the company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved cease for any reason to constitute at least a majority thereof; or (d) the complete liquidation of the company or the sale or disposition by the company of all or substantially all of the company’s assets.
Pursuant to the non-qualified stock option grant agreements, the option grants will become fully vested in the event of a Change in Control (as defined in the 2021 OIP or 2012 OIP, as applicable). In the event of a Change in Control that constitutes a Covered Transaction, the compensation committee may, in its sole discretion, terminate any or all outstanding options as of the effective date of the Covered Transaction; provided that the compensation committee may not terminate an option outstanding under the agreement earlier than twenty days following the later of: (i) the date on which the award became fully vested and (ii) the date on which the participant received written notice of the Covered Transaction. In the event of a termination of service by reason of death or Disability, then any unvested portion of the options will become fully vested. Starting with the option grants made in fiscal year 2018, in the event that a participant’s service terminates due to Retirement, the option will continue to vest in accordance with its terms, and if a participant’s service terminates due to Position Elimination, the unvested portion of the option will vest on a prorated basis. Disability has the meaning provided under (i) first, an employment agreement between the participant and the company, (ii) second, if no employment agreement exists, the long-term disability program maintained by the company or any governmental entity covering the Participant, or (iii) third, if no such agreement or program exists, permanent and total disability within the meaning of Section 22(e)(3) of the Code. Retirement is defined in the award agreements as the termination of a participant’s service following the attainment of a combination of age and years of service of at least 70, with a minimum of 55 years of age (other than a termination for Cause) (i.e., the “Rule of 70”). Position Elimination is the involuntary termination of a participant’s service due to the company’s elimination of the participant’s position due to an organizational change, expense reduction considerations, office closings or relocations, in which the participant will not be replaced by another person in the same position.

Pursuant to the restricted stock and restricted stock unit (RSUs) award agreements, the awards will become fully vested and all restrictions will lapse in the event of a participant’s death, Disability, or Change in Control (as defined in the 2021 OIP or 2012 OIP, as applicable). Starting with the RSU awards granted in fiscal year 2018, in the event that a participant’s service terminates due to Retirement, the RSUs will continue to vest in accordance with their terms, and if a participant’s service terminates due to Position Elimination, the unvested portion of the RSUs will vest on a prorated basis. Disability has the meaning provided under (i) first, an employment agreement between the participant and the company, (ii) second, if no such employment agreement exists, the long-term disability program maintained by the company or any governmental entity covering the participant, or (iii) third, if no such agreement or program exists, as defined under local law. Retirement and Position Elimination have the same definitions set forth in the option agreements.
For performance share units (PSUs), in the event of a participant’s death, the awards will vest at target; in the event of Disability or a termination due to Retirement or Position Elimination (each as defined above), the awards will vest on a prorated basis, based on actual performance through the end of the three-year performance period. In the event of a Change in Control prior to the end of the performance period, (i) if the PSUs are not assumed by the acquirer, the PSUs will vest at the target award level and be settled within 30 days following the Change in Control, and (ii) if the PSUs are assumed by the acquirer, the PSUs will be converted into RSUs that will vest at the end of the performance period. If the participant’s employment is terminated by the company without cause within the twelve-month period following the Change in Control, or if the participant’s employment otherwise terminates in a manner that would entitle him or her to benefits under a change in control severance agreement with the company (to the extent the participant is a party to such an agreement), the converted RSUs will immediately vest in full.

Compensation of Directors
The following table shows information concerning the compensation that the company’s non-employee directors earned during the last completed fiscal year ended September 30, 2021. A director who is also our employee receives no additional compensation for his or her services as a director.

 Name 
Fees Earned
or Paid
in Cash ($)1
  
Stock
Awards
($)2
  
Option
Awards
($)2
  
All Other
Compensation
($)
  
Total
($)
 
 William P. Noglows  140,000   95,852   89,998      325,850 
 Richard S. Hill  115,000   95,852   89,998      300,850 
 Barbara A. Klein  115,000   95,852   89,998      300,850 
 Paul J. Reilly  102,500   95,852   89,998      288,350 
 
Anne K. Roby 3
  30,000   140,756   68,145      238,901 
 Susan M. Whitney  102,500   95,852   89,998      288,350 
 Geoffrey Wild  90,000   95,852   89,998      275,850 

1
Represents actual fees paid in fiscal year 2021, which includes an annual retainer fee, and, as applicable, a board of directors Chair or committee Chair annual retainer fees, both earned quarterly, each as discussed in more detail below. For Mr. Reilly and Ms. Whitney, this includes partial year committee Chair fees. Dollar amounts are comprised as follows:
 Name 
Annual
Retainer Fee
($)
  
Committee
Chair Fee
($)
  
Non-
Executive
Board
Chair Fee ($)
 
 Mr. Noglows  90,000      50,000 
 Mr. Hill*  
90,000
   25,000    
 Ms. Klein**  
90,000
   25,000    
 Mr. Reilly***  90,000   12,500    
 Dr. Roby  
30,000
       
 Ms. Whitney  90,000   12,500    
 Mr. Wild  90,000       

*
Nominating and corporate governance committee Chair
**
Compensation committee Chair (effective as of March 2021)
***
Audit committee Chair (effective as of March 2021)
2
The amounts in the column headed “Stock Awards” represent the aggregate award date fair value of awards made in fiscal year 2021 computed in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 718, Stock Compensation (“ASC 718”). For these restricted stock unit awards, the fair value is equal to the underlying value of the stock and is calculated using the closing price of our common stock on the award date. The actual value realized by a non-employee director related to restricted stock unit awards will depend on the market value of our common stock on the date the underlying stock is sold following vesting of the awards.
The amounts in the column headed “Option Awards” represent the aggregate grant date fair value of grants in fiscal year 2021 computed in accordance with ASC 718 (see Note 17 of Notes to Consolidated Financial Statements included in Item 8 of Part II of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021 for a description of the assumptions used in that computation). The actual value realized by a non-employee director related to option awards will depend on the difference between the market value of our common stock on the date the option is exercised and the exercise price of the option.
The award date fair market value of each “Stock Award” and the grant date fair market value of each “Option Award” awarded or granted to our non-employee directors during fiscal year 2021, computed in accordance with ASC 718 (excluding the impact of estimated forfeitures for service-based vesting conditions), is as follows:

  Name
Award or
  Grant Date
 
Number of
Restricted Stock
Units
  
Award Date Fair
Value ($)
  
Number of
Options
  
Grant Date
Fair Value ($)
 
  Mr. Noglows3/3/2021  561   95,852   1,305   89,998 
  Mr. Hill3/3/2021  561   95,852   1,305   89,998 
  Ms. Klein3/3/2021  561   95,852   1,305   89,998 
  Mr. Reilly3/3/2021  561   95,852   1,305   89,998 
  Dr. Roby6/1/2021  914*  140,756   1,107   68,145 
  Ms. Whitney3/3/2021  561   95,852   1,305   89,998 
  Mr. Wild3/3/2021  561   95,852   1,305   89,998 
*Dr. Roby received both a prorated annual restricted stock unit award and an initial restricted stock unit award at the time of her appointment to the board of directors.

During fiscal year 2021, no stock awards held by any of our non-employee or other directors were modified or cancelled (forfeited).
The aggregate number of stock awards (restricted stock units) and the aggregate number of stock option awards held by each non-employee director that were outstanding as of the end of fiscal year 2021 are as follows:
  
Aggregate Number of Awards
Outstanding as of September 30,
2021
 
  Name Stock Awards*  Option Awards 
  Mr. Noglows  561   91,569 
  Mr. Hill  561   6,235 
  Ms. Klein  561   42,069 
  Mr. Reilly  561   14,431 
  Dr. Roby  914   1,107 
  Ms. Whitney  561   37,569 
  Mr. Wild  561   37,569 

*Restricted Stock Units

Our non-employee directors received an aggregate of 8,937 stock options and 4,280 restricted stock units in fiscal year 2021.

3
Dr. Roby was elected to the board of directors effective June 1, 2021.
As provided in our Corporate Governance Guidelines and the nominating and corporate governance committee charter, the nominating and corporate governance committee is responsible for reviewing and recommending to the board of directors compensation (cash and equity) for non-employee directors. The committee does this through review of director compensation benchmark information and analysis and recommendation provided by the independent non-employee director compensation consultant to the committee, which since April 2017 is Meridian.
As previously disclosed, the board of directors approved our current non-employee director compensation program effective at the time of our annual meeting in March 2016, with the objective of continuing our company’s ability to attract high caliber and experienced individuals to serve as directors. The board of directors reviewed the non-employee director compensation program in November 2021 and determined to maintain in its current form, which consists of the following elements:
Description of Director Compensation, Effective March 2016Amount/Value ($)
Annual Retainer Fee1
90,000
Committee Chair Annual Retainer Fees1:
Audit committee Chair25,000
Compensation committee Chair25,000
Nominating and corporate governance committee Chair25,000
No Standing Committee or Board Meeting Fees2
Non-Executive Board Chair Fee3
50,000
Annual Non-qualified Stock Option Grant4
90,000
Annual Restricted Stock Unit Award4
90,000
Initial Restricted Stock Unit Award5
90,000
 

1
Paid quarterly beginning with the quarter end following the effective date of appointment, and subsequently, beginning with the quarter end following our annual meeting. Directors do not receive additional compensation for serving as committee members.
2
To the extent a special committee is established by board of directors to address a unique matter, a committee meeting fee of $1,500 will be provided.
3
If a non-executive serves as Chair of the board of directors, he or she will receive a retainer amount in addition to the annual retainer fee.
4
Made at the time of our annual meeting (or initial appointment to the board of directors, on a pro-rata basis according to the number of days left until the subsequent annual meeting from the initial date of election) based on a fixed dollar value, with 100% vesting occurring on the first anniversary of the grant/award date. Number of units are calculated consistent with methodology used to calculate employee awards, using multiple-day average stock price in advance of award date (annual meeting), and Black-Scholes value of option grants, as applicable.
5
New directors receive initial restricted stock unit awards, based on a fixed dollar value. Each award vests 25% per year on the first four anniversaries of the award date.
Upon a non-employee director’s termination of service as a director of the company for reason of Death, Disability or a Change in Control, as defined in the 2012 OIP, 2021 OIP, and/or an award agreement, each grant or award of non-qualified stock options and restricted stock units held by the director will vest in full. In addition, if at the time of termination of service for any reason other than by reason of Cause, Death, Disability or a Change in Control, as defined in the 2012 OIP, 2021 OIP, and/or an award agreement, the non-employee director has completed at least two full terms as a director, as defined in our bylaws, each grant or award of non-qualified stock options and restricted stock units held by the director will vest in full.
Under our Directors’ Cash Compensation Umbrella Program, which only applies to non-employee directors and was first filed as an exhibit to our Annual Report on Form 10-K filed with the SEC on December 10, 2003, each non-employee director may choose to receive his or her cash compensation either in cash, in fully vested restricted stock under our 2021 OIP (as of the date the fees are earned, the fees would be converted into the equivalent number of fully vested restricted shares, which would be beneficially owned and reported on Form 4 filings), or as deferred compensation under our Directors’ Deferred Compensation Plan, as amended February 25, 2021, which first became effective in March 2001, and was filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on May 6, 2021. Under the Directors’ Deferred Compensation Plan, deferred amounts are payable only in the form of our common shares. A participating director is required to elect a date on which deferred compensation will begin to be distributed, which date generally must be at least two years after the end of the year deferrals are made and no later than the date of termination. As of the date the compensation is earned, the fees are converted into the right to acquire the equivalent number of shares of common stock at the end of the deferral period. These rights to acquire shares under the Directors’ Deferred Compensation Plan are reported as beneficially owned on Form 4 filings for each participating director. Currently, Messrs. Reilly and Wild are the only directors participating in our Directors’ Deferred Compensation Plan, and they each elected to defer the restricted stock units granted to them on March 3, 2021. These awards are currently unvested and thus are not reflected in the deferred balance under this plan. At present, non-employee directors receive their annual retainer and committee Chair fees on a quarterly basis. Non-employee directors also are eligible for reimbursement of travel and other out-of-pocket costs incurred in attending meetings. Non-employee directors are not eligible for any other compensation arrangement.
Compensation Policies and Practices Related to Risk Management
The company’s management, with a review by the audit committee and compensation committee of our board of directors and with support from the compensation committee’s independent compensation consultant, has assessed the risks associated with our compensation programs, policies and practices, and has determined that risks arising from them are not reasonably likely to have a material adverse effect on our company. In making this determination, our management considered the various elements of our compensation programs, policies and practices, such as the: mix of base salary, annual cash incentives under our STIP, and equity incentive program participations at various levels and throughout our company; balance between and among short-term and long-term compensation incentives in our programs; significant use of performance measures that are financial in nature such that they are readily measurable and verifiable, are regularly reviewed, and also are consistent with those that are publicly reported; use of performance measures that directly relate to the operations of our business such that they are readily measurable and verifiable, and are regularly reviewed; use of performance measures that relate to our business overall and avoid overdependence on one aspect of our business and its operations as opposed to another; multiple and cross-functional levels of review and verification prior to award approval; our system of internal controls and internal risk review and assessment processes; and, our general employment practices, policies and procedures.

CEO Pay Ratio
As required by Section 953(b) of the Dodd-Frank Wall Street Reform and Consumer Protection Act, and Item 13402(u) of Form 10-KRegulation S-K, we are providing the following information about the relationship of the annual total compensation of our employees and the annual total compensation of David H. Li, our President and CEO for the fiscal year ending September 30, 2021.
For the fiscal year ending September 30, 2021:
The median of the annual total compensation of all employees of the company (other than our CEO) was $93,504; and
The annual total compensation of our CEO was $5,595,460.
Based on this information, for the fiscal year ending September 30, 2021, our CEO’s annual total compensation was approximately 59.84 times that of the annual total compensation of the median employee (as determined below).
This pay ratio is a reasonable estimate calculated in good faith, in a manner consistent with Item 402(u) of Regulation S-K, based on our payroll and employment records and the methodology described below. The SEC rules for identifying the “median employee” and calculating the pay ratio based on that employee’s annual total compensation allow companies to adopt a variety of methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their compensation practices. As such, the pay ratios reported by other companies may not be comparable to the pay ratio set forth above, as other companies may have different employment and compensation practices and may utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.
To identify the median of the annual total compensation of all our employees, as well as to determine the annual total compensation of the “median employee,” we used the following methodology and the material assumptions, adjustments and estimates:

1.
We determined that, as of September 30, 2021, our employee population consisted of approximately 2,200 individuals working at the company and its consolidated subsidiaries, with approximately 1,200 of these individuals located in the United States and approximately 1,000 of these individuals located outside of the United States.

2.
We utilized the base pay for the fiscal year ending September 30, 2021 as our consistently applied compensation measure to identify the median employee from our total employee population, which we applied to all employees included in our analysis. We did not make any cost-of-living adjustments in identifying the median employee. Using this methodology, we determined that the median employee was a full-time, hourly employee located in the United States.

3.
With respect to the annual total compensation of the median employee, we identified and calculated the elements of such employee’s compensation for the fiscal year ending September 30, 2021 in accordance with the requirements of Item 402(c)(2)(x) of Regulation S-K, resulting in annual total compensation of $93,504.

4.
With respect to the annual total compensation of our CEO, we used the amount reported in the “Total” column (column (j)) of our 2021 Summary Compensation Table included in this Form 10-K/A and incorporated by reference under Item 11 of Part III of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021.
Compensation Committee Interlocks and Insider Participation
None of the current or former members of the compensation committee are or have been our employees.

Compensation Committee Report
The following report of the compensation committee does not constitute soliciting material and should not be deemed filed or incorporated by reference frominto any other of our filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent we specifically incorporate this report by reference therein.
The compensation committee of the board of directors has reviewed and discussed the Compensation Discussion and Analysis with our company’s management, and based on the review and discussions, the compensation committee has recommended to the board of directors that the Compensation Discussion and Analysis be included in this Form 10-K/A and the company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2021.
Submitted by Mses. Klein and Whitney, Mr. Reilly, and Dr. Roby, being all the current members of the compensation committee,
Barbara A. Klein (Chair)
Paul J. Reilly
Anne K. Roby
Susan M. Whitney

ITEM 12.SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Security Ownership of Certain Beneficial Owners and Management
The following table sets forth certain information containedregarding the beneficial ownership of our common stock as of January 7, 2022 (except as indicated below) by:
all persons known by us to own beneficially more than 5% of our outstanding common stock;
each of our directors;
each of the named executive officers in the section captioned "Certain RelationshipsCompensation Discussion and Related Transactions"Analysis Section and the Summary Compensation Table included in this Form 10-K/A; and
all our directors and executive officers as a group.
Unless otherwise indicated, each stockholder listed below has sole voting and investment power with respect to the shares of common stock beneficially owned by such stockholder.
Stock Ownership Table

 Name and Address
Number of Shares
Beneficially
Owned1
Approximate
Percent of Class1
 Certain beneficial owners:       
 
1.   BlackRock, Inc.
      55 East 52nd Street
      New York, New York 10055
  3,118,743
2 
  10.9% 
 
2.   The Vanguard Group, Inc.
      P.O. Box 2600
      Valley Forge, Pennsylvania 19482
  2,870,726
3 
  10.0% 
 
3.   Neuberger Berman Group LLC
      1290 Avenue of the Americas
      New York, NY 10104
  
1,898,913
4 
  6.6% 
 
4.   EARNEST Partners, LLC
      1180 Peachtree Street NE, Suite 2300
      Atlanta, Georgia 30309
  
1,674,339
5 
  5.9% 
 Directors and executive officers:         
 David H. Li  163,355
6 
  *  
 William P. Noglows  
156,668
67 
  *  
 Richard S. Hill  13,559
6 
  *  
 Barbara A. Klein  38,446
6 
  *  
 Paul J. Reilly  20,105
6 
  *  
 Anne K. Roby  924
6 
  *  
 Susan M. Whitney  48,643
6 
  *  
 Geoffrey Wild  48,643
6 
  *  
 Scott D. Beamer  39,642
6 
  *  
 Daniel D. Woodland  32,607
6 
  *  
 Jeffrey M. Dysard  11,195
6 
  *  
 H. Carol Bernstein  64,242
68 
  *  
 All directors and executive officers as a group (14 persons)  617,803
69 
  2.2% 
          

*
= less than 1%
1
“Beneficial ownership” generally means any person who, directly or indirectly, has or shares voting or investment power with respect to a security or has the right to acquire such power within 60 days. Shares of common stock subject to options, warrants or rights that are currently exercisable or exercisable within 60 days of January 7, 2022 are deemed outstanding for computing the ownership percentage of the person holding such options, warrants or rights, but are not deemed outstanding for computing the ownership percentage of any other person. The amounts and percentages are based upon 28,568,967 shares of our common stock outstanding as of January 7, 2022, unless otherwise indicated.
2
Of the shares reported as beneficially owned, BlackRock, Inc. exercises (a) sole power to vote 3,079,821 shares, (b) no power to vote 38,922 shares, and (c) sole investment power over 3,118,743 shares. The total number of shares reported as beneficially owned is 3,118,743, as of September 30, 2021. The number of shares indicated is based on information reported in Form 13F Holdings Report filed by BlackRock, Inc. on November 9, 2021.
3
Of the shares reported as beneficially owned, The Vanguard Group, Inc. exercises (a) shared power to vote 56,016, (b) sole investment power over 2,788,624 shares, and (c) shared investment power over 82,102 shares. The total number of shares reported as beneficially owned is 2,870,726, as of November 30, 2021. The number of shares indicated is based on information reported in the Schedule 13G/A filed by The Vanguard Group, Inc. on December 9, 2021.
4
Of the shares reported as beneficially owned, Neuberger Berman Group LLC exercises (a) sole power to vote 1,844,879 shares, (b) no power to vote 54,034 shares, (c) sole investment power over 16,497 shares, and (d) shared investment power over 1,882,416 shares. The total number of shares reported as beneficially owned is 1,898,913 shares, as of September 30, 2021. The number of shares indicated is based on the information reported in the Form 13F Holdings Report filed by Neuberger Berman LLC on November 12, 2021.
5
Of the shares reported as beneficially owned, EARNEST Partners, LLC exercises (a) sole power to vote 1,163,595 shares, (b) shared power to vote 3,180 shares, (c) no power to vote 507,564 shares, and (d) sole investment power over 1,674,339 shares. The total number of shares reported as beneficially owned is 1,674,339 shares, as of September 30, 2021. The number of shares indicated is based on the information reported in the Form 13F Holdings Report filed by EARNEST Partners, LLC on November 15, 2021.
6
Includes shares of our common stock that such person has the right to acquire pursuant to stock options granted pursuant to the 2012 OIP or pursuant to the 2021 OIP, in either case, exercisable within 60 days of January 7, 2022, as follows:

 Name
Upon Exercise
Shares Issuable
 Mr. Li69,677
 Mr. Noglows91,569
 Mr. Hill6,235
 Ms. Klein14,431
 Mr. Reilly14,431
 Dr. Roby
 Ms. Whitney37,569
 Mr. Wild37,569
 Mr. Beamer19,592
 Dr. Woodland22,096
 Dr. Dysard
 Ms. Bernstein18,009
Also includes restricted stock units awarded to such executive officer pursuant to the 2012 OIP or the 2021 OIP, as applicable, on January 16, 2018, December 6, 2018, December 5, 2019, December 3, 2020, and December 6, 2021, respectively, that are still subject to restrictions as of January 7, 2022, as set forth in the Proxy Statement.table below. On December 6, 2018, December 5, 2019, December 3, 2020, and December 6, 2021 as part of our annual equity incentive award program, we awarded restricted stock units to our executive officers with restrictions that lapse in equal increments upon each anniversary over four years. On January 16, 2018, as part of Mr. Beamer’s appointment as our Vice President and Chief Financial Officer, we awarded Mr. Beamer a sign-on award consisting of 13,128 restricted stock units and an annual equity incentive award consisting of 2,104 restricted stock units, in each case, with restrictions that lapse in equal increments upon each anniversary of the award over four years. The outstanding restricted stock unit awards have the same economic value as shares of common stock, are eligible to receive dividend equivalents, and may not be voted, sold or transferred, other than to immediate family members as provided in the 2012 OIP and 2021 OIP.
   Equity Incentive Program Restricted Stock Units 
 Name 1/16/18  1/16/18  12/6/18  12/5/19  12/3/20  12/6/21 
 Mr. Li      
1,716
  
3,106
  
5,010
  
7,580
 
 Mr. Beamer 
3,282
   526  618  860  
1,428
  
 
 Dr. Woodland      656  916  
1,503
  
2,274
 
 Dr. Dysard      375  626  
1,278
  
1,932
 
 Ms. Bernstein      543  760  
1,203
  
1,819
 
See “Transition Arrangement with Mr. Beamer” above for a description of the treatment of Mr. Beamer’s outstanding equity awards in connection with the termination of his employment with our company.
Also includes restricted stock units awarded to such non-employee director pursuant to the 2012 OIP or the 2021 OIP, as applicable, that are still subject to restrictions as of January 7, 2022, as set forth in the table below. For annual equity awards to non-employee directors, restricted stock units are currently awarded with restrictions that lapse in full upon the first anniversary of the award. Initial equity awards of restricted stock units to non-employee directors are currently made with restrictions that lapse in equal annual increments over four years beginning on the first anniversary of the award. Outstanding restricted stock unit awards have the same economic value as shares of common stock, are eligible to receive dividend equivalents, and may not be voted, sold or transferred, other than to immediate family members as provided in the applicable plan.
Name
Non-Employee Director
Restricted Stock Units
Mr. Noglows
561
Mr. Hill
561
Ms. Klein
561
Mr. Reilly
561
Dr. Roby
914
Ms. Whitney
561
Mr. Wild
561

7
Includes 41,125 shares of our common stock held in trust for the benefit of Mr. Noglows’ family members, comprised of 26,125 shares held in trust for the benefit of Mr. Noglows’ spouse, over which Mr. Noglows has no voting or investment power or ownership control,  7,500 shares held in trust for the benefit of a child of Mr. Noglows, over which Mr. Noglows has investment and voting, but no ownership, control, and 7,500 shares held in another trust for the benefit of another child of Mr. Noglows, over which Mr. Noglows has investment and voting, but no ownership, control.
8
Includes 20,808 shares of our common stock held in trust for the benefit of Ms. Bernstein’s family members, over which Ms. Bernstein has voting and investment, but no ownership, control.
9
Includes all individuals who were directors and executive officers as of January 7, 2022, and does not include individuals who ceased to be executive officers prior to such date, except for Mr. Noglows, who since January 1, 2016 has been a non-employee director. Includes 318,435 shares of our common stock that our directors and executive officers have the right to acquire pursuant to stock options exercisable within 60 days of January 7, 2022, and 43,661 restricted shares of our common stock or restricted stock units held by our executive officers still subject to restrictions as of January 12, 2022 (which include shares subject to restrictions or conditions pursuant to our Deposit Share Program).


43

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
INDEX
Equity Compensation Plan Information
Shown below is information as of September 30, 2021, with respect to the shares of common stock that may be issued under CMC’s existing equity compensation plans.

Plan category 
(a) Number of
securities to be
issued upon
exercise of
outstanding
options, warrants
and rights
 
(b) Weighted-
average exercise
price of
outstanding
options,
warrants and
rights
 
(c) Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column (a))
 
Equity compensation plans approved by security holders (1)  
1,010,486
(2)
$
89.61
(2)
2,361,281
(3)
Equity compensation plans not approved by security holders  
  
 
 
Total  
1,010,486
(2)
$
89.61
(2)
2,361,281
(3)
1.
See Note 16 of “Notes to the Consolidated Financial Statements” of the Original Form 10-K for more information regarding the composition of our equity compensation plans.
2.
Column (a) includes 779,010 shares subject to outstanding nonqualified stock options, 146,960 shares that employees and non-employee directors have the right to acquire upon the vesting of the equivalent RSUs that they have been awarded under our equity incentive plans, and 84,516 initial granted shares that certain employees have the right to acquire upon the vesting of the performance-based restricted stock units (PSUs) that they have been awarded under our equity incentive plans, which may be subject to downward or upward adjustment depending on the performance measures during the particular performance period pursuant to the PSU award agreement. Column (b) excludes all of these RSUs and PSUs from the weighted-average exercise price. The weighted average term of stock options is 6.04 years.
3.
Column (c) includes 239,941 shares available for future issuance under the Employee Stock Purchase Plan.
ITEM 13.CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE
Certain Relationships
At present we have no related party transactions and there are no currently proposed related party transactions.
Related Party Transactions
Although at present we have no related party transactions, we may from time to time enter into transactions with “related persons.” Related persons include our directors and executive officers, nominees for director, 5% or more beneficial owners of our common stock, and immediate family members of such persons. As set forth in our audit committee charter, a current copy of which is available on our website at www.cmcmaterials.com, any related person transaction must be reviewed and approved in advance by our audit committee. All our employees, including our executive officers and directors, are subject to our Code of Business Conduct, which is available on our website. Our Code of Business Conduct prohibits any relationship that may present, or appears to present, a conflict of interest with our company. Among other things, this includes a prohibition on the holding of more than a nominal financial interest in or financial relationship with any publicly held company with whom we do business or compete, and prohibits any financial interest in or financial relationship with such entities if they are privately held. Any request for waiver of our Code of Business Conduct for our directors and executive officers may be approved only by our board of directors; to date, no such waivers have been requested or approved. In addition to the provisions of our Code of Business Conduct, our nominating and corporate governance committee charter and our corporate governance guidelines, both of which are also available on our website, also contain provisions requiring the review of potential conflicts of interest of prospective and current directors and the requirement of notification, and offer of tender of resignation, by directors, and review by the nominating and corporate governance committee and the board of directors of any change in employment or for-profit board membership status.

Indemnification
Our bylaws and our certificate of incorporation require us to indemnify our directors and officers to the fullest extent authorized by the Delaware General Corporation Law. We have entered into indemnification agreements with all our directors and executive officers in which we confirm that we will provide to them the indemnification rights provided for in our bylaws and agree to maintain directors’ and officers’ liability insurance on their behalf.
Director Independence
The information required by Item 14board of Form 10-K is incorporated by reference from the information containeddirectors has determined that seven of our eight current directors, including Messrs. Hill, Noglows, Reilly and Wild, Ms. Klein and Ms. Whitney, and Dr. Roby are “independent” directors as defined in the section captioned "FeesNational Association of Independent AuditorsSecurities Dealers Automated Quotation (“NASDAQ”) Marketplace Rules and as defined in applicable rules by the SEC. In making its determinations of independence, in addition to consideration of the relevant SEC and NASDAQ rules (according to which the definition of “independent director” is set forth in our Corporate Governance Guidelines, a current copy of which is available on our website, www.cmcmaterials.com), the board of directors considered factors for each director such as any other directorships, any employment or consulting arrangements, and any relationship with our company’s customers, suppliers or advisors. In particular, the board of directors determined that, effective January 1, 2019, Mr. Noglows qualified as an independent director under applicable rules considering, among other things, that as of such time it had been more than three years since he was an employee of our company.
ITEM 14.PRINCIPAL ACCOUNTANT FEES AND SERVICES
Audit Committee Report"Pre-Approval
During fiscal years 2021 and 2020, the audit committee pre-approved 100% of all audit and non-audit services provided by our independent auditors, PricewaterhouseCoopers LLP (“PWC”), an independent registered public accounting firm. For such pre-approval of services, the audit committee follows its policy for the pre-approval of services provided by our independent auditors, a current copy of which is available on our website, www.cmcmaterials.com. The policy requires advance approval of all audit, audit-related, tax and other services performed by the independent auditor. This policy provides for pre-approval by the audit committee of permitted services before the independent auditor is engaged to perform them. The audit committee has delegated to the Chair of the audit committee authority to approve permitted services. The following table presents fees for audit services rendered by PWC for the audit of our annual financial statements for the fiscal year ended September 30, 2021, and September 30, 2020, and fees billed for other services rendered by PWC during those periods.
Fees Billed by Independent Auditors

 Fees 
Fiscal Year Ended
September 30, 2021 ($)
  
Fiscal Year Ended
September 30, 2020 ($)
 
 
Audit Fees1
  
2,912,803
   
3,622,542
 
 
Audit-Related Fees2
  
   
 
 
Tax Fees3
  
372,334
   
825,206
 
 
All Other Fees4
  
4,500
   
4,500
 
 Total  
3,289,637
   
4,452,248
 
         

1      Audit Fees include fees for professional services rendered by PWC for the audit of our annual financial statements and internal control over financial reporting and review of financial statements included in our Form 10-Q and for services that normally would be provided by PWC in connection with statutory and regulatory filings or engagements. In addition to including fees for services necessary to perform an audit or review in accordance with generally accepted auditing standards, this category also may include services that generally only PWC reasonably can provide, such as comfort letters, statutory audits, attest services, consents and assistance with and review of documents filed with the Proxy Statement.SEC.
2      Audit-Related Fees include assurance and related services traditionally performed by PWC that are reasonably related to the performance of the audit or review of our financial statements and not reported under the “Audit Fee” heading.
3      Tax Fees include fees billed for professional services related to tax compliance and other tax services. For fiscal years 2021 and 2020, $128,623 and $169,707, respectively, of total Tax Fees was for tax compliance services.
4      All Other Fees for fiscal years 2021 and 2020 primarily related to access to on-line software tools.

45


PART IV
ITEM 15.
ITEM 15.EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
(a) The following Financial Statements and Financial Statement Schedule are included in Item 8 herein:of our Original Form 10-K:
1.Financial Statements:
1.Financial Statements:
Report of Independent Registered Public Accounting Firm
Consolidated Statements of (Loss) Income for the years ended September 30, 2021, 2020 2019 and 20182019
Consolidated Statements of Comprehensive (Loss) Income for the years ended September 30, 2021, 2020 2019 and 20182019
Consolidated Balance Sheets at September 30, 20202021 and 20192020
Consolidated Statements of Cash Flows for the years ended September 30, 2021, 2020 2019 and 20182019
Consolidated Statements of Changes in Stockholders'Stockholders’ Equity for the years ended September 30, 2021, 2020 2019 and 20182019
Notes to the Consolidated Financial Statements
2.Financial Statement Schedule: Schedule II – Valuation and Qualifying Accounts for the years ended September 30, 2021, 2020 2019 and 20182019
3.Exhibits - The following exhibits are filed as part of, or incorporated by reference into, this Report on Form 10-K:10-K/A:

ITEM 16.
46

ITEM 16.
FORM 10-K SUMMARY
None.



Exhibit
No.
Description
Filed as an exhibit to, and incorporated by reference from
Exhibit No.FormDescriptionFormFile No.Filing Date
2.18-K000-30205September 28, 2015
2.28-K000-30205August 17, 2018
3.28-K000-30205October 1, 2020
3.38-K000-30205October 1, 2020
4.110-K000-30205November 17, 2020
4.210-K000-30205November 17, 2020
10.110-K000-30205November 17, 2020
10.210-K000-30205November 25, 2008
10.310-Q000-30205May 6, 2021
10.410-Q10-K000-30205February 8, 2013November 12, 2021
10.510-K000-30205November 25, 2008
84

10.610-K000-30205November 17, 2020
10.710-K000-30205November 25, 2008
10.810-K000-30205November 17, 2020
10.910-Q000-30205February 8, 2013
10.1010-Q000-30205February 8, 2013
10.1110-Q000-30205August 8, 2012
10.1210.1110-Q000-30205August 8, 2012
10.1310-Q000-30205February 6, 2015
10.14
10.1510-Q000-30205February 8, 2016
10.1610.1210-Q000-30205February 7, 2018
10.1710.1310-Q000-30205February 7, 2018
10.1810.1410-Q000-30205February 7, 2018
10.1910.1510-K000-30205November 12, 2021

10.1610-Q000-30205May 6, 2021
10.1710-Q000-30205May 6, 2021
10.1810-Q000-30205August 5, 2021
10.1910-K000-30205November 12, 2021
10.2010-Q000-30205February 6, 2015
10.2110-K000-30205November 12, 2021
10.228-K10-Q000-30205November 15, 2018February 4, 2021
10.2010.238-K000-30205December 24, 2019
21.110.248-K000-30205July 6, 2021
21.110-K000-30205November 12, 2021
23.110-K000-30205November 12, 2021
24.110-K000-30205November 12, 2021
31.1
31.2
32.110-K000-30205November 12, 2021
101.INSXBRL Instance Document - The Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHXBRL Taxonomy Extension Schema
101.CALXBRL Taxonomy Extension Calculation Linkbase
85

101.DEFXBRL Taxonomy Extension Definition Linkbase
101.LABXBRL Taxonomy Extension Label Linkbase
101.PREXBRL Taxonomy Extension Presentation Linkbase
104Cover Page Interactive Data File - The Cover Page Interactive Data File does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

*Management contract, or compensatory plan or arrangement.
**Substantially similar change in control severance protection agreements have been entered into with David H. Li, Scott D. Beamer, H. Carol Bernstein, Eleanor K. Thorp, Jeffrey M. Dysard, Colleen E. Mumford, Jeanette A. Press, and Daniel D. Woodland, with differences only in the amount of payments and benefits to be received by such persons.
***Substantially similar deposit share agreements have been entered into with Scott D. Beamer, Jeffrey M. Dysard, David H. Li, Jeanette A. Press, and Eleanor K. Thorp with differences only in the amount of initial deposit made and deposit shares purchased by such persons.
These documents are being re-filed solely to reflect the Company’s name change.


49


SIGNATURESINDEX
SIGNATURES
Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized:
CMC MATERIALS, INC.
Date: November 17, 2020January 19, 2022/s/ DAVID H. LI
David H. Li
President and Chief Executive Officer
[Principal Executive Officer]
Date: November 17, 2020/s/ SCOTT D BEAMER
Scott D. Beamer
Vice President and Chief Financial Officer
[Principal Financial Officer]
Date: November 17, 2020/s/ JEANETTE A. PRESS
Jeanette A. Press
Corporate Controller
[Principal Accounting Officer]
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated:
Date: November 17, 2020/s/ WILLIAM P. NOGLOWS*
William P. Noglows
Chairman of the Board
[Director]
Date: November 17, 2020/s/ DAVID H. LI
David H. Li
President and Chief Executive Officer
[Director]
Date: November 17, 2020/s/ RICHARD S. HILL*
Richard S. Hill
[Director]
Date: November 17, 2020/s/ BARBARA A. KLEIN*
Barbara A. Klein
[Director]
Date: November 17, 2020/s/ PAUL J. REILLY*
Paul J. Reilly
[Director]
Date: November 17, 2020/s/ SUSAN M. WHITNEY*
Susan M. Whitney
[Director]
Date: November 17, 2020/s/ GEOFFREY WILD*
Geoffrey Wild
[Director]
*by H. Carol Bernstein as Attorney-in-fact pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended.
8750